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Abstract
The enteroinvasive bacterium Shigella flexneri uses multiple secreted effector pro-
teins to downregulate interleukin-8 (IL-8) expression in infected epithelial cells.
Nevertheless, massive IL-8 secretion is observed in shigellosis. In this thesis, a
novel host mechanism of cell-cell communication that circumvents the effectors and
strongly amplifies IL-8 expression during bacterial infection is reported. By moni-
toring proinflammatory signals at the single-cell level during Shigella infection, we
found that activation of the transcription factor NF-κB and the MAP kinases JNK,
ERK and p38 rapidly propagates from infected to uninfected adjacent cells leading
to massive IL-8 production by uninfected bystander cells. Bystander IL-8 produc-
tion was also observed during Listeria monocytogenes and Salmonella typhimurium
infection. It was reproduced by microinjection of the Nod1 ligand L-Ala-D-γ-Glu-
meso-diaminopimelic acid and blocked by gap junction inhibitors. Thus, a novel
gap junction-mediated mechanism of cell-cell communication was identified that
broadly amplifies innate immunity against bacterial infection by rapidly spreading
proinflammatory signals to yet uninfected cells.
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Chapter I
Introduction
-14- I. Introduction
1 Preface
Amongst the top ten causes of death worldwide, infectious diseases are prominently
represented. In developing countries, lower respiratory infections, diarrhoeal dis-
eases and HIV are the three major causes for death (Fact Sheet N◦310, WHO,
2008). At the same time, multi-drug resistances present a severe and progressive
problem worldwide. However, the increasing need for new antibiotics is in sharp
contrast to the development of such drugs, which has been decreasing since the
1980s and has almost run dry with as little as four new classes of antibiotics ap-
proved during the last ten years1. The efficient treatment of infectious diseases is
therefore likely to be considered one of the major challenges in global health of the
coming decades.
The low number of newly available antibiotics in combination with the alarmingly
fast emergence of resistances suggests that common principles of antibiotic drug
development need to be revised and new strategies have to be exploited. Besides
the ’classical’ screens for new compounds and the chemical modification of known
antibiotics, more effort has been expended in screening natural compounds. The
search for drugs, which can support or even potentiate the activity of antibiotics
as well holds promise2. Still, most of these efforts might result in therapeutics
that are rapidly challenged by microbial resistance mechanisms. It seems therefore
worth searching for drug targets that are not subject to rapid adaption by the
pathogen. Intensive research in the field of infection biology has revealed that
bacteria and viruses exploit various host factors to evade the immune system,
infect cells and replicate. These host factors, which include receptors and signaling
proteins, but also metabolites, represent prime targets for new antimicrobials. Yet,
the host pathogen interaction is not a simple interplay between single components,
but rather has to be understood as the integration of two complex networks. The
identification of new drug targets therefore requires a system-level understanding
of the host pathogen interaction. The InfectX project* currently pursues such an
objective by identifying the host factors involved during cell invasion by various
bacterial and viral pathogens. Chapter III of this thesis summarizes the results
obtained so far for one of these pathogens, Shigella flexneri.
Besides the search for new antibiotics, the development of vaccines to control in-
fectious diseases represents a main area of research. Vaccinations make use of the
strongest and most precise weapon against infectious diseases, our own immune sys-
tem. The importance of the immune system during infectious diseases is certainly
not surprising, but is highlighted by the fact that bacterial and viral pathogens
have developed a plethora of mechanisms that downmodulate or shape the host’s
immune response. Although these mechanisms often form the basis for a successful
*The InfectX project is funded by the Swiss Initiative in Systems Biology. More information
about InfectX is available on the project homepage:
http://www.systemsx.ch/projects/systemsxch-projects/research-technology-and-development-
projects-rtd/infectx/
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infection, they might as well point out the pathogens Achilles’ heel. Eventually,
the components of the immune system targeted by the pathogen are likely to be
the most effective in fighting the infection. Specifically enhancing and shaping the
immune response during infection might therefore represent an elegant way of lim-
iting the disease, similarly to how vaccines allow for a rapid response by priming
the adaptive immune system. An example for such an approach is the enhancement
of the antimicrobial peptide production by the intestinal epithelium3.
Nonetheless, the precise mechanisms of how the various immune responses are
controlled remain only partially understood. Intensive research during the past
20 years has unveiled the molecular mechanisms of pathogen recognition and the
signaling cascades that are activated during infection. Nevertheless, a lot more is to
be learned, for example how the fine balance between tolerance of commensals and
detection of pathogens is achieved. A more complete understanding of the molecular
mechanisms that control the immune system will not only have an impact on the
field of infection biology, but also provide new insights into inflammatory disorders,
autoimmune diseases and cancer. Chapter II of the present work focuses on the
topic of inflammatory responses during bacterial infections and demonstrates that
uninfected cells also participate in the initiation of immune responses.
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2 Pathogen recognition by the innate immune sys-
tem
Recognition of invading pathogens is the essential first step for initializing an im-
mune response. It is therefore not surprising that evolution has brought forth sev-
eral immune surveillance mechanisms. Central to these systems is the recognition of
pathogen-associated molecular patterns (PAMPs). PAMPs are signature molecules,
which are essential for pathogen survival and virulence, and are broadly shared
among microorganisms. Immune cells, as well as epithelial cells, express several
pathogen recognition receptors (PRRs) that can sense the presence of PAMPs.
Intensive research over the past three decades has led to the discovery of entire
families of PRRs that allow the detection of various PAMPs associated with bac-
teria and viruses, as well as fungi and parasites4. PRRs are generally classified into
4 families: Toll-like receptors (TLRs), C-type lectin receptors (CLRs), which are
transmembrane receptors, and the soluble Nod-like receptors (NLRs) and RIG-I-
like receptors (RLRs)4,5. An overview of PAMPs and their corresponding PRRs is
presented in Table I.1.
Binding of PAMPs by the corresponding PRRs leads to downstream signaling
events, which will mount an inflammatory response. Depending on the PRR that
gets activated, a pathogen-specific immune response will be triggered that facil-
itates the eradication of the invader. Important mediators of the inflammatory
response are cytokines, chemokines and type-I interferons, which get expressed
and secreted upon pathogen recognition. These soluble mediators activate cells of
the innate immune system and attract them to the site of infection6,7. Addition-
ally, they contribute to the initiation of the second line of defense, the adaptive
immune system8. Finally, certain PRRs also initiate cell death pathways, leading
for example to pyroptosis in infected macrophages9.
In the following sections, pathogen recognition by the different PRRs will be dis-
cussed in more detail. Furthermore, the intracellular signaling cascades, which are
activated upon pathogen recognition, will be presented.
2.1 Pathogen recognition receptors
2.1.1 Toll-like receptors
TLRs were the first PRRs to be identified. In Drosophila, the Toll protein was found
to play an important role in the antifungal response10. Shortly later, a human ho-
mologue was found that could induce both NF-κB activation and the production
of cytokines11. To date, 10 functional TLRs (TLR1-10) have been identified in
humans covering a wide range of PAMPs5. TLR4, for instance, is able to detect
bacterial lipopolysaccharide (LPS), TLR5 binds flagellin and TLR9 is able to rec-
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Table I.1 Detection of PAMPs by their corresponding PRR.
Species PAMPs PRRs
Bacteria Lipoproteins TLR2/1
LPS TLR4
Flagellin TLR5, NLRC4, NAIP
Lipoteichoic acid TLR2/6
RNA TLR7, NLRP3
DNA TLR9, AIM2
Peptidoglycan NOD1, NOD2, NLRP1
T3SS basal body rod component NLRC4
Viruses Structural protein TLR2, TLR4
RNA TLR3, TLR7, TLR8, RIG-I, MDA5,
NOD2, NLRP3
DNA TLR9, AIM2, DAI, IFI16
Fungus Zymosan TLR2/6, Dectin-1
β-glucan TLR2/6, Dectin-1, NLRP3
Mannan TLR2, TLR4
DNA TLR9
RNA TLR7
Parasites tGPI-mutin (Trypanosoma) TLR2
Glycoinositolphospholipids (Try-
panosoma)
TLR4
DNA TLR9
Hemozoin (Plasmodium) TLR9, NLRP3
Profilin-like molecule (Toxoplasma
gondii)
TLR11
Adapted with modifications from Kawai and Akira5 and Kumar et al.4.
ognize DNA. A complete overview of PAMPs recognized by TLRs can be found in
Table I.1.
All members of the TLR family are type I transmembrane proteins that have an
extracellular domain containing leucine-rich repeats (LRRs). The LRR domain is
responsible for the detection of the corresponding PAMP. The cytosolic domain
has high similarity to the cytoplasmic domain of the human IL-1 receptor and is
therefore also called Toll-IL-1 receptor (TIR) domain12,13. Upon ligand binding,
TLRs are known to form homo- and heterodimers (in the case of TLR2/1 and
TLR2/6). Some TLRs additionally require co-receptors for efficient ligand binding.
TLR4, for example, interacts with MD-2 for effective LPS recognition12,14.
Localization and signaling of Toll-like receptors
Although all TLR family members are transmembrane proteins, they obtain dis-
tinct localizations within the cell. The localization reflects primarily the availabil-
ity of their ligands. TLR2/1, TLR2/6, TLR4 and TLR5, which are all located in
the plasma membrane, detect ligands that are released from the cell surface of
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pathogens (e.g. LPS or flagellin). TLR3, TLR7, TLR8 and TLR9 are targeted to
intracellular vesicles where they detect nucleic acids that originate from invading
viruses or from degradation of bacteria within lysosomes. The localization to in-
tracellular vesicles furthermore prevents the detection of "self" RNA or DNA. For
intracellular TLRs, the correct localization is crucial for becoming fully functional5.
UNC93B1, a membrane protein found in the endoplasmatic reticulum (ER), was
shown to interact with TLR3, TLR7 and TLR9 to control their trafficking from
the ER to endosomes. Mutations in UNC93B1, which interfere with this function,
abrogated cytokine production in response to TLR3, TLR7 and TLR9 ligands15,16.
Recently, Ewald and colleagues have demonstrated that TLRs get processed by
cathepsins and asparagine endopeptidases once reaching endosomal compartments.
This processing is essential for generating functional receptors and emphasizes the
importance of correct TLR localization17. A schematic representation of TLR lo-
calization within cells is presented in Figure I.1.
Upon ligand binding, TLRs initiate downstream signaling events that lead to a
pathogen-specific inflammatory response. These signaling cascades are triggered
by recruitment of a single or several adaptor proteins via TIR-TIR domain in-
teractions 18. Most TLRs (except for TLR3) recruit the MyD88 adaptor protein.
MyD88, in turn, recruits IRAKs, TRAF6 and the TAK1 complex. The TAK1
complex consists of the MAP3 kinase TAK1, TAB1 and TAB2. Upon stimulation,
TAK1 will lead to the activation of the IKK complex, which consists of IKKα,
IKKβ and NEMO. IKKβ, in turn, will phosphorylate IκBα, the inhibitor of tran-
scription factor NF-κB. Upon phosphorylation, IκBα is targeted for proteasomal
degradation and NF-κB will translocate to the nucleus. Additionally, the IKK com-
plex contributes to the activation of MAP kinases p38, JNK and ERK. In concert,
NF-κB and the MAP kinases lead to the production and secretion of proinflam-
matory cytokines5,19,20. Alternatively, MyD88 can activate interferon regulatory
factors (IRFs) like IRF3 and IRF7. These transcription factors lead to the expres-
sion of type I interferons. A similar pathway is initiated by the adaptor protein
TRIF that becomes recruited to TLR3 and TLR4. TRIF activates IRF3 via TBK1
and IKK. The receptor activated thus defines the kinds of cytokines that get pro-
duced, ensuring a pathogen-specific inflammatory response5,19,20. The downstream
signaling cascades of TLRs are summarized in Figure I.1.
Role of Toll-like receptors during bacterial infections
Bacterial infections can be detected by several TLRs. TLR4 binds LPS released
from the surface of Gram-negative bacteria21. Heterodimers formed by TLR2 and
TLR1 can detect lipopeptides from Gram-negative bacteria, while TLR2 and TLR6
heterodimers recognize lipopeptides released from Gram-positive bacteria22. Flag-
ellin, the ligand for TLR5, is a major component of bacterial flagella23. TLR7 was
reported to bind RNA of certain bacterial pathogens24 and the ligand for TLR9
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Figure I.1 Localization, trafficking and signaling of Toll-like receptors. TLR5, TLR2/1
and TLR2/6 are located in the plasma membrane. Upon ligand binding, they activate the canon-
ical NF-κB signaling cascade by interacting with the adaptor proteins MyD88 and TIRAP and
by recruiting IRAKs and TRAF6. TLR2 homodimers are found in endosomes where they induce
the production of type I interferons via IRF3 and IRF7 in response to viral infections. TLR4
localizes to the plasma membrane where it activates the canonical NF-κB pathway via TIRAP
and MyD88. Additionally, TLR4 is transported to phagosomes that contain bacteria and are pos-
itive for Rab11a. There, TLR4 interacts with the adaptor proteins TRAM and TRIF leading to
the activation of IRF3 and NF-κB. For the production of inflammatory cytokines, both the early
NF-κB activation via MyD88 and the late NF-κB activation via TRIF are required. TLR3, TLR7
and TLR9 are mainly targeted to the ER during the steady state. UNC93b1 and PRAT4A control
the trafficking of these receptors to endosomal compartments where they can engage with their
ligands. TLR3 interacts with TRIF activating both NF-κB and IRF3. TLR7 and TLR9 located in
endosomes lead to the production of inflammatory cytokines via the canonical NF-κB pathway. In
a process controlled by AP3, TLR7 and TLR9 can be transported to lysosome-related organelles
(LRO) where they lead to the activation of IRF7. This signaling cascade is mediated by IRAK1,
TRAF6, TRAF3 and IKKα and is facilitated by Viperin expressed in lipid bodies. As receptors
and adaptor proteins are differentially expressed in different cell types, not all signaling cascades
are active in a specific cell type. Cell types that are able to produce cytokines in response to a
specific TLR stimulation are indicated in brackets: LPDC, lamina propria DC; MP, macrophage;
cDC, conventional DC; iMO, inflammatory monocytes; pDC, plasmacytoid DC. Reproduced from
Kawai and Akira5.
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was found to be unmethylated deoxycytidylate-phosphate-deoxyguanylate (CpG)
DNA motifs mainly present in bacterial and viral DNA25. Finally, Tlr11 has been
associated with the detection of uropathogenic bacteria in mice, but the molecule
recognized by the receptor has not yet been identified26. Detection of PAMPs from
bacteria by TLRs leads to the activation of NF-κB and MAP kinases via the TAK1
complex. NF-κB and the MAP kinases JNK, ERK and p38 in turn contribute
cooperatively to the expression of proinflammatory cytokines27,28. Alternatively,
detection of DNA and RNA from bacteria, by TLR9 and TLR7 respectively, was
shown to lead to the production of type I interferons. This signaling cascade is
dependent on the transcription factor IRF724.
The importance of bacterial recognition by TLRs is emphasized by several experi-
ments that found a more severe course of disease when components of the signaling
cascade were missing. Tlr4 -deficient mice, for example, are more susceptible to S.
typhimurium infections29. In case of infections by the Gram-positive bacterium S.
aureus, Tlr2 was found to be crucial for survival in mice. MyD88 knockout mice
were shown to be even more susceptible to S. aureus infections, suggesting that
the combined action of several TLRs is required for efficient protection against the
pathogen30. Mutations that impair TLR signaling could also be linked to immun-
odeficiency in humans. Autosomal-recessive mutations in IRAK4 or MyD88 predis-
pose patients to recurrent life-threatening bacterial infections during childhood31,32.
Moreover, polymorphisms in TLR4 are associated with an increased risk of Gram-
negative infections and sepsis, asperigillosis and severe malaria33. Taken together,
intensive research over the past 15 years has established pathogen recognition by
TLRs as a central system for initiation and regulation of immune responses during
infectious diseases.
2.1.2 Nod-like receptors
Nod-like receptors (NLRs) are soluble proteins, which are located in the cell cy-
toplasm. They are mainly expressed in myeloid cell types, especially antigen-
presenting cells (APCs), but are also partially found in cells of the intestinal
epithelium34,35. Similar to TLRs, NLRs can detect pathogen-associated molecular
patterns (PAMPs) originating from bacteria, viruses, fungi and parasites36. De-
tection of PAMPs leads to self-oligomerization of the receptor and recruitment of
effector proteins. The effector proteins activate downstream signaling cascades that
overlap in part with the signaling downstream of TLRs and contribute to the ex-
pression of cytokines, type I interferons and antimicrobial peptides35,36. Some NLRs
are also able to detect stimuli, which are collectively termed danger-associated
molecular patterns (DAMPs). DAMPs originate from both exogenous and endoge-
nous sources (e.g. pore-forming toxins and uric acid, respectively). Upon ligand
binding, these NLRs, together with adaptor proteins, form multiprotein complexes
called inflammasomes. These signaling platforms process the inactive precursors of
cytokines by activating caspase-137.
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Figure I.2 Domain organization of the human Nod-like receptor (NLR) family. The hu-
man NLR family consists of 22 proteins that are grouped according to their N-terminal effector do-
mains: CARD domain containing NLR (NLRC) group or pyrin domain containing NLR (NLRP)
group. The proteins CIITA, NAIP and NLRX1 have a unique domain organization and are
therefore assigned to individual subfamilies: acidic domain containing NLR (NLRA), BIR do-
main containing NLR (NLRB) and no strong N-terminal homology NLR (NLRX), respectively.
Common to all proteins is a central nucleotide-binding domain (NBD) consisting of a NACHT and
NAD domain and a C-terminal leucine-rich repeat (LRR) domain. CARD, caspase recruitment
domain; PYD, pyrin domain; NAD, NACHT-associated domain; X, undefined domain; FIIND,
function-to-find domain; AD, acid transactivation domain; BIR, baculoviral inhibitory repeat.
Adapted with modifications from Werts et al.38 and according to naming standards defined by
Ting et al.39.
NLRs constitute a family of proteins sharing a domain architecture that is charac-
terized by a central nucleotide-binding domain (NBD) and a C-terminal leucine-rich
repeat (LRR) domain. The LRR domain, which is also found in TLRs, is respon-
sible for the recognition of PAMPs and DAMPs. Ligand binding by NLRs induces
a conformational change and self-oligomerization via the NBD domain. Additional
domains at the N-terminus allow for recruitment of downstream effector proteins
and are the basis for classification of the NLRs into 2 major subfamilies: Proteins
containing a caspase recruitment domain (CARD) (NLRC) and proteins containing
a pyrin domain (PYD) (NLRP)36,38. Protein names for NLRs used in this study
comply with the standard nomenclature introduced by Ting et al.39. An overview
over the domain organization of the human NLR protein family is presented in
Figure I.2.
The following paragraphs focus on the NLRs that have been described in detail over
the past decade: The Nod proteins and the NLRs being involved in the formation
of inflammasomes. A schematic illustration of NLR activation and signaling is
presented in Figure I.3.
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Nod1 and Nod2 receptors
The involvement of Nod receptors in innate immunity was first established when
Nod1 and Nod2 were found to be activators of NF-κB40–42. Shortly later, Girardin
and colleagues demonstrated that intracellular S. flexneri induce NF-κB and JNK
activation in a Nod1-dependent manner43. Initial reports speculated that Nod1
could be an intracellular sensor for LPS, which was rejected when both Nod1 and
Nod2 were found to recognize muropeptides originating from bacterial peptidogly-
can. Nod1 binds with high affinity peptidoglycan moieties containing the dipep-
tide γ-D-glutamyl-meso-diaminopimelic acid (iE-DAP)44,45. As iE-DAP is mainly
found in peptidoglycan from Gram-negative bacteria, Nod1 can be considered as
a specific sensor for Gram-negative pathogens. Nod2 was found to recognize the
muramyl dipeptide (MDP) MurNAc-L-Ala-D-isoGln, which is a common motif in
all bacterial peptidoglycans46,47. Nod1 and Nod2 therefore recognize the presence
of cytosolic bacteria, e.g. S. flexneri or L. monocytogenes, by binding peptido-
glycan moieties being shed from the bacterial surface44,48,49. Interestingly, several
reports have pointed out that Nod1 and Nod2 as well can be stimulated by bac-
teria residing in phagosomes or even outside of the cell. For example, H. pylori, a
non-invasive pathogen, delivers peptidoglycan moieties into the cytoplasm through
its type IV secretion system50. Additionally, cells are able to internalize muropep-
tides by clathrin-mediated endocytosis51,52 or through transporter proteins PepT1
and PepT2, which are located in the plasma membrane51,53,54. It has further been
proven that a fraction of Nod1 and Nod2 is associated with the plasma membrane
and can get recruited to sites of bacterial invasion55,56. Whether this localization
is essential for Nod1/2 signaling or might only facilitate an early recognition of
muropeptides is still a matter of debate.
Upon ligand binding, both Nod1 and Nod2 interact with the serine-threonine ki-
nase RIP2 via their CARD domain40,41,57,58. Furthermore, members of the IAP
protein family get recruited. Among these, cIAP1 and cIAP2 polyubiquitinate
RIP2, a modification that is required for downstream signaling59–61. RIP2 in turn
recruits TRAF6 and the TAK1 complex, that contributes to the activation of
the IKK complex40,41,57,62. The IKK complex phosphorylates IκBα, targeting it
for proteasomal degradation. In the absence of IκBα, NF-κB translocates to the
nucleus63. TAK1 represents a MAP3 kinase and hence contributes to the activation
of MAP kinases JNK, p38 and ERK, although the precise mechanism of activation
has not yet been described43,48,58,64. Together, JNK and p38 control the activ-
ity of the transcription factor AP-127, while p38 and ERK control the access of
chromatin to transcription factors (e.g. NF-κB or AP-1) via phosphorylation of
histone H328. The concerted action of NF-κB and MAP kinases induces a robust
inflammatory response resulting in the secretion of cytokines and chemokines (e.g.
IL-6, IL-8, CXCL1, CXCL2 and CCL265,66), as well as antimicrobial peptides (e.g.
β-defensins and PGRPs67). While antimicrobial peptides can directly contribute to
bacterial killing, secreted cytokines and chemokines will attract cells of the immune
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Figure I.3 Activation and signaling of Nod-like receptors. LEFT (A): Nod1 and Nod2
get activated by peptidoglycan moieties released from intracellular and extracellular bacteria.
iE-DAP, which is mainly present in Gram-negative bacteria, is recognized by Nod1, while Nod2
binds MDP, a common motif of all peptidoglycans. Upon ligand binding, Nod1 and Nod2 recruit
RIP2 that stimulates the activation of NF-κB and MAP kinases. Collectively, this leads to the
expression of cytokines, chemokines and antimicrobial peptides. Additionally, Nod1 and Nod2
were shown to recruit Atg16L to sites of bacterial phagocytosis thereby initiating autophagy.
Alternatively, Nod1 was reported to stimulate interferon-β expression in response to H. pylori
infections. Similarly, recognition of viral single-stranded RNA by Nod2 induces transcription of
type I interferons in a signaling cascade depending on the protein MAVS. The transcription of
type I interferons is mediated by IRF7 and IRF3.
RIGHT (B): Activation of NLRC4 or NLRP3 initiates the formation of inflammasomes. Recog-
nition of bacterial flagellin or components of the T3SS by NLRC4 induces pyroptosis, a form of
controlled cell death. At the same time, NLRC4 recruits ASC and caspase-1 to from the so-called
NLRC4 inflammasome that processes pro-IL-1β and pro-IL-18. NLRP3 is activated by microbial
PAMPs or by DAMPs (e.g. increased ROS concentration or lysosomal damage). Ligand binding
induces the formation of the NLRP3 inflammasome by recruiting ASC and caspase-1. The prote-
olytic activity of caspase-1 leads to the production and secretion of active IL-1β and IL-18. The
transcription of the cytokine precursors requires an initial signal delivered for instance by TLR
signaling. Reproduced from Elinav et al.36.
system that will help to limit and clear the infection. A schematic representation
of the downstream signaling cascades of Nod1 and Nod2 is presented in Figure I.4.
The spectrum of PAMPs recognized by Nod2 was recently extended when the
receptor was found to activate signaling in response to viral single-stranded RNA
(ssRNA). Interestingly, the recognition of ssRNA did lead to expression of type I
interferons, which is not observed when stimulating Nod2 with MDP. The signaling
pathway was further found to be independent of RIP2, but required the proteins
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MAVS and the transcription factor IRF368. Similarly, Nod1 was found to initiate
the production of interferon-β during H. pylori infection. In contrast to Nod2,
the signaling was dependent on RIP2 and additionally required TRAF3, IRF7
and ISGF369,70. Taken together, this indicates that Nod1/2 might have functions
beyond the recognition of peptidoglycan and that the receptors can induce a ligand-
specific response.
Several publications have also provided insight into the downregulation of Nod1
and Nod2 signaling. For example, the protein A20 has been shown to interfere with
Nod1/2-mediated NF-κB activation by de-ubiquitination of RIP271. Moreover, a
short isoform of Nod2 was found to act as a negative regulator for Nod2 signaling72.
Finally, Erbin, caspase-12 and MEKK4 were shown to act as negative regulators
by directly interacting with Nod2 or by disrupting the interaction between Nod2
and RIP273–75. More research is required to fully understand the mechanisms that
negatively regulate Nod1/2 signaling.
Recently, Nod1 and Nod2 have also been associated with the induction of au-
tophagy in response to S. typhimurium and S. flexneri infection. The receptors
were shown to recruit Atg16L to entry sites, thereby promoting the formation of
autophagosomes77,78. Strikingly, mutations in Nod2 and Atg16L that had previ-
ously been associated with Crohn’s disease, a chronic inflammatory disorder of the
intestine, were demonstrated to impair Nod2 induced autophagy78. At the same
time, Nod1 was proven to enhance systemic innate immunity through the recog-
nition of peptidoglycan, which is constantly released by the microbiota of the gut.
It is speculated that the constant detection of peptidoglycan by Nod1 primes neu-
trophils and facilitates a rapid innate immune response in case of an infection79.
Furthermore, derivatives of MDP and iE-DAP are known to act as adjuvants for
antigen-specific IgG production, which is attributed in part to a costimulatory ef-
fect in monocytes and dendritic cells80–82. This convincingly points out that Nod1/2
are also involved in the initiation of the adaptive immune response48,83. Notewor-
thy, Nod1 and Nod2 were both found to have additional functions independent
of their role in inflammation signaling. Nod1 was reported to negatively control
tumor growth in MCF-7 cells, while Nod2 promotes proliferation and survival of
colonic epithelial cells84,85.
In summary, Nod1 and Nod2 play a central role in the immune response during
bacterial infections. The association of Nod1/2 mutations and deficiency with both,
increased inflammation (e.g. in Crohn’s disease) and reduced immune responses
(e.g. infections in Nod1 deficient mice), further suggests that the receptors are key
players in the delicate regulation of intestinal inflammation.
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Figure I.4 Signaling pathways activated upon stimulation of Nod1 and Nod2. Recog-
nition of peptidoglycan moieties containing iE-DAP or MDP leads to oligomerization of Nod1
and Nod2, respectively. The activated receptors recruit the serine/threonine kinase RIP2, which
gets ubiquitinated by cIAP1 and cIAP2. This modification is required for the recruitment of the
TAK1 complex consisting of TAK1, TAB1 and TAB2. RIP2 further recruits the IKK complex,
consisting of NEMO, IKKα and IKKβ and promotes the ubiquitination of NEMO. Together with
the kinase activity of TAK1, this leads to the activation of the IKK complex that phosphory-
lates IκBα. Phosphorylated IκBα gets ubiquitinated and is targeted for proteasomal degradation,
allowing the previously bound transcription factor NF-κB to translocate to the nucleus. Addition-
ally, stimulation of Nod1 and Nod2 leads to the activation of the MAP kinase signaling pathway.
The precise mechanism of activation has not been described but is likely to involve TAK1, CARD9
and an unknown MAP2 kinase. Ultimately, the MAP kinases JNK, p38 and ERK get activated.
JNK and p38 control the activity of the transcription factor AP-1 thereby contributing to ex-
pression of proinflammatory genes. p38 and ERK induce changes in the chromatin structure
by phosphorylating histone H3 via MSK1 and MSK2. Several mechanisms have been described
that negatively control the downstream signaling cascades of Nod1 and Nod2. For example, A20
downregulates signaling by de-ubiquitination of RIP2. Adapted with modifications from Franchi
et al.76.
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The inflammasomes
Several Nod-like receptors have been reported to form higher molecular structures
upon stimulation by their corresponding ligands. Additional adaptor proteins as
well as caspase-1 get recruited to these complexes. Based on the proinflammatory
activity of caspase-1 and in analogy to the previously described apoptosome, these
signaling platforms were termed "inflammasomes"86. Up to date, four inflamma-
somes have been described. The NLRP1 inflammasome consists of NLRP1, the
adaptor protein ASC and caspase-1. In addition, caspase-5 is recruited. NLRP3
(also known as NALP3 or cryopyrin) forms the NLRP3 inflammasome together
with ASC and caspase-1. However, recent evidence has assigned an important role
to NLRC5 in the formation of the NLRP3 inflammasome87. The NLRC4 inflam-
masome consists of NLRC4 (also known as Ipaf), ASC and caspase-1, although
the requirement for ASC is a matter of debate. Finally, the protein AIM2, which
is not a member of the NLR protein family, was found to form an inflammasome
in conjunction with ASC and caspase-1. The precise mechanism of inflammasome
formation has not been described, but it is speculated that stimulation induces
CARD-CARD and PYD-PYD domain interactions between the NLRs, ASC and
caspase-136,37,76,88.
As for Nod1 and Nod2, the NLRs forming inflammasomes are believed to detect
molecular PAMPs and DAMPs via their LRR domain. NLRP1 senses muramyl
dipeptide from bacterial peptidoglycan as well as the anthrax lethal factor from
Bacillus anthracis lethal toxin89,90. The NLRC4 inflammasome forms upon detec-
tion of flagellin and conserved rod components of type III secretion systems91,92.
Recent evidence has indicated that the receptors detecting the stimuli might be
NAIP proteins. In mice it was demonstrated that Naip5 and Naip2 directly inter-
act with flagellin and T3SS rod components, respectively, thereby activating the
NLRC4 inflammasome. Similarly, NAIP, the sole NAIP family member in humans,
detects a T3SS rod component93. The NLRP3 inflammasome has been studied in-
tensively and is thought to be a general sensor for DAMPs. It is formed in response
to stimuli of bacterial or viral origin (e.g. pore-forming toxins), endogenous danger
signals (e.g. extracellular ATP) and crystalline particles37,94–96. Although many
stimuli have been described, the detailed mechanism of activation remains elusive.
The wide range of molecules detected by NLRP3 has implicated that the receptor
senses a common signal, which is induced by the various stimuli. In correspon-
dence with this hypothesis, the production of reactive oxygen species (ROS) is a
common feature to many NLRP3 stimuli96. On the other hand, there might be
additional, yet unknown receptors involved in the activation of the NLRP3 inflam-
masome, as has recently been exemplified by Davis and colleagues87. Finally, the
AIM2 inflammasome detects cytosolic double-stranded DNA (dsDNA), apparently
independent of its origin. AIM2 does not belong to the family of NLRs, but still
contains a PYD domain that allows for the recruitment of ASC. Instead of a LRR
domain, the recognition of dsDNA is mediated by a so-called HIN200 domain97,98.
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Common to all inflammasomes is the recruitment of caspase-1 in its inactive form
(also known as pro-caspase-1). The association of pro-caspase-1 with inflamma-
somes is likely to occur through CARD-CARD domain interactions and induces
its activation through autoproteolytic cleavage. Activated caspase-1 is released from
the inflammasome and forms oligomeric complexes. These complexes can convert
the cytokine precursors pro-IL-1β and pro-IL-18 into their active forms by prote-
olytic cleavage37,86. The availability of pro-IL-1β is additionally controlled at the
transcriptional level and requires the activation of NF-κB, for example through
TLR signaling. This assures that no excess of IL-1β is released, which would be
deleterious for the host. Secretion of mature IL-1β and IL-18 contributes to the
activation of the immune system. IL-1β is known as a potent inducer of endothe-
lial adhesion molecules and thus promotes the infiltration of the tissue by immune
cells. Additionally, it is well known as an inducer of fever. Mature IL-18 activates
NK cells and induces the production and secretion of interferon-γ99.
All four inflammasomes are activated in response to bacterial infections. The
NLRP1 inflammasome is associated with susceptibility to Bacillus anthracis in
mice. Macrophages expressing a certain allele of Nlrp1b are sensitive to anthrax
lethal toxin, resulting in caspase-1 dependent cell death89. Moreover, the NLRP1
inflammasome forms in response to MDP from bacterial peptidoglycan, suggesting
that it might act as a general sensor for bacteria100. So far, this could only be
confirmed in response to infection by Bacillus anthracis. Interestingly, the activa-
tion of the inflammasome requires the interaction of NLRP1 with Nod2101. The
NLRC4 inflammasome is associated with the recognition of Gram-negative bac-
teria expressing a type III or type IV secretion system (T3SS/T4SS). In case of
Salmonella and Legionella, NLRC4 activates caspase-1 in response to the bacterial
protein flagellin102,103. As the activation of the NLRC4 inflammasome is depen-
dent on functional secretion systems, it is currently hypothesized that flagellin
monomers might get translocated into the cytosol by the T3SS or T4SS103. Al-
though non-flagellated, the pathogen Shigella activates the NLRC4 inflammasome
as well. Indeed, NLRC4 detects the basal rod proteins of T3SSs (MxiI in the case
of Shigella) through a sequence motif that is found both in the T3SS rod proteins
and flagellin92. The NLRP3 inflammasome is activated in response to pore-forming
toxins that are produced by several pathogenic bacteria. For instance, Listeria
monocytogenes and Streptococcus pneumoniae activate the NLRP3 inflammasome
through Lysteriolysin O and Streptolysin O, respectively. This recognition seems
to be important in vivo, as Nlrp3 -/- mice show a delayed clearance of infection
in both cases94,104. NLRP3 inflammasome activation has further been reported in
response to S. aureus and M. tuberculosis infections94,105. Finally, the AIM2 in-
flammasome plays an important role in the detection of cytosolic bacteria, as well
as DNA viruses. Activation of caspase-1 through the AIM2 inflammasome was de-
tected upon vaccinia virus, Francisella tularensis and, partially, L. monocytogenes
infection106.
The central role of inflammasomes is emphasized by the fact that they have been
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associated with several inflammatory disorders107. Nlrp3 -/- mice were, for exam-
ple, found to be more susceptible to dextran sodium sulfate induced colitis108. In
humans, NLRP3 has a protective function against intestinal inflammation, as mu-
tations that reduced the NLRP3 expression level were strongly associated with
the risk of Crohn’s disease109. The NLRP3 inflammasome plays a crucial role in
gout and type II diabetes by contributing to constant secretion of IL-1β95,110. This
finding had an astonishing impact on the clinics, as the administration of an IL-1
receptor antagonist (anakinra) significantly improved glycemia and β cell secretory
functions in type II diabetes patients111. Finally, variants of NLRP1 have been as-
sociated with the autoimmune diseases vitiligo (destruction of melanocytes in the
skin) and Addison’s disease (destruction of the adrenal cortex)112,113.
2.2 Pathogen recognition and inflammation signaling during
S. flexneri infection
Tissue-resident macrophages, which are associated to M cells, are the first cells to
encounter invading Shigella in the submucosal space. The presence of S. flexneri
activates TLR signaling in macrophages. TLR2 was reported to detect a 34 kD
outer membrane protein of Shigella spp.. This leads to the activation of NF-κB
and MAP kinase p38 that promote cytokine and chemokine production114. The
heterodimer TLR2/6 was further reported to detect a porin from S. dysente-
riae. Again, ligand binding induces NF-κB activation and promotes secretion of
cytokines115. LPS from Shigella can also activate TLR4 signaling. Interestingly,
LPS from S. flexneri leads to a lower activation of NF-κB and reduced cytokine
release when compared to LPS from non-pathogenic E. coli. This can be attributed
to additional acetylation of lipid A in the case of Shigella116.
Although macrophages can efficiently phagocytose Shigella, they fail to degrade
the bacteria and instead undergo pyroptosis (see also section 4.1.2)117,118. The
induction of pyroptosis in macrophages is independent of TLR signaling and instead
requires the Nod-like receptor NLRC4 (also known as Ipaf). Miao and colleagues
could show that NLRC4 does detect the protein MxiI, which is a basal body rod
component of the T3SS. Recognition of MxiI leads to the assembly of the NLRC4
inflammasome, activation of caspase-1 and the massive release of IL-1β and IL-18,
a hallmark of pyroptosis92,118.
The cytoplasm of enterocytes represents the main replicative niche for Shigella.
The pathogen is able to trigger its uptake into enterocytes and escapes the phago-
cytic vacuole to reach the cytoplasm (refer to section 4.1.3 for more details). Al-
though enterocytes are of non-myeloid origin, they represent an integral part of
the innate immune system. They act as sentinels for intestinal infections and can
activate the immune system by secreting cytokines. In case of Shigella, the pres-
ence of intracellular bacteria is sensed through the pathogen recognition receptor
Nod1, which detects peptidoglycan moieties shed on the bacterial surface43,44. Ad-
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Table I.2 Cytokines and chemokines upregulated during S. flexneri infection.
Gene Fold increasea
Interleukin-8 304.79
CXCL1 133.74
CCL20 38.67
CXCL2 13.17
TNF-alpha inducible protein A20 4.23
CXCL3 3.12
TNF-α 3.06
TNF-alpha inducible protein B94 1.66
GM-CSF 33.24/12.64
IEX-1 1.88
a Comparing cells incubated with invasive S. flexneri (M90T) and
uninfected cells. Adapted with modifications from Pédron et al.119.
ditionally, GEF-H1 senses the presence of certain Shigella effector proteins that
get injected into the cell by the type III secretion system (T3SS) of the bacterium
(for more details on the T3SS and effector proteins refer to section 3.2). While
the mechanism, by which GEF-H1 detects effector proteins, remains currently un-
known, GEF-H1 was also reported to be involved in Nod1-mediated recognition of
peptidoglycan120.
Pathogen recognition by Nod1 induces the activation of the transcription factor
NF-κB and the MAP kinases JNK, p38 and ERK43,121,122. JNK and p38 regu-
late the activity of the transcription factor AP-127. At the same time, p38 and
ERK induce changes in the chromatin structure by phosphorylating histone H3
via the kinases MSK1 and MSK2. These rearrangements are believed to mark
promoters of inflammatory genes for enhanced recruitment of transcription fac-
tors like NF-κB28. Collectively, these signaling events initiate an inflammatory
response. Transcriptome analysis of epithelial cells revealed that several genes en-
coding for cytokines and chemokines get transcribed upon S. flexneri infection
(Table I.2). Remarkebly, the transcription of the chemokine IL-8 was upregulated
more than 300-fold119. This was in line with the previous finding of IL-8 playing a
central role during shigellosis by recruiting polymorphonuclear neutrophils to sites
of infection123. Additionally, enterocytes also produce antimicrobial peptides like
β-defensins in response to infection124.
Notably, S. flexneri is downmodulating the inflammatory response in infected cells
by injecting several effector proteins through its T3SS. For instance, the effector
OspF interferes with IL-8 expression by dephosphorylation of p38 and ERK125,126.
An overview of the different mechanisms applied by Shigella to control the host’s
inflammatory response is presented in section 4.2.2. The observation of a strong in-
flammatory response during S. flexneri infection – despite the immunosuppressive
activity of effector proteins – represents a steady matter of debate in the field. It is
hypothesized that the bacterial effector proteins only partially block inflammation
signaling. Alternatively, the host cell might be able to evade or compensate the ef-
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fect of effector proteins. Chapter II describes a novel mechanism, by which infected
cells can propagate proinflammatory signals to uninfected neighboring cells. This
cell-cell communication significantly amplifies the immune response and allows the
host cell to circumvent the inhibitory effect of bacterial effectors.
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3 Shigella – the causative agent of bacillary dysen-
tery
The Bacillus dysenterie, later identified as Shigella dysenteriae 1, was discovered
by Kiyoshi Shiga127. Shiga worked at the Institute for Infectious Diseases in Tokyo
where he isolated the etiological agent of dysentery – a dreaded disease with period-
ical outbreaks in Japan during the late 19th century – from patients. He accurately
described the bacillus as a gram-negative bacterium of which subcultures would
cause diarrhea when fed to dogs. He first published his findings in 1897 and an
article in German was published one year later128,129. In honor of his discovery, the
genus was later named "Shigella"127.
3.1 Shigellosis
More than 100 years after Shiga’s discovery, the bacillary dysentery – also called
shigellosis – caused by Shigella spp. still accounts for an estimated 5-15% of all
diarrheal episodes worldwide. It’s prevalent in developing countries and mainly
affects children under the age of 5 years. Although the disease can be efficently
treated with antibiotics and proper rehydration in most cases, 1.1 million fatal
incidents per year are attributed to Shigella infections. The genus Shigella consists
of 4 species: S. dysenteriae, S. flexneri, S. boydii and S. sonnei. S. flexneri and
S. sonnei are endemic in several countries of Asia, Africa and South America and
account for a majority of the infections. S. dysenteriae is responsible for epidemic
outbreaks and displays the most severe course of disease with significantly increased
mortality130.
Shigella spp. are transmitted via the feco-oral route by ingestion of contaminated
water or food. The pathogen proves to be highly contagious as small inocula of only
10-100 microorganisms can cause disease131. Infected patients suffer from abdom-
inal cramps, bloody and mucous diarrhea, fever and dehydration. In most cases,
proper rehydration will resolve the disease within a week. In young children and in
severe cases, antibiotics should be administered in combination with a nutritional
therapy to avoid malnutrition. As for many other pathogenic bacteria, Shigella
has acquired resistance towards many antibiotics. Especially in endemic regions,
strains have been described that are resistant towards antibiotics commonly used
to treat the disease including ciprofloxacin, ceftriaxone and azithromycin132.
The increasing number of antibiotic-resistant strains has emphasized the require-
ment for an efficient vaccine against Shigella. The major challenge in vaccine de-
velopment for shigellosis is the diversity of the Shigella genus. The majority of
incidents is caused by the three different species S. flexneri, S. dysenteriae and
S. sonnei. While the latter two are represented by only one or a predominant
serotype, 14 serotypes of S. flexneri are regularly isolated during disease. Kiyoshi
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Shiga was actually the first who had tested a vaccine by injecting himself with
a heat-killed whole-cell preparation127. Unfortunately, his approach showed little
success, an outcome that was shared by many vaccine trials up to now. Current vac-
cine trials have mainly focused on polysaccharide and synthetic conjugates, as well
as invasion complex-based and live attenuated preparations. Although significant
advances have been made in the field of Shigella vaccines, it seems that a broad-
spectrum vaccine that would protect from shigellosis in endemic areas around the
world is not within reach in the near future132,133.
3.2 Determinants of Shigella virulence
Shigella spp. are known to have evolved from non-pathogenic E. coli through the
acquisition of a large virulence plasmid and several chromosomal pathogenicity
islands (PAIs). The sequence of the chromosome as well as the virulence plasmid is
available for several Shigella strains and has revealed that the divergence from E.
coli K-12 is as little as 1.5%. In total, 5 PAIs have been identified on the Shigella
chromosome that were acquired at different times during evolution. Only for some
of the genes, located within pathogenicity islands, a virulence-associated function
could be assigned. Table I.3 summarizes the known virulence factors, which are
located within PAIs on the Shigella chromosome.
Besides the chromosomal virulence factors, invasive Shigella possess a virulence
plasmid that is approximately 200 kb in size. pWR100, the virulence plasmid of S.
flexneri strain M90T (serotype 5), is made up for one third by insertion sequence
elements. Approximately 100 open reading frames were identified, most of which
could be assigned to previously identified genes134. Of particular interest is the 31
kb gene cluster, which encodes the structural components of the Mxi-Spa type III
secretion system (T3SS), translocator and effector proteins, as well as chaperones
and regulatory proteins. As this part of the virulence plasmid is necessary and suf-
ficient for Shigella invasion of cells, it is referred to as "entry region". An overview
of the genetic organization within the "entry region" is presented in Figure I.5
(bottom).
The expression of the T3SS and its substrates is under tight control of a regula-
tory system that senses environmental stimuli. The major activating factor is a
temperature shift to 37◦C, which is indicative for uptake into the host organism136.
Osmolarity, pH and iron concentration are additional factors that control virulence
plasmid gene expression135. While the systems sensing the environmental cues are
encoded on the chromosome, the main transcriptional activator, VirF, is encoded
on the virulence plasmid itself. VirF expression is induced at 37◦C and will acti-
vate VirB, a second essential regulator136. VirB controls the expression of the genes
located in the "entry region" and a first set of T3SS substrates (also called "early
effectors"), including the translocators IpaB and IpaC137. Within the entry region,
a third transcriptional regulator, MxiE, is encoded. MxiE controls the expression
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Figure I.5 The Mxi-Spa type III secretion system and the "entry region" gene locus.
TOP: Schematic representation of the T3SS. The T3SS consists of a basal body that spans
the inner membrane, the periplasm and the outer membrane. The basal body is formed by the
oligomerization of MxiG, MxiJ, MxiD and MxiM. Spa33 forms the so-called C ring, which is
located in the cytoplasm and associated to the basal body. The C ring serves as a platform for
several proteins that energize secretion (ATPase Spa47), assemble the needle structure (MxiN,
MxiK) and control needle length and substrate-specificity (Spa32). The needle extends from the
basal body to the bacterial surface. At the tip of the needle IpaB and IpaC are exposed, which
will insert into the membrane upon contact with the host cell allowing direct translocation of
effector proteins.
BOTTOM: Genetic organization of the "entry region" located on the virulence plasmid pWR100.
The genes of the "entry region" encode for the structural components of the Mxi-Spa type III
secretion system (T3SS), translocator and effector proteins, as well as chaperones and regulatory
proteins. Genes are colored according to their corresponding function. Adapted with modifications
from Schroeder and Hilbi135.
of a second set of T3SS substrates (known as "late effectors"). Although MxiE is
expressed upon VirB activation, its target genes will only get transcribed once the
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early effectors have been secreted. This is achieved by the early effector OspD1 and
its chaperone Spa15 that bind MxiE and repress its transcriptional activity137,138.
The regulatory network allows the bacterium to temporally control the expression
and secretion of effector proteins. Thus, the bacterium is initially equipped with a
T3SS and a first set of effectors that allow host cell invasion. Only upon successful
invasion, the bacterium will express and secrete the late effectors.
The major part of the "entry region" consists of genes named membrane presen-
tation of Ipa antigens (mxi) and surface presentation of Ipa antigens (spa). The
proteins encoded by the mxi -spa locus are components of the T3SS, a molecular
syringe-like structure that allows Shigella to translocate proteins into mammalian
cells139,140. The Mxi-Spa T3SS consists of a basal body, which spans the bacterial
inner membrane (IM), the periplasm and the outer membrane (OM). The basal
body is formed by oligomerization of 4 proteins (MxiG, MxiJ, MxiD and MxiM)
that anchor the complex in the IM and OM141–143. Associated with the IM ring of
the basal body is Spa33, which forms the so-called C ring144. The C ring serves as a
platform for several proteins that energize secretion (ATPase Spa47), assemble the
needle structure (MxiN, MxiK) and control needle length and substrate-specificity
(Spa32)145–148. The needle structure itself is build by the subunits MxiI and MxiH.
The needle is 45-60 nm in length and contains a central channel having a diameter
of 2-3 nm143. Secretion of proteins through the narrow needle structure requires the
partial unfolding of the secreted proteins, which is mediated by proteins associated
to the C ring and energized by Spa47149. The translocator proteins IpaB, IpaC and
IpaD are exported to the tip of the needle. IpaD is believed to serve as a "plug"
only allowing secretion of IpaB and IpaC upon detection of a secretion signal (e.g.
host cell contact). Together, IpaB and IpaC form the translocator pore, which is
inserted into the host cell membrane in an IpgD-dependent manner139,150,151. Upon
successful insertion, the T3SS system is able to secrete effector proteins directly
into the host cell. A schematic representation of the T3SS is presented in Figure
I.5 (top).
In total, the virulence plasmid encodes approximately 25 T3SS substrates134. Ad-
ditionally, there are up to seven genes located on the chromosome that encode
effectors of the IpaH family152. Some of the T3SS effectors, especially the hy-
drophobic translocators IpaB and IpaC, require chaperones to prevent aggregation
or premature activation in the bacterial cytoplasm. Four chaperones (IpgA, IpgC,
IpgE and Spa15) are encoded within the "entry region"153. Some effector proteins
might further have the capacity of self-chaperoning, as was reported for IpaD154.
For some effectors, the biochemical activity, as well as their role during infection
has been described in detail (e.g. OspF). For others, little is known about their
activity upon secretion by the T3SS155,156. Table I.4 lists some T3SS effectors, their
function during Shigella infection and known homologues in other pathogenic bac-
teria. A detailed description of the functions of the various effectors during the
course of a Shigella infection is presented in section 4.1 and 4.2.
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Table I.3 Virulence factors encoded by chromosomal Shigella pathogenicity islands.
PAI Gene(s) Virulence function(s)
SHI-1 sigA Intestinal fluid accumulation, cytopathic toxin
pic Mucus permeabilization, serum resistance, hemagglutination
set1A, set1B Intestinal fluid accumulation, development of watery diarrhea
SHI-2 iucA-iucD, iutA Iron acquisition
shiD Colicin I and colicin V immunity
shiA Downregulation of inflammation by suppression of T-cell sig-
naling
SHI-3 iucA-iucD, iutA Iron acquisition (found only in S. boydii)
SHI-O gtrA, gtrB, gtrV Evasion of host immune response
SRL fecA-fecE, fecI, fecR Iron acquisition
tetA-tetD, tetR Tetracycline resistance
cat Chloramphenicol resistance
oxa-1 Ampicillin resistance
aadA1 Streptomycin resistance
Adapted with modifications from Schroeder and Hilbi135.
Table I.4 Activities of Shigella type III secretion system (T3SS) effectors.
T3SS effector Role in infection Selected homologues
IpaA Bacterial invasion Salmonella spp. SipA (also called SspA)
IpaB Macrophage apoptosis
and cell cycle arrest
Salmonella spp. SipB (also called SspB) and
Yersinia spp. YopB
IpaC Bacterial invasion Salmonella spp. SipC (also called SspC)
IpgB1 Bacterial invasion Salmonella spp. SifA and SifB; EHEC, EPEC
and C. rodentium Map; and EHEC EspM1/2
IpgB2 Unknown
IpgD Bacterial invasion and
host-cell survival
Salmonella spp. SopB (also called SigD)
VirA Bacterial invasion and
intracellular spreading
EHEC, EPEC and C. rodentium EspG and
EPEC EspG2 (also called Orf3)
IcsB Escape from autophagy Burkholderia spp. BopA
OspC1 Polymorphonuclear
transepithelial migra-
tion
Shigella OspC2, OspC3 and OspC4 and V.
parahaemolyticus OspC2
OspE2 Intercellular spreading Shigella OspE1; Salmonella spp. EspO1STYM;
and EHEC EspO1-1 and EspO1-2
OspF Suppression of innate
immune responses
Salmonella spp. SpvC; P. syringae HopAI1;
and C. violaceum VirA
OspG Suppression of innate
immune responses
Y. enterocolitica YE2447; C. rodentium NleH;
and EHEC NleH1-1 and NleH1-2
IpaH9.8 Suppression of innate
immune responses
Shigella IpaH4.5; Salmonella spp. SspH1,
SspH2 and SlrP; Y. pestis YP3416 and YP3418;
P. syringae PSPTO1492 and PSPTO4093; and
Rhizobium spp. Y4fR
IpaH7.8 Escape from endocytic
vacuoles of phagocyte
Chromosomal
IpaHs
Suppression of innate
immune responses
Adapted with modifications from Ogawa et al.155.
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4 Molecular mechanisms of Shigella pathogenesis
Upon ingestion, Shigella is passaged through the stomach and the small intestine
in order to reach the large intestine where an infection is established. Shigella is not
able to directly infect colonic enterocytes from the apical side157. To get access to
the submucosal space, the bacteria need to cross the epithelial lining by transcytosis
through microfold cells (M cells). Associated with M cells are resident macrophages
and dendritic cells, which readily phagocytose the invading bacteria158. Shigella is
able to lyse the phagocytic vacuole and escape into the cytoplasm of these cells159.
Infected macrophages very rapidly undergo pyroptosis, thereby releasing IL-1β
and IL-18, which will attract polymorphonuclear neutrophils (PMNs) and induce
immune activation via natural killer (NK) cells, respectively117,118.
When released from macrophages, Shigella becomes able to colonize enterocytes
through their basolateral pole. Upon contact with cell surface receptors, Shigella
translocates several effector proteins into the host cell using its T3SS. A subset
of these effectors (IpaA, IpaB, IpaC, IpaD, IpgB1, IpgB2, IpgD and VirA) are
required to promote Shigella uptake into non-phagocytic cells155,156. The molecu-
lar mechanisms of the entry process have been studied intensively over the past
two decades and significant insight has been gained on how the bacterial effectors
shape the cytoskeletal machinery to allow for efficient invasion. Main targets for
the effectors are the small guanosine triphosphatases (GTPases) Cdc42, Rac and
Rho, which are central regulators of the actin cytoskeleton. The coordinated ac-
tion of the bacterial effectors leads to the formation of filopodia and lamellipodia,
which will engulf the invading pathogen135,160. In contrast to Salmonella, Shigella
rapidly disrupts the surrounding membrane after internalization to get access to
the cytoplasm of the host cell159.
Within the cytosol, Shigella exerts directed actin polymerization that allows the
bacteria to move intra- and intercellularly. The remarkable feature of actin-based
motility is shared by other intracellular pathogens like Listeria, Rickettsia and
the vaccinia virus161. Actin-based motility allows Shigella to rapidly disseminate
throughout the epithelium, thereby extending the pool of available nutrients. Note-
worthy, IcsA – the bacterial factor mediating directed actin polymerization – con-
tains a recognition site for autophagy. To avoid the engulfment by autophagic
vacuoles, the recognition site is masked by the T3SS substrate IcsB162,163.
Shigella efficiently replicates within the cytoplasm with a generation time of less
than 40 minutes. Transcriptional analyses have revealed an excellent adaptation of
the pathogen to the intracellular environment. Still, little is known about the host-
pathogen interactions required for efficient replication. Besides adaptation to the
replicative niche, Shigella is known to promote survival of infected cells. The T3SS
effectors IpgD and Spa15 induce survival signals and inhibit apoptosis, respectively.
A key feature in Shigella pathogenesis is the ability to modulate the host inflamma-
tory response. Several effectors (OspB, OspC1, OspF, OspG, OspZ and proteins
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Figure I.6 Schematic representation of Shigella pathogenesis. Shigella crosses the
colonic epithelium through M cells and gets phagocytosed by resident macrophages. Infected
macrophages rapidly undergo pyronecrosis releasing IL-1β and IL-18. Upon release from
macrophages, Shigella infects enterocytes in a process resembling macropinocytosis. Within the
host cell cytoplasm, Shigella replicates and disseminates to neighboring cells by actin-based motil-
ity. Intracellular bacteria are detected by pathogen recognition receptors leading to the secretion
of IL-8. The release of proinflammatory cytokines from enterocytes and macrophages activates
the immune system and attracts PMN cells to the site of infection. PMNs transmigrate across the
epithelial layer thereby facilitating further invasion. Ultimately, PMNs phagocytose the invading
bacteria, contributing to the clearance of the infection. Adapted with modifications from Schroeder
and Hilbi135.
from the IpaH family) are injected into the cytoplasm where they interact with
components of the proinflammatory signaling cascade. Central targets are proteins
of the MAPkinase and NF-κB signaling pathways, resulting in a dampened inflam-
matory host response.
In the following sections, the different steps in Shigella pathogenesis will be pre-
sented in more detail with emphasis on invasion of enterocytes and downregulation
of inflammatory signals. A schematic overview of Shigella infection is presented in
Figure I.6.
4.1 Colonization of the gastrointestinal tract
Before reaching the colonic mucosa, where Shigella establishes an infection, the
pathogen needs to sustain the acidic environment (pH = 1.5-3.5) of the stom-
ach. Shigella has a survival rate of 50% when incubated at pH 2.5 for 2 hours164.
This characteristic is shared with E. coli, while for example S. typhimurium is less
resistant to acidification165. The acid resistance of Shigella is attributed to two
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independent sytems. The glutamate-dependent acid resistance pathway stabilizes
the intracellular pH by decarboxylation of glutamate and export of the product
gamma-aminobutyric acid. Alternatively, the intracellular pH is maintained by the
oxidative system, which is poorly understood but involves the alternative sigma
factor RpoS166. The acid resistance of Shigella has been proposed as a major de-
terminant for the low infective dose that is associated with shigellosis131,164.
4.1.1 Crossing the epithelial layer by transcytosis
When reaching the colon, Shigella is not able to directly infect enterocytes from the
apical side. The pathogen can barely interact with the apical surface of intestinal
epithelial cells (IECs). In vitro infections using subconfluent Caco-2 cells revealed
that invasion was almost exclusively limited to cells at the periphery of cell islets.
Infected cells were shown to be stained with basolateral markers, suggesting that
efficient invasion requires surface receptors that are only exposed at the basolateral
surface of epithelial cells157.
In vivo experiments using macaque monkeys revealed that sites of Shigella infec-
tion were located preferentially over lymphoid follicles167. Microfold cells (M cells)
are associated with lymphoid tissues in the intestine. These specialized epithelial
cells sample antigens, viruses, bacteria and even parasites from the gut lumen and
present them to resident lymphocytes. This process is important for the home-
ostasis of the mucosal immune responses, but is at the same time exploited by
different pathogens (e.g. Salmonella and Yersinia) to invade the host168. Wassef
and colleagues proved that this is also true for Shigella. In the rabbit intestinal
loop model, Shigella infected M cells and was transcytosed to the subepithelial
space169. This process is actively controlled by Shigella, as the non-invasive strain,
lacking the virulence plasmid, only poorly colonized M cells158.
4.1.2 Evasion of killing by macrophages
After transcytosis through M cells, Shigella gets phagocytosed by tissue-resident
macrophages and dendritic cells. To avoid phagosome-lysosome fusion, the phago-
some is rapidly lysed in a IpaB/C-dependent way159,170. Within the cytoplasm,
the bacteria can multiply, which kills the lymphocytes and results in a strong in-
flammatory response. Early publications have described the Shigella-induced cell
death of macrophages as an apoptotic event that is mediated via the interaction
of IpaB and caspase-1171,172. More recent publications have characterized the cell
death as pyroptosis117,118, a type of programmed cell death that is accompanied by
nuclear condensation, membrane permeability and release of the cytokines IL-1β
and IL-18173. It was further shown that caspase-1 activation, which is necessary for
pyroptosis, is mediated by the NOD-like receptor NLRC4 and its adaptor protein
ASC9. Finally, Miao and colleagues found evidence that NLRC4 is recognizing the
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basal body rod component of the T3SS of various pathogens. In case of Shigella,
NLRC4 is binding to MxiI92. Noteworthy, pyroptosis was shown to be negatively
regulated by autophagy9. It is tempting to speculate that Shigella’s ability to in-
terfere with autophagy might further promote pyroptosis in infected macrophages.
At later time points and when infecting macrophages at higher multiplicity of in-
fection (MOI), cell death takes another pathway resembling necrosis. NLRP3/ASC
have been identified to mediate these signaling events in a caspase-1-independent
way118,174. While it is currently not clear, which is the predominant pathway of
macrophage cell death under physiological conditions, both lead to the massive re-
lease of cytokines IL-1β and IL-18, major mediators of the inflammatory response
observed during Shigella infections. IL-1β promotes the infiltration of the infected
tissue by PMNs. Additionally, PMNs transmigrate towards the gut lumen, thereby
disrupting epithelial integrity. At initial stages, this can promote infection, as Shi-
gella in the gut lumen get direct access to the basolateral pole of enterocytes175. At
later stages, PMNs contribute to the clearance of infection by degrading Shigella
virulence factors176 and entrapping bacteria in NETs177. IL-18 activates NK cells,
which in turn amplify the innate immune response by releasing INF-γ. INF-γ is an
important mediator for the clearance of a Shigella infection178.
4.1.3 Invasion of epithelial cells
The following paragraphs introduce several molecular mechanisms that allow Shi-
gella to trigger its uptake into non-phagocytic cells. These processes are controlled
by several bacterial effectors, which are translocated by the T3SS. They target host
cell systems including the actin cytoskeleton, focal adhesions and microtubules. The
coordinated action of the bacterial effectors ultimately results in the uptake of the
bacterium into the cell. A schematic overview of the most important molecular
interactions during the entry process is presented in Figure I.7.
Invasion of enterocytes from the basolateral side requires initial contact of Shigella
with the host cell membrane. The establishment of the initial interaction is poorly
understood. Shigella is known to inefficiently adhere to host cell surfaces, what
can be attributed to the lack of an adhesin. Expression of an ectopic adhesin (e.g.
AfaE from UPEC179) or centrifugation are therefore common techniques to boost
cell adhesion in in vitro experiments. Recently, Romero and colleagues proposed
the initial contact to be established by thin filopodial structures that extend a few
microns above the cell surface and capture bacteria. Contact formation is depen-
dent on the T3SS tip complex and leads to retraction of the extension, bringing
the bacterium in contact with the cell body. The retraction of the filopodial exten-
sions requires the activation of the MAPkinase ERK1/2. While this process was
observed frequently when infecting HeLa cells, it was observed at a lower rate in
polarized Caco-2 cells. In fact, the relevance of this process in vivo remains to be
validated180.
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Shigella interacts with CD44 and α5β1 integrin receptors
When getting in contact with the cell surface, Shigella preferentially interacts with
cholesterol-enriched microdomains within the membrane, known as lipid rafts. The
translocator component IpaB and its Salmonella homologue SipB bind cholesterol
with high affinity and can integrate into liposomes mimicking lipid raft composition
even in the absence of proteins181,182. Depletion of cholesterol and sphingolipids,
known components of lipid rafts, reduces Shigella invasion183. Besides different
physical properties, lipid rafts are believed to be enriched in receptors. Among
these, the hyaluronic acid receptor CD44 accumulates in lipid rafts in a cholesterol-
dependent way, where it interacts with the underlying actin cytoskeleton184. CD44
has been shown to colocalize with F-actin in Shigella entry foci. IpaB directly binds
to the extracellular part of CD44. While pretreatment of cells with a CD44 antibody
reduces Shigella invasion by 70%, it does not block infection completely, suggesting
that the receptor is not essential for a successful entry process185. Furthermore, the
interaction between IpaB and CD44 is not sufficient for bacterial entry as ipaC
or ipaD mutants are deficient for invasion186. It was suggested that CD44 might
promote close association of the bacterium with the host cell thereby favoring
insertion of the translocator pore (IpaB/C) into the membrane.
A second putative receptor for Shigella was described by Watarai and colleagues187.
The tip complex proteins IpaB, IpaC and IpaD immunoprecipitate with α5 and
β1 integrins. The α5β1 integrin receptor binds fibronectin, a major component
of the extracellular matrix. Indeed, the binding of IpaB/C/D was outcompeted
by superfibronectin, a multimeric form of fibronectin. Surprisingly, the interaction
with α5β1 integrin was only observed when the Ipa proteins were released from
the bacterial surface187. This finding was supported by the observation that Ipa
proteins are released from the bacteria upon contact with the host cell or with
proteins from the extracellular matrix188 and that IpaB and IpaC formed a soluble
complex189. The release of Ipa proteins is required for efficient bacterial invasion.
For instance a spa32 mutant, in which the Ipa proteins still form the tip complex,
but can no longer be released, was strongly impaired in invasion188–190. Taken
together, these results indicate that the interaction with the integrin receptor is
not required for docking to the cell surface, but instead promotes bacterial invasion
by outside-in signaling. Yet, the exact role of integrins in Shigella infection has not
been clarified.
Activation of the small GTPases Cdc42 and Rac leads to the formation
of filopodia and lamellipodia
Rho GTPases Rac, Cdc42 and Rho are central regulators of the eukaryotic cy-
toskeleton and are therefore involved in processes like cell migration, cell cycle and
cell polarity. Guanine-nucleotide exchange factors (GEFs) and GTPase-activating
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proteins (GAPs) control the activation status of small GTPases. The wide range
of host cell processes that are controlled by small Rho GTPases makes these pro-
teins, as well as their corresponding guanine-nucleotide exchange factors (GEFs)
and GAPs, prime targets for virulence factors191. As cell invasion by Shigella is
known to lead to massive rearrangements of the actin cytoskeleton179, it is not
surprising to find the small GTPases to be involved.
Ménard and colleagues have reported that latex beads being coated with the
IpaB/C complex were internalized into cells189. Although the internalization was
not very efficient, it was further shown that this process is sensitive to C. difficile
toxin B, a known inhibitor of Rho family proteins. The involvement of Rho family
GTPases was confirmed through expression of dominant negative forms of Rac1,
Cdc42 and Rho. For all constructs, a reduction in infection rate was observed192.
The dominant negative forms of Rac1 and Cdc42, but not Rho, further showed less
actin polymerization and a reduced number of entry foci193. In addition, Rac1 and
Cdc42 were demonstrated to localize to Shigella entry foci192.
The bacterial effector mediating the activation of Rac1 and Cdc42 was proven to
be the translocator protein IpaC. Expression or microinjection of IpaC leads to the
formation of filopodial structures and promotes Shigella invasion194. While the ac-
tivation of Rac1 primarily induces the formation of lamellipodia, Cdc42 promotes
both filopodial and lamellipodial structures194. Lamellipodia are cell extensions re-
sulting from a mesh-like arrangement of actin filaments at the plasma membrane.
Formation of lamellipodia can be observed at the leading edge of migrating cells.
Filopodial structures arise from bundled actin filaments, which can extend over
several microns. Actin-binding proteins like fascin or T-plastin mediate the forma-
tion of actin bundles by cross-linking individual filaments. In a Shigella infection,
T-plastin is involved as the expression of a dominant negative construct reduces
infection rate significantly195. To summarize, these data indicate that Shigella is
promoting its entry by inducing the formation of filopodia and lamellipodia, which
is controlled by the small GTPases Cdc42 and Rac.
Src is targeted by IpaC and plays a central role in foci formation
The tyrosine kinase Src was first discovered as a proto-oncogene in chicken, having
high similarity to the v-src gene of the sarcoma virus. Src plays a role in develop-
ment and cell division and has been associated with a number of human cancers.
Dehio and colleagues found that Src, together with its substrate cortactin, is re-
cruited to Shigella entry foci196. While cortactin colocalized with F-actin, Src was
associated with membranes in the vicinity of the invading bacterium. Cortactin was
further demonstrated to be tyrosine-phosphorylated upon Shigella infection. Over-
expression of Src did increase the amount of tyrosine-phosphorylated cortactin,
indicating that this process is mediated by Src196. Remarkably, overexpression of
Src significantly increased the internalization of non-invasive Shigella by HeLa
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cells. Similar results were found when stimulating cells with EGF and are likely at-
tributed to the induction of membrane ruffles in either of the two conditions196,197.
The importance of Src in the Shigella entry process is emphasized by a strong re-
duction in infection rate and foci formation when expressing a dominant-negative
form of the kinase. At the same time, expression of a constitutively active form
also decreased infection rate and shortened the lifetime of entry foci, indicating
that the level of Src activation is fine-tuned by Shigella to allow for efficient
entry199. The delicate behavior of Src is likely to arise from a negative feedback loop
that is mediated by Rho. Activated Rho is required for Src recruitment to entry
sites. At the same time, Src negatively regulates Rho activation through tyrosine-
phosphorylation of the Rho GAP ARHGAP35193. The level of Src activation might
therefore indirectly control the kinetics of Src recruitment to the plasma membrane
and the rate of entry foci formation.
A recent publication by Mounier et al. has clarified the role of the translocator pro-
tein IpaC in activating Src200. The carboxyterminal domain of IpaC recruits and
activates Src. This process is independent of other translocated effectors. In agree-
ment with previous results, Src mediates tyrosine-phosphorylation of cortactin,
which can be efficiently inhibited by the Src family inhibitor PP2. Translocation
of the carboxyterminal domain alone – using the Iota toxin system – is sufficient
to induce Src activation and the formation of microspikes in HeLa cells200.
Abl1/2 control membrane recruitment of cortactin and Rac via Crk
Similar to Src, the oncogenes Abelson tyrosine-protein kinases 1 and 2 (Abl1/2,
also known as Abl/Arg) are activated and recruited to entry sites during Shigella
invasion with similar kinetics as seen for Src activation201. Infection rate decreased
by 80-90% when infecting Abl1/2 knockout mouse embryonic fibroblasts (MEFs),
as compared to wildtype MEFs. Furthermore, the Abl inhibitor STI-571 reduced
infection rate up to 98% when used at micromolar concentrations201. This is of
particular interest, as STI-571 – better known as Glivec R© – is already successfully
applied in the clinic treating chronic myelogenous leukemia and gastrointestinal
stromal tumors202.
The strong impact of Abl1/2 on Shigella infection is likely to be attributed to
Figure I.7 (following page) Schematic representation of Shigella entry into epithelial
cells. Shigella triggers its uptake into non-phagocytic cells by injecting effector proteins (orange)
through its type III secretion system (T3SS) into the cell cytoplasm where they interact with
proteins of the host (green). Several systems of the host cell are targeted including the actin
cytoskeleton, focal adhesions and microtubules. The coordinated action of the effectors will pro-
mote membrane protrusions engulfing the bacterium and ultimately result in its uptake into the
cell. For more details, refer to the corresponding sections of the manuscript. The data presented
here has also been covered by several reviews135,155,160,198.
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its role in the activation of Rac and Cdc42. In Abl1/2 -/- MEF, no activation of
Rac or Cdc42 could be observed upon Shigella infection201. A recent study found
that knockdown of Unc119, an adaptor protein inhibiting Abl1/2 kinase activity,
promoted Shigella invasion in the mouse pulmonary infection model203, thereby
providing further evidence for the importance of Abl1/2 during Shigella invasion.
Finally, Abl together with Src play a central role in H. pylori infections204.
Burton and colleagues reported that tyrosine-phosphorylation of the adaptor pro-
tein Crk by Abl1/2 is an essential step in Shigella invasion201. The phosphory-
lation of Crk had previously been described to lead to membrane localization of
the protein205. Indeed, Crk is recruited to entry foci and colocalized with cortactin
and F-actin during Shigella invasion. Crk directly interacts with cortactin, which
is strongly increased by Src-mediated phosphorylation of cortactin. Together, Crk
and cortactin contribute to the formation of actin foci in a process dependent on
the Arp2/3 binding domain of cortactin206. Crk has as well been reported to ac-
tivate Rac by recruiting it to the plasma membrane205. It seems likely that the
inability of Abl1/2 knockout MEFs to recruit and activate Rac and Cdc42 can
partially be attributed to mislocalization of Crk.
In conclusion, Abl1/2 kinases are essential to localize cortactin and possibly Rac
to bacterial entry sites via phosphorylation of Crk. The recruitment of cortactin
is significantly enhanced by Src-dependent tyrosine-phosphorylation. Cortactin in
concert with Rac/WAVE leads to actin polymerization through the Arp2/3 com-
plex promoting the formation of a permissive entry structure.
IpgB1 and IpgB2 are bacterial GEF mimics
IpgB1 and IpgB2 show 17% amino acid sequence identity and are both secreted
into host cells via the T3SS. While an ipgB1 mutant displays a significant decrease
in invasiveness, the ipgB2 mutant has no phenotype in cell invasion assays and
the Sereny test207,208. The ipgB1/2 double mutant displays a pronounced defect
in invasion and attenuated virluence in the Sereny test, as well as in the mouse
pulmonary infection model, thereby indicating that the two effectors cooperate to
facilitate invasion208. IpgB1 furthermore induces membrane ruffles when expressed
in HeLa cells. The ruffle formation is sensitive to Rac1 or Cdc42 inhibition but is
independent of Src and Abl1/2207,209.
Initial reports have indicated that IpgB1/2 might mimic activated G proteins.
IpgB1 is believed to mimic the activated form of RhoG, which results in the re-
cruitment of ELMO and Dock180 to entry sites209. As Dock180 is a specific GEF for
Rac1210, it is hypothesized that IpgB1 activates Rac1 via ELMO/Dock180. IpgB2
was first reported to act as a mimic of activated RhoA, thereby interacting with
Rock and mDia1 to induce actin stress fibers211. However, more recent publications
have revealed that IpgB1/2 act as mimics of GEFs. IpgB1 has GEF activity for
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Rac1 and to a lesser extent for Cdc42212. IpgB2 shows GEF activity for RhoA and
with lower affinity for Rac1 and Cdc42. This was confirmed as the structure of the
IpgB2/RhoA complex could be solved and the model agreed with the GEF activity
of IpgB2212,213.
Effectors harboring GEF activity for Rho family proteins have emerged as a com-
mon concept for controlling cytoskeletal rearrangements by bacterial pathogens214.
Bacterial effectors that have been described as GEF mimics, including IpgB1 and
IpgB2, all share a WxxxE sequence motif, which is essential for GEF activity211.
Among these, one can find Map, EspM and EspT from EPEC and EHEC, BepF
from Bartonella henselae and Salmonella effectors SopE, SifA and SifB.211,215,216.
Structural analysis of the interaction between Map and Cdc42 has provided fur-
ther evidence on how the effectors interact with Rho proteins. Besides two well
conserved domains mediating GEF activity, there are two domains that define the
specificity for a certain Rho protein. Changing several residues in the recognition
site of Rho proteins can therefore alter substrate specificity of bacterial effectors
(e.g. changing 4 amino acids in Rac1 makes it a substrate for Map)212.
In summary, IpgB1 is interacting with ELMO and Dock180 and exhibits GEF
activity mainly towards Rac1. In concert with the GEF activity of Dock180, IpgB1
might therefore be the main activator for Rac1, leading to membrane ruffles during
Shigella invasion. IpgB2 binds Rock and mDia1, two proteins known to interact
with RhoA, and exhibits GEF activity towards RhoA. RhoA in turn controls the
formation of actin stress fibers and, via PKC, focal adhesion structures. As an
ipgB2 mutant shows no major phenotype in invasion assays, one can speculate
that the effector might play a role at later stages of infection. In fact, IpgB2 is
involved in NF-κB activation120. Further work is required to delineate the precise
function of IpgB2 during Shigella infection.
Focal adhesions are involved in Shigella cell invasion
Besides the small GTPases Cdc42 and Rac, Rho plays an important role during
Shigella invasion. Inhibition of Rho activity by the exotoxin C3 of Clostridium
botulinum reduced infection rate by almost 90% and significantly less actin po-
lamerization was observed. All three isoforms (RhoA, RhoB and RhoC) localize to
entry foci, although at discrete locations within the entry structure217,218. Active
RhoA was shown to activate and recruit PKC to the site of entry. Inhibitors of
PKC (e.g. calphostin C) interfere with efficient cell invasion. PKC is known to
be involved in the regulation of focal adhesion by phosphorylating focal adhesion
kinase (FAK)218.
The involvement of focal adhesion in Shigella infections is supported by the fact
that the addition of Ipa invasins (IpaB/C/D) to the culture medium leads to actin
rearrangements and accumulation of FAK, paxillin, vinculin and talin. Besides
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that, FAK and paxillin get tyrosine phosphorylated218. As it is known that IpaB
and IpaC form a soluble complex that interacts with α5β1 integrins187,189, it seems
likely that the accumulation of proteins involved in focal adhesion is mediated by
outside-in signaling through α5β1 integrins. However, the exact mechanism of this
signaling cascade has not been described. Additionally, Skoudy et al. found ezrin, a
protein that links actin filaments to the plasma membrane, to play a role in Shigella
invasion. Expression of a dominant-negative form of ezrin significantly reduced
infection rate219. This is of particular interest, as ezrin associates with CD44220, the
hyaluronic acid receptor targeted by IpaB185. Besides outside-in signaling through
integrins, IpaB might therefore promote cytoskeletal rearrangements by interacting
with CD44 and ezrin.
Tran van Nhieu and colleagues discovered another pathway through which Shigella
can control focal adhesions221. The effector IpaA binds vinculin, a protein involved
in anchoring actin filaments to the membrane. An ipaA mutant displayed a 10-fold
decrease in infection rate. However, infection was not entirely blocked and could
still occur in a delayed fashion independent of vinculin. The mutant also induced
an equal amount of actin polymerization when compared to the wildtype, with the
only difference that the F-actin was not as closely associated with the invading
bacterium. The importance of vinculin is emphasized by the fact that the invasion
efficiency positively correlates with the amount of ectopically expressed vinculin in
vinculin-deficient cells. IpaA also recruits vinculin and its interaction partner α-
actinin to Shigella entry sites221. Noteworthy, the interaction of IpaA and vinculin
is another example for molecular mimicry. Two groups independently discovered
that IpaA mimics talin-vinculin binding and activation222,223.
More recent studies define IpaA functions more precisely, pointing out that IpaA is
controlling F-actin dynamics and disrupting focal adhesions as well as stress fibers.
The interaction of IpaA and vinculin stabilizes the interaction of vinculin with
barbed ends of actin filaments, thereby controlling polymerization and depolymer-
ization 224,225. IpaA furthermore disrupts stress fibres. At first, it was assumed that
this was a result of actin depolymerization through interaction with vinculin224.
However, a later study showed that it was independent of vinculin but required
the activation of Rho226. In fact, IpaA activates Rho, which leads to an increased
phosphorylation of myosin light chain (MLC) mediated through Rho kinase. The
phosphorylation of MLC results in a loss of stress fibers and increased contractility.
Only recently, a similar pathway was described for Salmonella invasion involving
myosin II227. And myosin VII plays a role in L. monocytogenes infections228. Fur-
thermore, IpaA reduces the binding of vinculin and talin to the cytoplasmic domain
of β1 integrins, which leads to a disruption of focal adhesions.
To sum up, the regulation of focal adhesion plays an important role in Shigella
invasion. Initial results suggested that the formation of focal adhesion structures
at entry sites promotes invasion. This is supported by the fact that proteins from
focal adhesions are recruited to sites of entry via outside-in signaling through in-
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tegrins, which is mediated by the IpaB/C complex187,189. Moreover, inhibition of
PKC reduces invasion218. And ezrin, which interacts with CD44 and promotes
membrane anchoring of actin filaments, is involved in Shigella invasion219. Con-
tradictory, the effector IpaA promotes disruption of actin stress fibers and focal
adhesions226. While these effects seem to be antagonistic at the first glance, it is
worthwhile to note that focal adhesions in cells – in the absence of any perturbation
– are turned over by an endocytic process229. One might hypothesize that Shigella
first triggers assembly of a focal adhesion structure through outside-in signaling
involving integrins and CD44 and subsequently disrupts this structure by inject-
ing IpaA, thereby promoting endocytic processes. While there is no in vivo data
available for Shigella that could support such a mechanism, a recent study has pro-
posed a similar mechanism for L. monocytogenes, where InlB promotes junctional
endocytosis through interaction with the receptor c-Met230.
IpgD and VirA accomplish dual functions during Shigella invasion
The enzymatic activity of IpgD has been defined very precisely as phosphatidyli-
nositol (PtdIns) phosphatase that can convert PtdIns4,5-bisphosphate (PIP2) into
PtdIns5-phosphate (PIP)231. PIP2 regulates membrane-cytoskeleton adhesion232
and binds several actin-interacting proteins like vinculin, WASP and ezrin233. The
depletion of PIP2 from the membrane through IpgD leads to a lower adhesion en-
ergy between membrane and cytoskeleton which is believed to promote dissociation
of F-actin from membranes. In fact, the overexpression of IpgD in HeLa cells gives
rise to membrane blebbing and cell rounding. This effect on actin filaments seems
to enhance the effect of Cdc42 and Rac on cytoskeletal rearrangements. An ipgD
mutant induces much smaller entry foci having a cup-like structure231. A recent
publication has confirmed the effect of IpgD on the cytoskeletal organization by
showing that the effector inhibits migration of T lymphocytes234. Besides its effect
on the actin cytoskeleton, IpgD promotes cell survival through activation of PI3K
and Akt235. A precise description of the mechanism can be found in section 4.2.1.
VirA is another effector secreted into host cells by Shigella. Infections using a
virA mutant have revealed a defect in intercellular spread of Shigella236,237. Ad-
ditionally, Uchiya and colleagues have reported a strong defect in cell invasion236.
This observation could not be reproduced by Demers et al., although they had no-
ticed attenuated virulence in the Sereny test. Furthermore, infections with the virA
mutant using the rabbit ileal loop model did not show any major phenotypes237,
indicating that VirA might only possess an accessory role in cell invasion.
More recent publications describe that VirA interacts with tubulins in vitro and
destabilizes microtubules in vivo238. It was initially speculated that VirA might
directly cleave α-tubulin as it shares similarities with cysteine proteases239. How-
ever, structural data for VirA revealed a unique fold that did not resemble any
known cysteine proteases, but shared homology with the EspG virulence factor of
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pathogenic E. coli240,241. VirA might therefore destabilize microtubules by inter-
acting with host proteins controlling microtubule dynamics. VirA further promotes
Rac1 activation leading to membrane ruffles through an unknown mechanism238.
It was suggested that microtubule disassembly might promote Rac1 activity by
releasing microtubule-associated GEFs (e.g. GEF-H1)242.
In summary, VirA destabilizes microtubules, which is considered to be important
for efficient intracellular motility and cell-to-cell spread239. Additionally, VirA pro-
motes Rac1 activity that might enhance cell invasion238. It is noteworthy that two
recent publications have described the VirA homologue EspG to act as a scaffold-
ing protein for PAK and Arf6, thereby altering membrane trafficking. However,
no destabilizing effect on microtubules could be found243,244. Whether VirA works
similarly or has diverging activities from EspG remains to be validated.
4.1.4 Intercellular motility and intracellular growth
Upon successful uptake into host cells, Shigella is surrounded by a lipid bilayer
termed the phagosome. In contrast to S. typhimurium, which modifies the mem-
brane compartment into a so-called Salmonella-containing vacuole (SCV) permis-
sive for replication, Shigella lyses the phagosome and escapes into the cytoplasm
in less than 15 minutes. Membrane lysis is dependent on the T3SS and the translo-
cators IpaB, IpaC and IpaD159,179,245. Although all three proteins are required,
IpaC is the biochemical mediator of phagosome lysis246. Remarkably, IpaC is also
capable of lysing the SCV when expressed in Salmonella247.
Within the host cell cytoplasm, Shigella is able to move by actin-based motility.
This special feature is shared by other pathogens including Listeria monocytogenes,
Rickettsia rickettsii, Mycobacterium marinum, Burkholderia pseudomallei and the
vaccinia virus161. The driving force for the movement is directed actin polymer-
ization at one pole of the bacterium. The mediator for actin polymerization is
the Shigella IcsA protein248,249. Its polar localization is controlled by the serine
protease SopA (IcsP) and the apyrase PhoN2250,251. IcsA directly interacts with
the host protein N-WASP, which will in turn recruit the Arp2/3 complex. The
recruited host cell factors mediate actin nucleation and directed elongation of the
actin tail, propelling Shigella through the cytoplasm252.
Besides intracellular movement, actin-based motility allows Shigella to move from
cell to cell. Intercellular spread is achieved by forming protrusions at tight junctions
connecting adjacent enterocytes. These protrusions can be endocytosed by the tar-
geted cell in a process that requires the host factor myosin light-chain kinase253. Af-
ter successful intercellular movement, Shigella lyses the surrounding double mem-
brane in a process that requires again the IpaB/C/D invasins and is believed to
be identical to the lysis of the phagosome245,254. Efficient intra- and intercellular
movement was reported to be dependent on the Shigella virulence factor VirA. It
was suggested that VirA destabilizes microtubules, which might otherwise hinder
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movement within the cytoplasm239. A recent publication has demonstrated that the
host cell can interfere with actin-based motility. Bacteria producing actin comet
tails got associated with septins, proteins involved in cell devision. In fact, some
bacteria got entrapped in a cage-like structure formed by septins, which prevented
intercellular spread255.
An important feature of Shigella in order to survive and multiply within the
host cell cytoplasm is the evasion of autophagy. Autophagy is a mechanism of
eukaryotic cells, which is able to degrade host cell components, including entire or-
ganelles, by surrounding them in double-membrane-bound compartments that get
targeted for lysosomal degradation256. Besides the function of cell maintenance,
autophagy plays pivotal roles in the host innate immune system257. For instance,
proteins from the autophagic machinery associate with intracellular bacteria even-
tually leading to their degradation. Furthermore, autophagy acts downstream of
pathogen-recognition receptors (PRRs) like Nod177. Ogawa and colleagues were
the first to describe that intracellular Shigella get targeted for autophagy when
the T3SS effector IcsB is absent. IcsB prevents autophagy by masking the surface-
exposed virulence factor VirG that mediates actin-based motility. In the absence
of IcsB, VirG is recognized by the autophagy protein Atg5, which recruits the au-
tophagic machinery163,258. A recent report additionally implicated the PRRs Nod1
and Nod2 to promote autophagy of Shigella by interacting with the autophagy
regulator Atg16L1 and recruiting it to bacterial entry sites77,78. Moreover, the en-
trapment of Shigella in septin-cages is more efficient when autophagic markers like
Atg5 are present255.
The cytoplasm of enterocytes represents the main replicative niche for Shigella
where it multiplies with a generation time of less than 40 minutes. Lucchini and
colleagues revealed that after successful cell invasion almost 25% of the Shigella
genes are significantly up- or downregulated259. This indicates that survival and
replication within enterocytes requires a high degree of adaptation to the intracel-
lular environment. At the same time, little is known about critical factors for in-
tracellular survival and replication. The study from Lucchini argued that access to
iron, magnesium and phosphate might be a limiting factor. TonB, a membrane pro-
tein providing energy for iron uptake systems, is required for intracellular growth
of Shigella dysenteriae. However, a tonB mutant is not affected in iron uptake,
suggesting that TonB might be crucial for the uptake of a nutrient other than
iron260. Mutants, which cannot synthesize guanine, thymine and p-aminobenzoic
acid were shown to be defective in intracellular replication. Additionally, mutants
auxotrophic for diaminopimelate can not survive in the cytoplasm261–263. The car-
bon sources for intracellular Shigella are not known, but it was shown that uhpT,
which encodes for a hexose phosphate transporter, is highly upregulated upon
successful infection. Nevertheless, a uhpT mutant is able to grow intracellulary
indicating that Shigella is accessing alternative carbon sources264. A very recent
study has indicated that Shigella can sustain oxidative stress, which is regulated by
the transcriptional activators oxyR, soxR and soxS. While resistance to oxidative
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stress is important at different stages of a Shigella infection, it proves to play a role
in intracellular growth as mutants show a slight decrease in plaque formation265.
Finally, efficient intracellular growth also requires the host cell to remain permis-
sive for intracellular growth. Different ways of how Shigella controls the fate of the
host cell are discussed in the following section.
4.2 Modulation of host cell signaling
As presented in the previous section, Shigella very efficiently subverts the cytoskele-
tal machinery to promote its uptake into non-phagocytic cells. These processes are
mediated by a set of effector proteins that get secreted into the host cell cytoplasm
via the T3SS. Besides the effectors that manipulate signaling cascades controlling
cytoskeletal rearrangements, there are further effector proteins injected, which con-
trol post-invasion aspects during a Shigella infection. First of all, the intracellular
bacteria promote the survival of the host cell in order to protect the replicative
niche. Secondly, Shigella slows down self-renewal mechanisms of the intestinal ep-
ithelium that would otherwise result in a rapid clearance of the infection. And
finally, several effectors target proinflammatory signaling cascades resulting in a
modulated immune response that is more permissive for bacterial survival and
replication.
4.2.1 Shigella promotes host cell survival
The first effector that was described to promote the survival of infected epithe-
lial cells was IpgD. Pendaries and colleagues found that cells overexpressing IpgD
are protected from apoptosis induced by staurosporin235. The inhibition of apop-
tosis is dependent on the phosphoinositide phosphatase activity of IpgD resulting
in the production of phosphatidylinositol-5-phosphate (PIP)231. Furthermore, IpgD
induces the phosphorylation of Akt and its substrates GSK3 and FKHR. The phos-
phorylation of Akt in turn requires a class IA PI3K. Noteably, the activation of Akt
is dependent on tyrosine-phosphorylation, as treatment with the tyrosine-inhibitor
herbimycin A blocks Akt phosphorylation235. This observation was recently con-
firmed when the EGF receptor (EGFR), a receptor tyrosine-kinase, was demon-
strated to be required for activation of Akt266. Furthermore, the EGFR is recruited
to entry foci in an IpgD-dependent manner. It seems likely that production of PIP
by IpgD targets EGFR to the membrane, where it tyrosine-phosphorylates PI3K
and leads to survival signaling via Akt.
Moreover, PIP, together with EGFR, gets enriched in endosomes where it interferes
with trafficking of early endosomes to lysosomes. This impairs EGFR degradation
in lysosomes and represents an essential mechanism prolonging the survival signal-
ing via PI3K/Akt266. In addition, the perturbation of membrane trafficking might
explain the entry phenotype observed in an ipgD mutant infection231. Localization
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of Cdc42, the small GTPase essential for Shigella entry, is dependent on mem-
brane traffic in the context of cell migration and polarity267,268. It is tempting to
hypothesize that the capability of IpgD to alter membrane trafficking by produc-
ing PIP promotes localization of Cdc42 (and possibly other G proteins) to the
plasma membrane. Although this hypothesis seems plausible, there is currently no
experimental data available supporting this conclusion.
A second effector known to promote host cell survival is Spa15. This protein has
already been described as a chaperone for several effectors269. Faherty et al. unveiled
that Spa15 is secreted by the T3SS and that a spa15 mutant is not able to protect
infected cells from staurosporin-induced cell death to the same extent as the wild
type. In fact, cells infected with the spa15 mutant display activated caspase-3,
while no activation is found in wild type infections270. This indicates that Spa15 is
able to interfere with apoptosis upstream of caspase-3.
Intestinal epithelial cells are subject to rapid turnover and exfoliation, which repre-
sents an innate defense mechanism271. Nevertheless, many intestinal pathogens are
able to efficiently colonize these cells. Shigella overcomes this defense mechanism
by secreting the effector OspE. OspE consists of the proteins OspE1 and OspE2
and is highly conserved among pathogenic E. coli and Salmonella strains. OspE
interacts with integrin-linked kinase within focal adhesions of HeLa cells, thereby
facilitating the formation of focal adhesions and suppressing their turnover. This, in
turn, promotes the attachment of infected cells to the extracellular matrix through
integrins. The importance of OspE was demonstrated in vivo where an ospE mu-
tant displayed reduced inflammation and colonization in the guinea pig infection
model272.
In the intestine, self-renewal is mediated by progenitor cells, which provide new
epithelial cells through cell division and are located at the base of crypts. Iwai and
colleagues revealed that Shigella interferes with this process by inducing a cell cycle
arrest273. The inhibition of cell cycle progression is mediated by the translocator
IpaB, which targets Mad2L2, a protein involved in metaphase-to-anaphase tran-
sition. It was proposed that Shigella infects progenitor cells directly or through
intercellular motility. Upon infection, Shigella blocks cell cycle progression and
therefore self-renewal of the epithelial tissue. While most of these effects are diffi-
cult to directly demonstrate in vivo, an ipaB mutant unable to bind Mad2L2 was
shown to reduce colonization in the rabbit intestinal loop model273.
In summary, Shigella is promoting cell survival and inhibiting apoptosis in infected
epithelial cells. Additionally, it modulates self-renewal and exfoliation at the level
of the infected epithelium by strengthening cell attachment and inducing cell cycle
arrest in progenitor cells. Presumably, these processes protect the replicative niche
and allow for a prolonged infection of the host. It is though important to note that
Shigella induces cell death in epithelial cells at later stages of infection274,275. This
implies that during the early phase of infection, survival signals are dominating,
while at later stages, when the bacterial load is increasing and conditions might
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become less favorable, cell death pathways are activated.
4.2.2 Modulation of proinflammatory signaling cascades
Besides the protection of the replicative niche by promoting host cell survival, the
control of the inflammatory response is a key factor for a successful infection. The
presence of intracellular pathogens is sensed by the cytoplasmic pathogen recog-
nition receptor Nod1. Nod1 is activated upon binding of peptidoglycan moieties
that are shed from the bacterial surface44. In turn, Nod1 oligomerizes and activates
the NF-κB and MAPkinase signaling cascades, which promote the expression of
proinflammatory genes276. Among these genes are several cytokines (e.g. IL-8) that
get secreted and promote the attraction of immune cells to the site of infection123.
Furthermore, the enterocytes express antimicrobial peptides (e.g. β-defensins) that
can contribute to the clearance of the pathogen124.
Shigella has brought forth several effector proteins that get injected into the host
cell cytoplasm through the T3SS where they manipulate proinflammatory signal-
ing cascades155,277. OspG, for instance, inhibits NF-κB activation by preventing
the degradation of IκB, the negative regulator of NF-κB. OspG specifically targets
UbcH5, a ubiquitin-conjugating enzyme, thereby interfering with the ubiquitina-
tion of IκB. Consequently, IκB fails to be degraded and NF-κB is retained in
the cytoplasm278. The effector OspZ, when ectopically expressed in HeLa cells,
prevents NF-κB nuclear translocation in response to TNFα or IL-1β stimulation.
Similar to OspG, IκB is no longer degraded when OspZ is present, but the mech-
anism of inhibition remains currently unknown279. Finally, IpaH9.8 was found to
act as a ubiquitin ligase targeting NEMO for proteasomal degradation. NEMO is
part of the IKK complex that phosphorylates IκB as a prerequisite for subsequent
ubiquitination. Accordingly, the IpaH9.8-induced degradation of NEMO leads to
a reduction in NF-κB activation280. Noteworthy, IpaH9.8 exerts a second function
upon translocation to the nucleus. Nuclear IpaH9.8 interacts with the splicing factor
U2AF35, thereby reducing the mRNA level for several cytokines including IL-8 and
IL-1β281. In addition, IpaH proteins constitute an entire family of T3SS effectors,
which are all presumed to be ubiquitin ligases282. It is therefore highly probable
that Shigella modifies additional host proteins by ubiquitination283.
Figure I.8 Phosphothreonine lyase reaction catalyzed by Shigella effector OspF. The
Shigella effector OspF irreversibly dephosphorylates p38 and ERK by its phosphothreonine lyase
activity. Reproduced from Li et al.126.
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Figure I.9 Shigella modulates the host immune response. Intracellular Shigella secrete
several effector proteins via the T3SS into the cytoplasm of the host cell. These effectors interfere
with the NF-κB and MAPkinase signaling cascades, downregulate the production of cytokines
and antimicrobial peptides and promote transepithelial migration of neutrophils. For more details,
refer to the corresponding sections of the manuscript. Adapted with modifications from Ashida et
al.277.
The Shigella effector OspF is well known to interfere with the MAPkinase signal-
ing pathway. The effector exhibits phosphothreonine lyase activity towards p38 and
ERK, which is – in contrast to dephosphorylation – an irreversible modification
(Figure I.8)125,126. The inhibition of p38 and ERK, in turn, reduces the phospho-
rylation of histone H3, which is required for chromatin modifications that allow
transcriptional activation of NF-κB-regulated genes. The activity of OspF there-
fore leads to a downregulation of proinflammatory genes like IL-828,125. OspF was
further shown to interact, together with the effector OspB, with the retinoblastoma
protein, another regulator of chromatin. Again, this leads to a downregulation of
the proinflammatory response284.
The effectors OspC1, OspZ and OspF are involved in the regulation of PMN
transepithelial migration. During Shigella infection, PMNs are recruited to the
site of infection where they transmigrate across the epithelial layer. The migration
in between enterocytes can promote infection, as it disrupts tight junctions giv-
ing bacteria in the gut lumen direct access to the basolateral pole of IECs. OspC1,
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OspZ and OspF phosphorylate ERK in the cytoplasm, which leads to the activation
of phospholipase A2 (PLA2). PLA2 produces arachidonic acid that gets converted
to Hepoxilin A3 via the 12/15-lipoxygenases pathway. Hepoxilin A3 is secreted into
the gut lumen where it acts as potent chemoattractant for PMNs285–288.
The importance of antimicrobial peptides (AMPs) for controlling a Shigella in-
vasion has been demonstrated in the newborn mouse model and in rabbits124,289.
Yet again, Shigella has evolved mechanisms to evade the action of these antimi-
crobial agents. Islam et al. have reported that LL-37 and β-defensin-1, two human
AMPs, are downregulated early during Shigella infection290. Another study found
that an entire set of AMPs get suppressed at the transcriptional level291. How Shi-
gella interferes with the production of AMPs remains currently unknown. Islam
and colleagues proposed that bacterial DNA plays a role, while Sperandio et al.
reported the suppressing effect to be dependent on Shigella’s transcriptional reg-
ulator MxiE, suggesting the involvement of effector proteins290,291. Noteworthy, a
recent report has pointed out that AMPs might not always be beneficial for the
host, as the release of AMPs from neutrophils promoted Shigella adhesion and
invasion of epithelial cells292.
In conclusion, Shigella has brought forth several T3SS effectors that can control
various aspects of the innate immune response by modulating signaling cascades
within infected cells. While some effectors dampen an inflammatory response (e.g.
OspG, IpaH9.8), others can promote attraction and transmigration of neutrophils
(e.g. OspC1, OspZ). This exemplifies that Shigella is not completely blocking the
inflammatory response, but rather shapes it to allow an efficient colonization and a
prolonged infection. A schematic overview of the effectors that modulate the innate
immune system is presented in Figure I.9.
4.3 Shigella flexneri as a versatile model system for host-
pathogen interactions
Shigella flexneri is an attractive model organism to study various aspects of host
pathogen interactions. First of all, the pathogen interacts both with cells from the
immune system and non-myeloid cells. In vitro infection models have been estab-
lished that enable the study of macrophage killing and invasion of epithelial cells at
the molecular level. Secondly, the pathogen harbors a T3SS, which is also found in
other enteroinvasive pathogens. Intensive research on Shigella’s T3SS has signifi-
cantly contributed to the current knowledge about the structure of this remarkable
injection machinery. Of equal interest are the T3SS effector proteins, which are
injected into host cells and control various cellular functions like cytoskeletal rear-
rangements, cell survival and inflammation signaling. Remarkably, effector proteins
can also be used as molecular tools to dissect host signaling networks. A publica-
tion from our group has exemplified this on the basis of the Shigella effector OspF
(see Chapter V)293. A more complete picture of the impact of effector proteins can
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be obtained by comparing the phosphoproteome of cells infected with Shigella wild
type or effector deletion mutants (Ch. Schmutz, unpublished results). Finally, the
in vitro infection models are well suited to study cell invasion and inflammation
signaling using high-throughput image-based RNAi screens (see Chapter III)294.
A major restriction, however, is the lack of a suitable animal model for Shigella in-
fection. A similar pathology to the disease in humans could only be observed when
infecting primates. Vaccine trials, for instance, have been successfully conducted
in macaque monkeys295. Some aspects of Shigella pathogenicity can be studied in
the rabbit ileal loop model296. Shigella virulence is often assessed by infections
of the corneal epithelium in guinea pigs (also known as Sereny test)297. Although
highly desirable, mice have proven to be refractive to Shigella infections once they
are older than five days298. Nevertheless, intragastric infection of newborn mice, as
well as intranasal infections are two model systems, which have been established for
Shigella infections in mice299,300. Additionally, Zhang and colleagues have demon-
strated the infection of human intestinal xenografts, which are transplanted into
SCID mice301. Recently, intrarectal infection of guinea pigs has been introduced as
a new promising animal model for shigellosis and was already successfully applied
in vaccine trials272,302,303.
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5 Aim of the thesis
A hallmark of shigellosis is an acute mucosal inflammation, which is accompanied
by the massive production and secretion of cytokines. On the other hand, Shi-
gella is known to downregulate inflammation signaling, as several T3SS effectors
interfere with the expression of cytokines in infected epithelial cells. One might
speculate that this discrepancy results from an incomplete inhibition of inflamma-
tion signaling in infected cells. Alternatively, host mechanisms might compensate
for the immunosuppressive activity of Shigella effectors.
The main objective of my thesis was to investigate inflammation signaling dur-
ing Shigella infection in epithelial cells. In particular, we focused on the proposed
mechanisms explaining the massive cytokine secretion despite the presence of im-
munosuppressive effectors. In order to study the immune response of epithelial cells
in response to Shigella, we applied an in vitro infection model using HeLa cells. By
means of immunofluorescence microscopy and automated image analysis, the acti-
vation of proinflammatory signaling cascades at the single-cell level was quantified.
Furthermore, the production of cytokines was measured both with immunofluores-
cence and enzyme-linked immunosorbent assay (ELISA). In addition, we compared
inflammation signaling during infection with Shigella wild type or effector deletion
strains.
In a second project, we aimed at systematically identifying proteins that mediate
inflammation signaling during Shigella infection. We adapted the in vitro infection
assay to allow for the application of high-throughput screening techniques. Using
RNA interference, two independent human kinome libraries and a genome-wide
library were screened. By means of automated microscopy and image analysis, we
quantified the production of the cytokine IL-8, as well as Shigella cell invasion and
intracellular growth.
In the course of this thesis, the results found for inflammation signaling in epithelial
cells during Shigella infection are presented and a novel host mechanism amplify-
ing cytokine production is proposed (Chapter II). In a second part, a high-content
image-based siRNA screen for in vitro Shigella infections is introduced and pre-
liminary results from screening the human kinome are summarized (Chapter III).
Chapter II
Cell-Cell Propagation of NF-κB
Transcription Factor and MAP
Kinase Activation Amplifies Innate
Immunity against Bacterial Infection
This chapter has been published as:
Kasper CA, Sorg I, Schmutz C, Tschon T, Wischnewski H, Kim ML, Arrieumerlou C. Cell-
cell Propagation of NF-κB Transcription Factor and MAP Kinase Activation Amplifies Innate
Immunity against Bacterial Infection. Immunity, 33(5):804-16, 2010.
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1 Summary
The enteroinvasive bacterium Shigella flexneri downregulates inflammation by in-
jecting a set of effector proteins into the cytoplasm of infected epithelial cells. Yet,
massive production and secretion of cytokines, especially IL-8, is a hallmark of Shi-
gella infections. In our studies, we found a mechanism of cell-cell communication
that allows the infected cell to circumvent the action of effector proteins by prop-
agating inflammatory signals to uninfected bystander cells. These cells contribute
to a massive amplification of the immune response by expressing and secreting
proinflammatory cytokines.
By monitoring proinflammatory signals at the single-cell level, we found that the
activation of the transcription factor NF-κB is rapidly propagated to neighboring
cells within the first 15 minutes after infection. The MAP kinases JNK, ERK and
p38 were also found to be activated in cells adjacent to infected cells. While infected
cells did not produce cytokines, uninfected bystander cells were found to efficiently
express IL-8, TNFα and GM-CSF. Cytokine production in bystander cells was
also observed during Listeria monocytogenes and Salmonella typhimurium infec-
tions and could be reproduced in various cell lines including HeLa, Caco-2 and
HUVEC cells. Additionally, microinjection of peptidoglycan moieties was sufficient
to trigger the response. The cell-cell communication was found to be independent
of paracrine secretion, but instead was sensitive to gap junction inhibitors. Further-
more, overexpression of connexin 43, the protein forming gap junctions, massively
increased the number of bystander cells producing IL-8. Taken together, we have
identified a host mechanism that allows infected cells to propagate proinflamma-
tory signals to uninfected bystander cells thereby amplifying the immune response
during bacterial infections.
2 Statement of contribution
I conducted most of the experiments mentioned in the paper. Additionally, I per-
formed all quantifications that were based on image analysis. Additional experi-
ments were contributed by Isabel Sorg (microinjection, Fig. 5 and S5), Christoph
Schmutz (IL-8 upon infection with S. flexneri ∆ospF, Fig. 4E/F; validation of
Cx43 knockdown, Fig. S7F), Therese Tschon (in situ hybridization, Fig. 4B; in-
fections in Tnfr -/- MEF, Fig. 6A and S6A/B; TNFα and GM-CSF in bystander
cells, Fig. S4E-G), Man Lyang Kim (ELISA for IL-8 secretion, Fig. 4A) and Cécile
Arrieumerlou (Infections under flow conditions, Fig. 6D and S6D; Infections in HU-
VEC cells, Fig. S1A and S4D). The manuscript was written by Cécile Arrieumerlou
and myself.
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SUMMARY
The enteroinvasive bacterium Shigella flexneri uses
multiple secreted effector proteins to downregulate
interleukin-8 (IL-8) expression in infected epithelial
cells. Yet, massive IL-8 secretion is observed in Shig-
ellosis. Here we report a host mechanism of cell-cell
communication that circumvents the effector pro-
teins and strongly amplifies IL-8 expression during
bacterial infection. By monitoring proinflammatory
signals at the single-cell level, we found that the acti-
vation of the transcription factor NF-kB and the MAP
kinases JNK, ERK, and p38 rapidly propagated from
infected to uninfected adjacent cells, leading to IL-8
production by uninfected bystander cells. Bystander
IL-8 production was also observed during Listeria
monocytogenes and Salmonella typhimurium infec-
tion. This response could be triggered by recognition
of peptidoglycan and is mediated by gap junctions.
Thus, we have identified a mechanism of cell-
cell communication that amplifies innate immunity
against bacterial infection by rapidly spreading
proinflammatory signals via gap junctions to yet
uninfected cells.
INTRODUCTION
The ability of a host organism to mount an innate immune
response after pathogen infection is critical for survival. The
epithelial cells, which represent the first physical barrier to inva-
sive pathogens, play a critical role in this process. They act as
sentinels of the immune system and largely contribute to the
secretion of factors that orchestrate inflammation in infected
tissues. Infection by Shigella bacteria is a well-suited model to
analyze the complex host-pathogen interactions that shape the
immune response of intestinal epithelial cells (IECs) to invasive
bacteria (Phalipon and Sansonetti, 2007). Shigella are Gram-
negative foodborne bacteria that invade the colonic and rectal
epithelium of humans, causing an acute mucosal inflammation
called Shigellosis, responsible for 1.1 million deaths annually
(Schroeder and Hilbi, 2008).
Shigella flexneri, the etiological agent of the most endemic
form of Shigellosis, translocates across the intestinal epithelial
barrier by transcytosis through M cells. In the submucosal
area, S. flexnerimakes use of a type III secretion (T3S) apparatus
to trigger apoptosis in macrophages and to actively invade IECs
via their basolateral surface. The T3S apparatus is a syringe-like
nanomachine enabling the translocation of bacterial effector
proteins (Cornelis, 2006) that subvert various host cellular path-
ways in order to promote bacterial entry, modulate cell cycle,
and dampen inflammation signaling (Iwai et al., 2007; Parsot,
2009; Phalipon and Sansonetti, 2007). Once internalized, S. flex-
neri multiplies in the cytoplasm and uses actin-based motility to
spread to adjacent IECs. During infection, massive mucosal
inflammation is observed in the intestine of infected patients
(Islam et al., 1997). IECs are critical in this process. They sense
pathogenic invasion and respond by inducing a transcriptional
program whose major function is to stimulate innate immune
defense mechanisms. Shigella recognition by IECs occurs
essentially intracellularly via the pattern recognition receptor
Nod1 that recognizes the core dipeptide structure, g-D-glu-
tamyl-meso-diaminopimelic acid (Girardin et al., 2003), found
in the peptidoglycan of all Gram-negative and certain Gram-
positive bacteria (Kufer et al., 2006). Upon ligand recognition,
Nod1 homodimerizes and recruits the kinase RIPK2 (Strober
et al., 2006). This leads to the sequential recruitment and activa-
tion of the TAK1-TAB1-TAB2 and IKKa-IKKb-IKKg complexes
and the phosphorylation of inhibitor of NF-kB alpha (IkBa).
Once phosphorylated, IkBa undergoes polyubiquitination and
proteasomal degradation. NF-kB, released from IkBa, translo-
cates to the nucleus and upregulates expression of proinflam-
matory genes. TAK1 activation also leads to activation of the
MAP kinases c-Jun-N-terminal kinase (JNK) and p38 (Lee
et al., 2000; Ninomiya-Tsuji et al., 1999; Wang et al., 2001). The
MAP kinase ERK is also activated during S. flexneri infection of
IECs (Ko¨hler et al., 2002). NF-kB, JNK, ERK, and p38 contribute
collectively to the initiation of a proinflammatory program. JNK
and p38 regulate the activity of the transcription factor AP-1
(Holtmann et al., 1999). p38 and ERK control the access of chro-
matin to transcription factors via phosphorylation of histone H3
by the kinases MSK1 and MSK2 (Saccani et al., 2002). Among
the genes upregulated during infection of IECs, the chemokine
interleukin-8 (IL-8) plays a central role (Sansonetti et al., 1999)
by attracting polymorphonuclear cells (PMNs) from the periph-
eral circulation to the infected area to limit the spread of S. flex-
neri invasion.
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S. flexneri uses multiple strategies to downregulate inflamma-
tion. For example, T3 secreted effector proteins OspG and OspF
attenuate IL-8 expression by preventing IkBa degradation and
dephosphorylating nuclear p38 and ERK, respectively (Arbibe
et al., 2007; Kim et al., 2005; Li et al., 2007).
Despite the immunosuppressive activity of multiple bacterial
effector proteins, massive IL-8 expression is observed in IECs
during Shigellosis, suggesting that the secreted molecules may
partially block IL-8 expression or that a host mechanism
compensates for their effect. Here, we report the discovery of
a host cell-cell communication mechanism that circumvents
the bacterial effector proteins and amplifies IL-8 expression.
By monitoring proinflammatory signals at the single-cell level,
we found that, within minutes of infection, the activation of
NF-kB and the MAP kinases JNK, ERK, and p38, propagates
from infected to uninfected bystander cells. These cells, in which
signaling is not altered by bacterial effector proteins, represent
the main source of IL-8 secretion during S. flexneri infection.
Bystander IL-8 expression can be triggered by recognition of
peptidoglycan via Nod1 and is mediated by gap junctions.
Thus, we have identified a gap junction-mediated cell-cell com-
munication mechanism that strongly amplifies innate immunity
during bacterial infection by rapidly spreading proinflammatory
signals to yet-uninfected cells.
RESULTS
NF-kB Is Activated in Bystander Cells
of S. flexneri Infection
To better characterize the molecular mechanisms that control
inflammation during bacterial infection, we analyzed NF-kB acti-
vation at the single-cell level during S. flexneri infection of epithe-
lial cells. The nuclear translocation of the NF-kB p65 subunit,
which follows IKK-mediated IkBa degradation, was used as
readout for NF-kB activation and was visualized by immunofluo-
rescencemicroscopy. HeLa cells were infected with noninvasive
BS176 or wild-type invasive M90T S. flexneri strains at low and
high multiplicity of infection (MOI). As expected, extracellular
bacteria failed to activate NF-kB in HeLa cells as shown by the
fact that p65 remained exclusively cytosolic after infection with
BS176 S. flexneri (Figure 1A, top left). In contrast, cells infected
with M90T at MOI 20 showed massive nuclear localization of
p65, reflecting the detection of intracellular bacteria and activa-
tion of NF-kB (Figure 1A, top right). Surprisingly, when cells were
challenged with M90T at low MOI, a strong p65 nuclear translo-
cation was also observed in some cells that were not infected
(Figure 1A, bottom left). Single-cell measurements of S. flexneri
invasion and p65 nuclear/cytoplasmic ratio (NF-kB activation
ratio) confirmed that, at low MOI, more cells were NF-kB acti-
vated than infected (Figure 1A, bottom right). False color repre-
sentations of the NF-kB activation ratio clearly showed that unin-
fected NF-kB-activated cells were not randomly distributed in
the field of view but located in close proximity with infected cells
forming NF-kB activation foci around them (Figure 1B). A similar
pattern of NF-kB activation was observed during S. flexneri
infection of the colonic epithelial cell line Caco-2, the lung epithe-
lial cell line A549, and the human umbilical vein endothelial
cells (HUVECs) derived from umbilical cord (Figure S1 available
online), suggesting that bystander activation of NF-kB repre-
sents a broad response to S. flexneri infection.
During infection, S. flexneri uses actin-basedmotility to spread
to adjacent IECs. To control that bystander NF-kBactivation was
not due to bacterial intercellular motility, we examined NF-kB
activation in cells infected with the nonmotile virG deletion
mutant (DvirG) (Makino et al., 1986). As expected, DvirG bacteria
efficiently invaded HeLa cells (Figure 1C, right). However, unlike
wild-type (Figure 1C, left), they failed to form actin comet tails
and accumulated overtime in the perinuclear region (Figure 1C,
right). Interestingly, infection with the DvirG mutant induced
p65 nuclear translocation in infected and in bystander cells (Fig-
ure 1D) similarly to infection with wild-type S. flexneri (Figure 1A),
suggesting that bystander NF-kB activation was not caused by
intercellular motility, but reflected instead a novel host response
to bacterial infection. Because the intracellular microcolonies
formed by the DvirG mutant were easily detected by automated
image analysis, this mutant was used hereafter in our studies.
In order to further characterize bystander NF-kB activation, we
analyzed its kinetic during S. flexneri infection in HeLa cells.
Representative examples of bystander activation at different
time points were chosen for illustration (Figure 1E). Within
15 min of infection, NF-kB was almost exclusively activated in
infected cells. Then, at 30 min and up to 120 min, NF-kB activa-
tion was observed in infected and bystander cells, suggesting
that the signals underlying bystander NF-kB activation were
generated very early during infection (within 30 min) and propa-
gated from infected to bystander cells. Considering that each
infected cell was surrounded by approximately 2–6 NF-kB-acti-
vated cells, our results demonstrate that this mechanism of cell-
cell communication strongly amplifies the total NF-kB response
to S. flexneri infection.
JNK and ERK Are Also Activated in Bystander Cells
of S. flexneri Infection
The activation of the JNK signaling pathway is required to mount
an inflammatory response, and in particular, to induce IL-8
expression. We therefore tested, whether in addition to NF-kB,
the JNK pathway was also activated in bystander cells of S. flex-
neri infection in HeLa and Caco-2 cells. JNK activation was
analyzed by immunofluorescence microscopy via a phospho-
specific antibody that detects p46 and p54 JNKs phosphory-
lated at residues threonine 183 and tyrosine 185 (p-JNK). Cyto-
solic p65 localization and basal p-JNK staining indicated that
both pathways were inactive in control cells (Figure 2A). As ex-
pected, a clear nuclear translocation of p65 and a significant
increase of p-JNK were observed in S. flexneri-infected cells.
Interestingly, bystander cells of infection also showed an
increase of p-JNK, indicating that the JNK pathway was turned
on in these cells as well (Figure 2A and Figure S2A). This obser-
vation was confirmed by measuring with automated image pro-
cessing the degree of nuclear p-JNK in control, infected, and
bystander cell populations (Figure 2B, see Supplemental Exper-
imental Procedures).
In addition to JNK, the activation of ERK was analyzed by
immunofluorescence microscopy by means of an antibody that
recognizes p22 and p44 ERKs phosphorylated at residues thre-
onine 202 and tyrosine 204 (p-ERK). Representative images of
NF-kB and p-ERK at different time points were chosen for
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Figure 1. NF-kB Is Activated in Bystander Cells of S. flexneri Infection
(A) Nuclear localization of NF-kB p65 during S. flexneri infection. HeLa cells were infected for 1 hr with BS176 (MOI = 20, top left) and M90T (MOI = 20, top right;
MOI = 0.5, bottom left), stained with a p65 antibody, and visualized by fluorescence microscopy (p65 in red, S. flexneri in green). Arrows indicate S. flexneri.
Percent of NF-kB activated and infected cells at high and low MOI (bottom right, means ± SD of triplicate wells, graph representative of two independent exper-
iments). Scale bars represent 40 mm.
(B) False color representation of NF-kB activation ratio during S. flexneriM90T infection of HeLa cells. Stars indicate infected cells. Scale bar represents 40 mm.
(C) Actin-basedmotility ofS. flexneriM90T (left) andDvirGmutant (right). After infection, cells were stained for F-actin with phalloidin (F-actin in green, S. flexneri in
red). Scale bars represent 10 mm.
(D) Bystander NF-kB activation during infection with S. flexneri DvirG (left). p65 in red, S. flexneri in green. Arrow indicates S. flexneri. Percent of NF-kB activated
and infected cells at high and low MOI (right, means ± SD of triplicate wells, graph representative of two independent experiments). Scale bar represents
40 mm.
(E) Time course of p65 translocation during infection with S. flexneri DvirG. Representative images were selected for illustration. Scale bars represent 40 mm.
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illustration (Figure 2C). Within 15 min of infection, ERK activation
was observed in only a fraction of infected cells. At 30min and up
to 90 min, ERK was also activated in bystander cells of infection
(Figures 2C and 2D and Figure S2B). NF-kB and ERK activation
did not strictly correlate at the single-cell level. Indeed, after
45min of infection, ERK activation was no longer visible in a frac-
tion of infected or proximal bystander cells, suggesting that this
pathway was only transiently induced. Furthermore, ERK activa-
tion was observed in cells located outside the NF-kB activation
foci, suggesting that ERK activation preceded NF-kB activation
(Figures 2C and 2E). Altogether, these results suggested that
besides the activation of NF-kB, the activation of JNK and ERK
also propagates from infected to bystander cells during S. flex-
neri infection of HeLa and Caco-2 cells.
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Figure 2. JNK and ERK Are Activated in Bystander Cells of S. flexneri Infection
(A) Analysis of JNK and NF-kB activation by immunofluorescence microscopy. HeLa cells were left untreated or infected with S. flexneri DvirG at MOI = 0.5 for
90 min and costained with p65 and p-JNK antibodies. Arrows indicate S. flexneri. Scale bars represent 40 mm.
(B) Quantification of nuclear p-JNK intensity in control, infected (INF), and bystander (BST) cell populations by automated image processing (a.u., arbitrary units,
means ± SD of triplicate wells, graph representative of five independent experiments, *p = 7.2E-5, **p = 7.6E-4).
(C) Time course of ERK andNF-kBactivation during infection withS. flexneri.HeLa cells were infectedwithS. flexneriDvirG at MOI = 0.5 for indicated time periods
and costained with p65 and p-ERK antibodies. Scale bars represent 40 mm.
(D) Percent of ERK-activated cells during S. flexneri infection. Cells were infected for 1 hr at MOI = 5. Quantification was performed by automated image
processing as described in Supplemental Experimental Procedures (means ± SD of triplicate wells, graph representative of three independent experiments,
*p = 1.9E-3, **p = 4.7E-3).
(E) False color representations of NF-kB activation ratio and nuclear p-ERK 1 hr after infection with S. flexneri DvirG. Stars indicate infected cells. Scale bar repre-
sents 40 mm.
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p38 Activation and Histone H3 Phosphorylation Mainly
Occur in Bystander Cells of Infection
Because p38 activation is also critical for IL-8 expression, we
examined whether p38 was activated in bystander cells of
S. flexneri infection in HeLa and Caco-2 cells. p38 activation
was analyzed by immunofluorescence microscopy by means
of an antibody that detects p38 phosphorylated at residues thre-
onine 180 and tyrosine 182 (p-p38). As reported previously
(Arbibe et al., 2007), a very modest increase of p38 activation
was observed in infected cells (Figures 3A and 3B and Figure S3).
In contrast, a strong increase was found in bystander cells of
infection indicating that, in addition to NF-kB, JNK, and ERK,
p38 was also activated in these cells (Figures 3A and 3B and Fig-
ure S3). Signal transduction in infected cells is altered bymultiple
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Figure 3. p38 Activation and Histone H3 Phosphorylation Occur Mainly in Bystander Cells
(A) Analysis of p38 and NF-kB activation by immunofluorescence microscopy. HeLa cells were left untreated or infected with S. flexneri DvirG at MOI = 0.5 for
90 min and costained with p65 and p-p38 antibodies. Scale bars represent 40 mm.
(B) Quantification of nuclear p-p38 intensity in control, infected (INF), and bystander (BST) cell populations (a.u., arbitrary units, means ± SD of triplicate wells,
graph representative of five independent experiments, *p = 4.1E-3, **p = 1.0E-4).
(C) Phosphorylation of p38 in cells infected with DvirG or DvirG DospF S. flexneri visualized by immunofluorescence microscopy. Scale bars represent 40 mm.
(D) Quantification of nuclear p-p38 intensity by automated image processing in control, infected, and bystander cell populations during infection with DvirG or
DvirG DospF S. flexneri (means ± SD of triplicate wells, graph representative of five independent experiments, *p = 4.2E-3).
(E) Analysis of histone H3 phosphorylation by immunofluorescence microscopy. HeLa cells were left untreated or infected with S. flexneri DvirG at MOI = 0.5 for
90 min and costained with p65 and H3pS10 antibodies. Scale bars represent 40 mm.
(F) Quantification of nuclear H3pS10 intensity in control, infected, and bystander cell populations (means ± SD of triplicate wells, graph representative of five
independent experiments, *p = 4.9E-2, **p = 1.1E-3).
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effectors that translocate into the host cytoplasm via the T3S
apparatus. In particular, p38 is dephosphorylated in the nucleus
of infected cells by the phosphothreonine-lyase activity of OspF
(Li et al., 2007). Given that bystander cells showed massive
p38 activation, we hypothesized that the activation of p38 in
bystander cells was not affected by OspF. To test this assump-
tion, HeLa cells were infected with DvirG and DvirG DospF
S. flexneri mutants. As previously reported (Arbibe et al., 2007),
p38 activationwas restored in cells infectedwithDospF bacteria,
confirming the role of OspF in p38 dephosphorylation (Figures
3C and 3D). In contrast, the amount of p38 activation in
bystander cells remained unchanged (Figure 3D), indicating
that OspF failed to impair the ability of the host to spread p38
activation to neighboring cells. Taken together, our data showed
that the mechanism of bystander p38 activation circumvents the
suppressive activity of OspF in infected cells and amplifies p38
activation during S. flexneri infection.
In addition to its role in AP-1 phosphorylation, p38 controls
IL-8 expression by regulating chromatin accessibility to tran-
scription factors such as NF-kB via the phosphorylation of
histone H3 by MSK1 and MSK2 (Saccani et al., 2002). To assess
whether bystander p38 activation led to histone H3 phosphory-
lation in bystander cells, phosphorylation at serine 10 (H3pS10)
was analyzed by immunofluorescence microscopy via a phos-
pho-specific antibody. To minimize H3pS10 staining from
mitotic cells, HeLa cells were arrested in S phase by a double-
thymidine block. Consistent with the pattern of p38 activation
during S. flexneri infection, H3pS10 was higher in bystander
than infected cells (Figures 3E and 3F). Furthermore, the deletion
of ospF restored H3pS10 in infected cells but had no effect in
bystander cells (Figure 3F). Collectively, these results demon-
strate that p38 activation and the subsequent phosphorylation
of histone H3, which are both impaired in infected cells because
of the activity of OspF, are fully operating in bystander cells of S.
flexneri infection.
Cell-Cell Propagation of Proinflammatory Signals
Amplifies Cytokine Expression
The NF-kB, JNK, ERK, and p38 signaling pathways were turned
on in bystander cells of S. flexneri infection. Given that these
pathways control the expression of proinflammatory genes
including IL-8, we tested whether bystander cells of S. flexneri
infection secreted IL-8. IL-8 secretion was first measured by
an enzyme-linked immunosorbent assay (ELISA) in the superna-
tant of HeLa cells infected by S. flexneri at different MOIs. We
observed that the amount of secreted IL-8 decreased as the
MOI was raised (Figure 4A). Because low and high MOIs corre-
sponded to low and high infected to bystander cell ratios,
respectively (Figure S4A), this result suggested that IL-8 was
most probably secreted by bystander cells of infection. This
hypothesis was tested by in situ mRNA hybridization to visualize
at the single-cell level the amount of IL-8mRNA produced during
S. flexneri infection. As shown in Figure 4B, IL-8 mRNAs were
almost exclusively present in bystander cells of infection. To
confirm that bystander cells were the main IL-8-producing cells
during S. flexneri infection, we performed an intracellular IL-8
immunofluorescence microscopy assay in cells treated with
monensin, a protein transport inhibitor that blocks secretion
and enables intracellular IL-8 accumulation in the Golgi appa-
ratus (Mollenhauer et al., 1990). In line with the ELISA and the
mRNA data, almost no IL-8 was visible in infected cells, but
massive intracellular IL-8 accumulation was found in bystander
cells (Figures 4C and 4D). An average of 2.8 ± 1.6, 4.2 ± 2.5,
6.5 ± 4.7, and 29.3 ± 13.5 bystander IL-8-producing cells per
infected one was measured in HeLa, Caco-2, A549, and HUVEC
cells, respectively (Figures S4B–S4D). Interestingly, tumor
necrosis factor a (TNF-a) and granulocyte macrophage colony-
stimulating factor (GM-CSF), two other inflammatory cytokines
upregulated during S. flexneri infection of epithelial cells (Pe´dron
et al., 2003), were also found in bystander cells (Figures S4E–
S4G), suggesting that the mechanism of bystander activation
contributes to different facets of inflammation during infection.
Strong cytokine expression in bystander cells indicated that
cell-cell communication was not affected by S. flexneri effector
proteins. This was tested by investigating the effect of OspF
on IL-8 expression in infected and bystander cell populations.
As previously reported (Arbibe et al., 2007), an increase of IL-8
production was observed in cells infected with DospF S. flexneri
(Figure 4E). In contrast, the number of bystander cells producing
IL-8 was independent of OspF (Figure 4F) indicating that, in line
with our p38 activation and H3pS10 results, OspF failed to affect
IL-8 expression in bystander cells.
To further characterize the mechanism of bystander activa-
tion, we tested whether it also occurred after infection with Liste-
ria monocytogenes or Salmonella typhimurium, two enteroinva-
sive bacteria that induce IL-8 expression during invasion of
IECs (Eckmann et al., 1993). Consistent with data on S. flexneri
infection, IL-8 accumulation was also observed in bystander
cells of L. monocytogenes and S. typhimurium infection (Fig-
ure 4G) but at a lower frequency. In conditions where bystander
IL-8 expression was observed for nearly 100% of S. flexneri-
infected cells, it occurred for approximately 40% and 70% of
Listeria- and Salmonella-infected cells, respectively. In contrast
to S. flexneri infection, IL-8 accumulation was also detected in
a fraction of cells infected with L. monocytogenes or S. typhimu-
rium (approximately 20% and 40%, respectively), indicating that
these bacteria do not manipulate their host to the same extent as
S. flexneri, for which low levels of IL-8 were detected in less than
5% of infected cells (Figure 4E). Altogether these results show
that cell-cell communication between infected and uninfected
bystander cells leads to the potentiation of inflammatory cyto-
kine expression during bacterial infection. They also establish
that this is a general host response to invasive bacteria that
occurs with an amplitude and a frequency that vary between
cell types and pathogens.
Nod1-Mediated Peptidoglycan Sensing Is Sufficient
to Induce Bystander IL-8 Expression
During S. flexneri infection, the presence of intracellular bacteria
is sensed through peptidoglycan recognition by the intracellular
receptor Nod1 (Girardin et al., 2003). To determine whether
pathogen sensing via Nod1 was sufficient to induce bystander
IL-8 production, we monitored IL-8 accumulation after microin-
jection of the synthetic Nod1 ligand L-Ala-D-g-Glu-meso-diami-
nopimelic acid (TriDAP) into the cytoplasm of A549 cells. An
Alexa 488-labeled IgG antibody (IgG A488) was used as fluores-
cent marker to identify microinjected cells. In response to IgG
A488 microinjection, no IL-8 was detected (Figure 5A, left, and
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Figure 5B). In contrast, when TriDAP was combined with IgG
A488, both microinjected and bystander cells showed massive
intracellular IL-8 accumulation (Figure 5A, right, and Figure 5B).
To verify that IL-8 production was not caused by extracellular
TriDAP leaking during microinjection, the concentration of
TriDAP used in the microcapillary was uniformly applied to the
extracellular medium. In contrast to TNF-a, extracellular TriDAP
failed to induce IL-8 expression (Figure 5C and Figure S5).
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Figure 4. IL-8 Production by Bystander Cells Is a General Response to Bacterial Infection
(A) Measurements of IL-8 secretion by ELISA 6 hr after infection (means ± SD of triplicate wells, graph representative of two independent experiments).
(B) Visualization of IL-8 mRNA 2 hr after infection by in situ hybridization (IL-8 mRNAs in red, S. flexneri in green, Hoechst in blue, MOI = 2). Scale bar represents
40 mm.
(C) IL-8 accumulation in bystander cells of infection. IL-8 staining of monensin-treated HeLa cells 3 hr after infection (IL-8 in red, S. flexneri in green, Hoechst in
blue, F-actin in gray, MOI = 2). Scale bars represent 40 mm.
(D) Percent of infected and uninfected cells among all IL-8-producing cells (MOI = 1). Quantification was performed by automated image processing based on
the use of threshold intensity values for bacterial and IL-8 detection (means ± SD of triplicate wells, graph representative of three independent experiments,
*p = 3.9E-16).
(E) Percent of infected cells producing IL-8 during infection with DvirG and DvirG DospF S. flexneri (MOI = 5). Quantification was performed as described in (D)
(means ± SD of triplicate wells, graph representative of two independent experiments, *p = 4.5E-4).
(F) Number of uninfected cells producing IL-8 per site of infection during infection with DvirG and DvirG DospF S. flexneri (MOI = 1). Quantification was performed
as described in (D) (means ± SD of triplicate wells, graph representative of two independent experiments).
(G) IL-8 production (in red) in bystander cells during L. monocytogenes (MOI = 0.25, green) and S. typhimurium (MOI = 0.5, green) infection of A549 cells. F-actin in
gray, arrows indicate bacteria. Scale bars represent 40 mm.
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Together, these results suggested that Nod1-mediated recogni-
tion of intracellular TriDAP was necessary and sufficient to
induce IL-8 expression by bystander cells of microinjection.
Because Nod1-mediated recognition of peptidoglycan also
takes place in S. flexneri-infected cells, this result suggested
that pathogen sensing may be sufficient to trigger IL-8 expres-
sion in bystander cells of S. flexneri infection.
Bystander Activation Is Not Mediated by Paracrine
Signaling but Requires Cell-Cell Contact
Reports indicating that TNF-a is upregulated during S. flexneri
infection and that NF-kB, p38, ERK, and JNK are activated by
TNF-a suggested that this cytokine may induce bystander acti-
vation via paracrine signaling (Dong et al., 2002; Pe´dron et al.,
2003). This hypothesis was tested by examining bystander acti-
vation in tumor necrosis factor receptor 1 (TNFR1)-deficient
mouse embryonic fibroblasts (Tnfr1/ MEFs). Because mice
are deficient for the IL8 gene, the chemokine macrophage
inflammatory protein-2 (MIP-2) was chosen as readout of inflam-
mation. Whereas Tnfr1/ cells did not respond to TNF-a stimu-
lation, massive MIP-2 expression was observed in bystander
cells of S. flexneri infection (Figure 6A; Figures S6A and S6B),
indicating that TNF-a was not the mediator of bystander activa-
tion. To investigate the role of protein secretionmore broadly, we
tested whether this process was impaired when protein secre-
tion was abolished by the protein transport inhibitor brefeldin A
(BFA). For conditions of drug treatment that blocked phorbol
12-myristate 13-acetate (PMA)-induced IL-8 secretion (Fig-
ure S6C), BFA had no effect on bystander activation during
S. flexneri infection of Caco-2 cells (Figures 6B and 6C), suggest-
ing that cell-cell propagation of proinflammatory signals was not
mediated by secreted proteins.
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Figure 5. Intracellular Recognition of
a Nod1 Ligand Is Sufficient to Induce IL-8
Expression in Bystander Cells
(A) IL-8 accumulation in bystanders of microin-
jected A549 cells. After injection of IgG Alexa 488
alone (left) or combined with TriDAP (right), cells
were stained for IL-8, F-actin, and DNA (IgG
A488 in green, IL-8 in red, F-actin in gray, Hoechst
in blue).
(B) Number of IL-8-producing cells per injected
cell. Quantification was performed by counting
all IL-8-expressing cells located in contact withmi-
croinjected cells or other bystander cells (control,
n = 20; TriDAP, n = 21; *p = 1.0E-9).
(C) Percent of cells containing IL-8 after extracel-
lular treatment with TNF-a, IgG A488 alone, or
combined with TriDAP. Cells were stained for
IL-8 and DNA and analyzed by automated image
processing (means ± SD of triplicate wells, graph
representative of two independent experiments).
To further explore the hypothesis
of paracrine signaling, experiments of
S. flexneri infection were performed in
a flow chamber where fresh medium
was perfused to wash away any potential
secreted factors. A flow rate correspond-
ing to the replacement of the entire volume of the chamber every
second was used. IL-8 accumulation was still visible in
bystander cells of infection located along an axis perpendicular
or opposite to the direction of the flow (Figure S6D). Quantifica-
tion of IL-8 (Figure 6D) showed no effect of perfusion, indicating
that bystander activation was very improbably mediated by
a long-ranged diffusing soluble factor.
To characterize the mechanism of bystander activation, we
investigated whether it was cell-cell contact dependent. Infec-
tion was performed at subconfluent cell density to evaluate
IL-8 expression in Caco-2 cells that had no physical interactions
with infected cells. Inspection of images and manual quantifica-
tion indicated that IL-8 was exclusively found in cells having
direct or indirect contacts with infected cells and defined as
class 1 (Figures 6E and 6F). Class 2 cells present in the vicinity
of the infected cell (Experimental Procedures) but, separated
by a gap, did not exhibit markedly more IL-8 than class 3 cells
distant from any infection foci (Figure 6F). Collectively, these
results demonstrated that the expression of IL-8 in bystander
cells depends on cell-cell contact and is most probably not
mediated by paracrine signaling.
Cell-Cell Propagation of Inflammatory Signals
Is Mediated by Connexin Gap Junctions
An alternative hypothesis to paracrine signaling is direct
communication via gap junction channels formed by connexin
proteins. This hypothesis was directly tested by evaluating
the effect of the gap junction blocker 18b-glycyrrhetinic acid
(18b-GA) on IL-8 expression in bystander cells during S. flexneri
infection of Caco-2 cells. In conditions of drug treatment that
blocked Lucifer Yellow transfer through gap junctions of adja-
cent Caco-2 cells (Figure S7A), IL-8 expression in bystander
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cells of infection was strongly reduced (Figures 7A and 7B). In
contrast, TNF-a-induced IL-8 secretion, used as control, was
not affected (Figures S7B and S7C). A similar result was ob-
tained with the gap junction inhibitor carbenoxolone (Figures
S7D and S7E). Furthermore, treatment with glycyrrhizic acid,
a compound structurally related to 18b-GA but which fails to
block gap junction communication at concentrations below
100 mM (Davidson et al., 1986), had no effect on S. flexneri-
induced IL-8 expression by bystander cells (Figure 7B). Taken
together, these results suggested that IL-8 expression by
bystander cells of infection was mediated by communication
through gap junctions.
Because gap junction inhibitors have unspecific effects, we
further validated this finding by testing whether the propagation
of inflammatory signals was connexin dependent. In A431 cells
that are poorly coupled via gap junctions and express con-
nexin43 (Cx43) below the level of detection with antibodies
(Troyanovsky et al., 1994), very limited activation of NF-kB,
JNK, p38, and ERK and residual IL-8 expression were found in
bystander cells of S. flexneri infection (Figure 7C, left, and Fig-
ure 7D, top). In contrast, in Cx43-overexpressing A431 cells
(A431-Cx43) that are effectively coupled via gap junctions (Neijs-
sen et al., 2005), large foci of NF-kB, JNK, p38, and ERK activa-
tion and IL-8 expression were found around infected cells (Fig-
ure 7C, right, and Figure 7D, bottom). Quantification of IL-8
expression in consecutive A431 or A431-Cx43 bystander cells
by automated image processing, as described in Supplemental
Experimental Procedures, confirmed that the propagation of
IL-8 expression was Cx43 dependent (Figures 7D and 7E).
As expected, bystander IL-8 expression was strongly reduced
when A431-Cx43 cells were depleted of Cx43 by RNA interfer-
ence (Figure 7F and Figure S7F) or treated with 18b-GA (Fig-
ure 7G and Figure S7G).
In contrast to typical hemichannel-based signaling, com-
munication via gap junction channels requires connexin pro-
teins in both donor and recipient cells. To confirm that this
condition was fulfilled for bystander activation, the propagation
of inflammatory signals from S. flexneri-infected A431-Cx43
cells to either A431-Cx43 or A431 bystander cells was analyzed
in experiments where A431-Cx43 and A431 cells were mixed
prior seeding. Cx43, used to discriminate A431 and A431-
Cx43 cells, as well as IL-8 were detected by immunofluores-
cence. Whereas IL-8 expression robustly spread within con-
secutive A431-Cx43 cells, the propagation from infected
A431-Cx43 to adjacent A431 cells was very limited (Figure S7H).
This observation, quantified by automated image processing
(Figure 7H and Figure S7I), indicated that Cx43 proteins were
also required in uninfected bystander cells to efficiently poten-
tiate inflammation. Taken together, these data convincingly
showed that the propagation of inflammation during bac-
terial infection of epithelial cells depends on connexin gap
junctions.
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(A) MIP-2 expression in wild-type and Tnfr1/
MEF cells after TNF-a stimulation or S. flexneri
infection visualized by fluorescence microscopy.
After infection, cells were stained for MIP-2 and
DNA with a MIP-2 antibody and Hoechst, respec-
tively (MIP-2 in red, S. flexneri in green, Hoechst in
blue). Scale bars represent 20 mm.
(B) Bystander IL-8 expression in Caco-2 cells pre-
treated with BFA and infected with S. flexneri.
After infection (S. flexneri in green), cells were
stained for IL-8, DNA, and F-actin with an IL-8
antibody (in red), Hoechst (in blue), and phalloidin
(in gray), respectively. Scale bars represent
20 mm.
(C) Quantification of bystander IL-8 expression
upon BFA treatment by automated image anal-
ysis (means ± SD of triplicate wells, graph repre-
sentative of two independent experiments).
(D) Quantification of bystander IL-8 expression
under flow conditions. IL-8 was quantified by
measuring for each infected cell the area of IL-8
staining (a.u., arbitrary units, means ± SD,
n = 10, graph representative of two independent
experiments).
(E) Cell-cell contact analysis of bystander IL-8
expression. Caco-2 cells, seeded at subconfluent
density and infected with S. flexneri (in green),
were stained for IL-8 (in red) and F-actin (in
gray). Scale bar represents 50 mm.
(F) Fractions of IL-8-producing cells in class
1, 2, 3 cell populations as defined in Experimental
Procedures (means ± SD, n > 38, graph represen-
tative of two independent experiments).
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(A) Effect of 18b-GA on IL-8 expression during infection of Caco-2 cells. Cells were pretreatedwith 18b-GA, infectedwithDvirG S. flexneri, and stained for IL-8 and
F-actin with an IL-8 antibody and phalloidin, respectively (IL-8 in red, S. flexneri in green, F-actin in gray). Scale bars represent 50 mm.
(B) Quantification of IL-8 accumulation per site of infection in cells left untreated or pretreated with 18b-GA or glycyrrhizine. Quantification was performed by
automated image processing as described in Supplemental Experimental Procedures (means ± SD of triplicate wells, graph representative of two independent
experiments).
(C) Cell-cell propagation of proinflammatory signals in A431 and A431-Cx43 cells visualized by immunofluorescence. NF-kB p65, p-JNK, p-p38, and p-ERK
immunofluorescence staining in A431 cells (left) and A431-Cx43 cells (right) after S. flexneri infection (NF-kB p65, p-JNK, p-p38, and p-ERK in gray, S. flexneri
in red). Scale bars represent 40 mm.
(D) Propagation of IL-8 expression during S. flexneri infection of A431 and A431-Cx43 cells visualized by immunofluorescence. After infection, cells were
stained for IL-8 and DNA with an IL-8 antibody and Hoechst, respectively (IL-8 in red, S. flexneri in green, Hoechst in blue). Inserts show the infection foci
(magnification: 32.5). Scale bars represent 40 mm.
(E) Spatial propagation of IL-8 expression in consecutive A431 or A431-Cx43 bystander cells during S. flexneri infection (means ± SD of six wells; graph repre-
sentative of two independent experiments). Quantification was performed as described in Supplemental Experimental Procedures.
(F) Quantification of bystander IL-8 expression after siRNA-mediated Cx43 depletion. IL-8 was analyzed by immunofluorescence in A431 and A431-Cx43 cells
transfected with control or Cx43 siRNAs and infected with S. flexneri and quantified by automated image analysis (means ± SD of triplicate wells, graph repre-
sentative of two independent experiments, p = 3.9E-06).
(G) Quantification of bystander IL-8 expression in A431-Cx43 cells pretreated with 18b-GA and infected with S. flexneri (means ± SD of triplicate wells, graph
representative of three independent experiments).
(H) Spatial propagation of IL-8 expression from S. flexneri-infected A431-Cx43 cells into either A431-Cx43 or A431 adjacent cells. Each number corresponds to
the fraction of IL-8-producing cells for a given bystander cell position. Quantification was performed by automated image processing and is described in Supple-
mental Experimental Procedures (means ± SD of triplicate wells, graph representative of two independent experiments, p < 7.5E-04 at any given position).
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DISCUSSION
In the present study, we provide evidence that during S. flexneri
infection, the activation of the proinflammatory pathways NF-kB,
JNK, ERK, and p38 propagates from infected to uninfected
adjacent cells leading to IL-8 expression in bystander cells of
infection. This mechanism, mediated by gap junction communi-
cation between infected and uninfected cells, circumvents the
immunosuppressive activity of bacterial effectors and massively
amplifies inflammation during bacterial infection.
Nod1 contributes to the detection of intracellular S. flexneri via
the recognition of peptidoglycan-derived peptides (Girardin
et al., 2003). In infected IECs, Nod1 ligation leads to NF-kB acti-
vation and upregulation of proinflammatory genes. By using an
in vitro single-cell assay of S. flexneri infection, we found that
NF-kB activation was not restricted to infected cells. Indeed,
by performing infections at low MOIs, we observed within
minutes of infection the propagation of NF-kB activation from
infected to uninfected bystander cells. This cell-cell communica-
tion mechanism resulted in massive amplification of the total
NF-kB response to S. flexneri infection. Because NF-kB controls
the expression of proinflammatory genes, this result suggested
that the mechanism of bystander activation may amplify the
inflammatory response of an infected epithelial cell layer. This
hypothesis was supported by the observation that JNK, ERK,
and p38, three kinases involved in the control of inflammation,
were also activated in bystander cells of S. flexneri infection.
Noticeably, p38 activation was markedly higher in bystander
than infected cells, suggesting that the effector OspF, which
dephosphorylates p38 in the nucleus of infected cells via its
phosphothreonine-lyase activity, did not affect p38 bystander
activation. This hypothesis was validated by the observation
that the deletion of ospF enhanced p38 activation in infected
but not in bystander cells. Infection at low MOI reflects the early
phase of Shigellosis, when the number of bacteria that have
reached the basolateral surface of the IECs is limited. By rapidly
propagating NF-kB and MAP kinase activation to uninfected
cells, the mechanism of bystander activation may enable the
host to fully activate these signaling pathways before their
manipulation by future internalized bacteria, for instance via
the effectors OspG and OspF (Arbibe et al., 2007; Kim et al.,
2005).
The concept of bystander responses has been previously
described in the context of ionizing radiation where nonirradiated
cells receive signals from neighboring or distant irradiated
ones (Hamada et al., 2007), in wound healing (Yang et al.,
2004), or more recently after double-stranded DNA recognition
(Patel et al., 2009). In all cases, the activation of signaling path-
ways emanates from cells exposed to local stress and propa-
gates into the adjacent healthy tissue to amplify and orchestrate
a multicellular response to an aggression. Here, we provide
evidence for a similar mechanism in innate immunity against
pathogenic bacteria.
By attracting neutrophils to the infected area, IL-8 has a central
function in innate immunity against pathogens and in Shigellosis,
in particular. It has been proposed that IL-8 is secreted byS. flex-
neri-infected cells after recognition of intracellular peptido-
glycan-derived peptides via Nod1 (Girardin et al., 2003). Yet,
the immunosuppressive activity of several effectors that alters
signaling in infected cells challenges the ability of these cells to
secrete large amounts of IL-8 as observed in Shigellosis. To
directly address this question, we analyzed IL-8 expression
during S. flexneri infection at the mRNA and protein level by
in situ hybridization and intracellular immunofluorescence
microscopy, respectively, two methods that combine single-
cell resolution and spatial information at the site of infection.
Here, we showed that the propagation of NF-kB, JNK, ERK,
and p38 activation leads to IL-8 expression in bystander cells
of infection. This mechanism efficiently amplifies the total IL-8
response of the infected cell monolayer by increasing the
number of IL-8-producing cells per site of infection. Furthermore,
our results clearly demonstrated that infected cells were ineffi-
cient at producing IL-8, confirming the immunosuppressive
activities of secreted effectors on IL-8 expression. In line with
the effect of OspF on p38 and histone H3 phosphorylation,
IL-8 production was increased in cells infected with a DospF
mutant. However, the deletion of ospF had only a limited effect
on IL-8 expression, suggesting that the complete block
observed in infected cells is mediated by multiple effectors.
Additional effectors such as OspG, OspB, and IpaH9.8 may
also contribute to block IL-8 expression in infected cells (Kim
et al., 2005; Okuda et al., 2005; Zurawski et al., 2009). Interest-
ingly, we showed that OspF did not affect IL-8 expression in
bystander cells, indicating that through cell-cell communication,
the host appears to circumvent the activity of OspF in infected
cells and amplifies the global IL-8 response to S. flexneri infec-
tion. In the rabbit intestinal loop model of Shigellosis, IL-8
expression was found in epithelial cells located beyond the
zones of bacterial invasion, providing evidence for the physiolog-
ical relevance of bystander IL-8 expression in vivo (Sansonetti
et al., 1999).
IL-8 expression was also found in bystander cells of S. typhi-
murium and L. monocytogenes infection, showing that the
potentiation of innate immunity by cell-cell communication cor-
responded to a broad host response to bacterial infection.
However, the contribution of this mechanism to inflammation
can vary for different pathogens. It depends on its frequency of
occurrence but also on the ability of bacteria to alter signaling
in infected cells. For S. flexneri that very efficiently blocks
signaling in infected cells, bystander activation clearly consti-
tutes the key pathway of IL-8 expression.
We addressed the role of peptidoglycan recognition in the
mechanism of cell-cell communication leading to IL-8 expres-
sion in bystander cells and its underlying molecular basis. Inter-
estingly, we found that the microinjection of the Nod1 ligand
TriDAP was sufficient to induce IL-8 expression in bystander
cells of microinjection, suggesting that the recognition of Nod1
ligands in infected cells may be sufficient to generate the under-
lying signals that mediate IL-8 expression in bystander cells of
S. flexneri infection. Cell-cell communication can be mediated
by different mechanisms: paracrine signaling, direct diffusion
of small molecules through gap junctions, or membrane protein
interactions. In Caco-2 cells, bystander IL-8 expression was not
inhibited by BFA treatment or by perfusion, indicating that this
processwasmost probably notmediated by paracrine signaling.
Furthermore, it was cell-cell contact dependent, and therefore
compatible with gap junction-mediated communication that
enables direct diffusion of small molecules between adjacent
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cells. This hypothesis was confirmed by showing that the mech-
anism of bystander IL-8 expression was blocked by gap junction
inhibitors, limited in cells that are poorly coupled via gap junc-
tions, and massively amplified by the overexpression of the
gap junction protein Cx43. Finally, as required for the formation
of connexins gap junction channels between adjacent cells, we
showed that the presence of connexin proteins was necessary
in both infected and bystander cells to efficiently propagate
inflammation during bacterial infection.
Further studies are required to identify the small molecules
(i.e., <2 kDa) diffusing from infected to bystander cells that
control NF-kB, JNK, ERK, and p38 activation and lead to IL-8
expression during S. flexneri infection. Among potential candi-
dates, the roles of known second messengers, which are
involved in proinflammatory gene expression, including calcium,
IP3, and cAMP, should be examined. An alternative hypothesis is
the direct diffusion of small peptidoglycan-derived peptides
through gap junctions.
In summary, we show that during S. flexneri infection, the acti-
vation of the proinflammatory pathways NF-kB, JNK, ERK, and
p38 propagates from infected to uninfected adjacent cells
leading to IL-8 expression in bystander cells of infection. This
mechanism enables the host to circumvent the immunosuppres-
sive activity of bacterial effectors and to massively amplify
inflammation during bacterial infection. Moreover, by showing
that this process is gap junction mediated, we provide evidence
for a direct connection between gap junction communication
and amplification of innate immunity during bacterial infection.
EXPERIMENTAL PROCEDURES
Cell Culture
HeLa, A549, Caco-2, A431, and MEF cells were cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 10%FCS and 2mML-Gluta-
mine. HUVECs were generously provided by C. Dehio (Biozentrum, University
of Basel, Switzerland) and cultivated as previously described (Dehio et al.,
1997).
Bacterial Strains
The S. flexneri strains M90T wild-type, its noninvasive derivative BS176, and
the icsA (virG) deletion mutant were generously provided by P. Sansonetti
(Bernardini et al., 1989). The DvirG DospF deletion mutant was generated as
described in Supplemental Experimental Procedures (Table S1). The Salmo-
nella typhimurium LT2 strain was provided by U. Jenal (Biozentrum, University
of Basel, Switzerland) and the stably expressing GFP Listeria monocytogenes
A21/B5 strain by M. Loessner (ETH Zurich, Switzerland).
Infection Assays
S. flexneri, S. typhimurium, and L. monocytognes were used in exponential
growth phase. S. flexneri and S. typhimurium were coated with poly-L-lysine
prior to infection. Cells seeded in 96-well plates were infected at indicated
MOIs in DMEM supplemented with 10 mM HEPES and 2 mM L-glutamine.
After adding bacteria, plates were centrifuged for 5 min and placed at 37C
for indicated time periods. Extracellular bacteria were killed by gentamicin
(100 mg ml1). Infection assays were stopped by 4% PFA fixation.
Immunofluorescence and IL-8 Measurements
Immunofluorescence and IL-8 measurements were performed as described in
Supplemental Experimental Procedures.
Automated Microscopy and Image Analysis
Images were automatically acquired with an ImageXpress Micro (Molecular
devices, Sunnyvale, USA). Image analysis was performed via CellProfiler
(Carpenter et al., 2006) and MATLAB (The MathWorks, Inc, Natick, USA) as
described in Supplemental Experimental Procedures.
Microinjection and Flow Chamber Experiments
Microinjection and flow chamber experiments are described in Supplemental
Experimental Procedures.
Analysis of Cell-Cell Contact
Infection was performed at subconfluent cell density. Cellular contacts and
IL-8 were visualized by phalloidin and IL-8 staining, respectively. For each
site of infection, the distance between the infected cell and the most distant
bystander cell producing IL-8 was used as the radius of the ‘‘circle of
bystander activation’’ centered on the infected cell. Within this circle, cells
contacting directly the infected cell or indirectly by interacting with other
bystander cells were classified as class 1. Cells making no direct or indirect
contact with infected cells were defined as class 2. Cells located outside the
circle and distant from any sites of infection were defined as class 3.
Statistical Analysis
Data are expressed as mean ± standard deviation of triplicate samples.
p values were calculated with a two-tailed two-sample equal variance t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
doi:10.1016/j.immuni.2010.10.015.
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 SUPPLEMENTAL DATA 
 
SUPPLEMENTAL FIGURES AND LEGENDS 
 
Figure S1, relates to Figure 1. NF-B is activated in bystander cells during S. 
flexneri infection of Caco-2, A549 and HUVEC cells.  
(A) Caco-2 cells 
(B) A549 cells 
(C) HUVEC cells 
White arrows indicate bacteria. Bars, 50m.  
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Figure S2, relates to Figure 2. JNK and ERK are activated in bystander cells of 
S. flexneri infection in Caco-2 cells 
(A) JNK is activated in infected and bystander cells of S. flexneri infection in Caco-2 
cells. Control or virG infected cells (MOI=2, 90 minute infection) were stained for p-
JNK (overlay: S. flexneri in red, p-JNK in green). Bars, 20 m. 
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 (B) ERK is mostly activated in bystander cells of S. flexneri infection in Caco-2 cells. 
Control or virG infected cells (MOI=2, 90 minute infection) were stained for p-ERK 
(overlay: S. flexneri in red, p-ERK in green). Bars, 20 m. 
 
 
Figure S3, relates to Figure 3. p38 is activated in bystander cells of S. flexneri 
infection in Caco-2 cells 
p38 is activated in bystander cells of S. flexneri infection in Caco-2 cells. Control or 
virG infected cells (MOI=2, 90 minute infection) were stained for p-p38 (overlay: S. 
flexneri in red, p-p38 in green). Bars, 20 m. 
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Figure S4, relates to Figure 4. Proinflammatory cytokines are expressed in 
bystander cells of S. flexneri infection.  
(A) Infected to bystander cell ratios at different MOIs. HeLa cells were infected with 
the virG mutant at indicated MOIs. The ratio between infected and bystander cells 
was determined by automated image processing. Results represent the mean +/- SD 
of triplicate wells. The graph shows a representative of 2 independent experiments. 
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 (B) IL-8 production in bystander cells during S. flexneri infection of Caco-2 cells. 
Arrow indicates the infected cell (IL-8 in red, S. flexneri in green, Hoechst in blue, F-
actin in grey). Bar, 40 m. 
(C) IL-8 production in bystander cells during S. flexneri infection of A549 cells Arrows 
indicate infected cells (IL-8 in red, S. flexneri in green, Hoechst in blue, F-actin in 
grey). Bar, 40 m.  
(D) HUVEC cells were infected for 3 hours with S. flexneri virG. Bar, 50 m. 
(E) TNF- accumulation in bystander cells of S. flexneri infection in Caco-2 cells. 
TNF- staining of monensin-treated Caco-2 cells during infection (TNF- in red, S. 
flexneri in green, F-actin in grey). Bar, 20 m. 
(F) Quantification of TNF- expression during S. flexneri infection of Caco-2 cells. 
The vast majority of cells producing TNF- are uninfected cells. In conditions were 
2% of cells were infected, around 1% of all cells exhibited TNF- expression. Results 
represent the mean +/- SD of triplicate wells. The graph shows a representative of 2 
independent experiments, *p = 2.16E-06. 
(G) GM-CSF accumulation in bystander cells of S. flexneri infection in Caco-2 cells. 
GM-CSF staining of monensin-treated Caco-2 cells during infection (GM-CSF in red, 
S. flexneri in green, F-actin in grey). Bar, 20 m. 
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Figure S5, relates to Figure 5. Extracellular treatment with TriDAP failed to 
induce IL-8 expression.  
IL-8 staining in A549 cells left untreated or treated extracellularly with TNF-, IgG 
Alexa 488 alone or combined with TriDAP.  
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Figure S6, relates to Figure 6. S. flexneri-induced bystander IL-8 expression is 
not mediated by paracrine signaling but is cell-cell contact dependent.  
(A) Tnfr1-/- MEF cells are TNF--irresponsive. MIP-2 expression was not induced in 
response to TNF- stimulation in Tnfr1-/- MEF cells (mean +/- SD of triplicate wells, 
graph representative of 3 independent experiments, *p = 2.0E-03).  
(B) Massive bystander MIP-2 expression was found during S. flexneri infection of 
Tnfr1-/- MEF cells (mean +/- SD of triplicate wells, graph representative of 3 
independent experiments). 
(C) BFA blocks PMA-induced IL-8 secretion. Effect of BFA pretreatment on IL-8 
secretion measured by ELISA in the supernatant of resting or PMA-stimulated Caco-
2 cells (mean +/- SD of triplicate wells, graph representative of 2 independent 
experiments).  
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 (D) IL-8 expression in bystander cells of infection is not abolished under flow 
conditions. The direction of the flow is given by the white arrow (IL-8 in red, S. 
flexneri in green, F-actin in grey).  
 
Figure S7, relates to Figure 7. S. flexneri-induced bystander IL-8 expression is 
mediated by gap junctions. 
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 (A) Caco-2 cells have functional gap junctions that are sensitive to 18-GA. Lucifer 
Yellow transfer from microinjected to neighboring cells in absence or in presence of 
18-GA (Control: n=334, 18-GA: n=207). 
(B) TNF--induced IL-8 accumulation is not affected by 18-GA (5 M) in Caco-2 
cells. Bars, 50 m.   
(C) Effect of 18-GA and glycyrrhizic acid on TNF--induced IL-8 accumulation 
quantified by automated image analysis (a.u., arbitrary unit; mean +/- SD of triplicate 
wells, graph representative of 2 independent experiments).  
(D) Quantification of intracellular IL-8 accumulation per site of S. flexneri infection in 
cells left untreated or pretreated with carbenoxolone (mean +/- SD of triplicate wells, 
graph representative of 2 independent experiments).  
(E) Quantification of total IL-8 production in cells left untreated or pretreated with 
carbenoxolone following TNF- stimulation (mean +/- SD of triplicate wells, graph 
representative of 2 independent experiments). 
(F) siRNA-mediated depletion of Cx43 in A431-Cx43 cells. Cells were transfected 
with control or Cx43 siRNAs. Cx43 expression was analyzed 72 hours after 
transfection by a Cx43 immunoblot (top panel). Equal loading was verified with an 
actin immunoblot (bottom panel).  
(G) S. flexneri-induced bystander IL-8 expression is inhibited by 18-GA (5 M) in 
A431-Cx43 cells. Bars, 300 m.  
(H) Images illustrating the spatial propagation of IL-8 expression from S. flexneri 
infected A431-Cx43 cells into either A431-Cx43 or A431 adjacent cells. Left panels: 
Cx43 in green, S. flexneri in red, Hoechst in blue. Right panels: IL-8 in red, S. flexneri 
in green, Hoechst in blue. Arrows indicate infected cells. Bars, 40 m.  
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 (I) Sketch representing the analysis algorithm used to quantify the propagation from 
S. flexneri infected A431-Cx43 cells into either A431-Cx43 or A431 adjacent cells. 
Numbers represent the position of the cell in the “path” from the infected cell. Cells at 
position 1-4 were exclusively considered for analysis. Cells containing an “X” were 
excluded from analysis. Black arrows indicate A431 cells in contact with A431-Cx43 
producing IL-8. Dashed black arrows indicate invalid paths.  
 
SUPPLEMENTAL TABLES 
 
Mutant Forward Reverse 
∆ospF 
ATTCTATTATATAGATAAAATATCT
CCTGCAAAAGATACGGGTATTTT 
TGTGTAGGCTGGAGCTGCTTCG 
TCAAAAGTTCGATGTTCCACCACAT
CGACCGTAGAAGAGATGAGATAGTA
CATATGAATATCCTCCTTAG 
  
Table S1. Oligonucleotide primers used to generate the ospF mutant. 
The underlined sequences represent the priming sites used to amplify the cat 
resistance cassette from pKD3. 
 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES  
 
Bacterial strains 
All Shigella and Salmonella strains were transformed with the pMW211 plasmid to 
express the DsRed protein under control of a constitutive promoter. The pMW211 
plasmid was a generous gift from Dr. D. Bumann (Biozentrum, University of Basel, 
Switzerland).  
The virG ospF deletion mutant was generated from the virG mutant by allelic 
exchange using a modification of the lambda red-mediated gene deletion (Datsenko 
and Wanner, 2000). The genes for lambda red recombination were expressed from 
the pKM208 plasmid (Murphy and Campellone, 2003). The chloramphenicol 
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 resistance cassette (cat) of the pKD3 plasmid was amplified using the primers listed 
in Table S1. After DpnI digestion, the PCR product was electroporated into the virG 
mutant. Recombinants were selected on TSB plates containing 5 or 10 μg ml-1 
chloramphenicol. The cat cassette was removed by transformation of pCP20 and 
incubation at 30°C on TSB plates containing 100 μg ml-1 ampicillin. Single colonies 
were screened by PCR.  
 
Double-thymidine block 
HeLa cells were seeded in a 96-well plate at 2750 cells per well. The next day, 2 mM 
thymidine was added. After 19 hours, cells were washed and incubated with fresh 
growth medium for 9 hours. Thymidine was, then, added again for a period of 16 to 
18 hours. Cells were washed and infection performed as described above.  
 
Immunofluorescence  
After fixation, cells were permeabilized in 0.3-0.5% Triton X-100 for 10 minutes, 
incubated in PBS supplemented with 5% goat serum for 2 hours and then, overnight 
at 4°C, with different combinations of primary antibodies. NF-B p65 localization was 
visualized by using a mouse monoclonal anti-p65 antibody (Santa Cruz 
Biotechnology, Santa Cruz, USA). The phosphorylated forms of p38, JNK and ERK 
were stained with a rabbit monoclonal anti-phospho(T180/Y182)-p38, a rabbit 
polyclonal anti-phospho(T183/Y185)-SAPK/JNK and a rabbit monoclonal anti-
phospho(T202/Y204)-p44/p42 antibody (Cell signaling technology, Beverly, USA), 
respectively. The phosphorylated form of histone H3 was detected with a rabbit 
polyclonal anti-phospho(S10)-Histone H3 (Upstate signaling solution, Billerica, USA). 
Intracellular TNF- and GM-CSF were stained with a purified mouse anti-human 
TNF- and a purified rat anti-human GM-CSF antibody, respectively (BD 
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 Pharmingen, San Jose, USA). Cells were then stained with Cy5-, Alexa 647- or FITC-
conjugated secondary antibodies accordingly (Invitrogen, Carlsbad, USA). DNA and 
F-actin were stained with Hoechst and FITC-phalloidin, respectively.  
 
IL-8 and MIP-2 measurements  
IL-8 secretion was measured by ELISA in the supernatant of HeLa cells infected with 
S. flexneri for 6 hours. The cell-free supernatant from triplicate wells was analyzed for 
its IL-8 content using the commercial ELISA kit (BD Pharmingen, San Jose, USA). In 
situ hybridization of IL-8 mRNA was performed with the QuantiGene ViewRNA Plate-
Based Assay kit (Panomics, Fremont, USA) 2 hours after infection. Alternatively, the 
production of IL-8 and MIP-2 was measured by immunofluorescence using an anti 
human IL-8 antibody (BD Pharmingen, San Jose, USA) and an anti mouse MIP-2 
antibody (BD Pharmingen, San Jose, USA) 3 hours after infection. Monensin (50 M) 
was used in the infection assay to trap IL-8 and MIP-2 in intracellular compartments.  
 
Drug treatments 
When specified, cells were pretreated 30-60 minutes before infection with drugs at 
concentration indicated on the figures. Brefeldin A, 18-glycyrrhetinic acid, 
glycyrrhizine and carbenoxolone were from Sigma-Aldrich (Saint Louis, USA). 
 
siRNA transfection and western blot analysis 
A431-Cx43 cells were transfected with ON-TARGETplus SMARTpool siRNAs 
targeting Cx43 or ON-TARGETplus siCONTROL (Dharmacon, Dallas, USA). 72 
hours after transfection, cells were lysed in Phosphosafe Extraction Buffer (Novagen, 
Darmstadt, Germany) supplemented with 1x protease inhibitor cocktail (Calbiochem, 
Darmstadt, Germany). Protein concentration was measured using the bicinchoninic 
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 acid (BCA) kit (Pierce, Rockford, USA). Equal amounts of proteins were resolved by 
SDS-PAGE and transferred to Hybond C-Extra membrane (Amersham Bioscience, 
Pittsburgh, USA) for immunoblotting with a rabbit anti-Cx43 antibody or an anti actin 
antibody (Invitrogen, Carlsbad, USA). Primary antibody was detected using 
horseradish peroxidase-conjugated anti-rabbit and visualized with the ECL system 
(Pierce).  
 
Image acquisition and analysis 
At each site, images were acquired at 360 nm, 480 nm, 594 nm and 640 nm to 
visualize Hoechst, FITC-phalloidin or FITC-conjugated secondary antibodies, DsRed 
expressing S. flexneri and Cy5- or Alexa 647-conjugated secondary antibodies, 
respectively. For image analysis, the Hoechst staining was used as a mask to 
automatically identify cell nuclei. Cellular area was defined by extension of the 
nuclear mask. Subtraction of the nuclear area from the cellular area was used to 
define the cytoplasm.  
For each cell, the ratio of p65 intensity in the nucleus and in the cytoplasm, defined 
as the NF-B activation ratio, was calculated. In order to automatically quantify the 
fraction of NF-B activated cells, a threshold of activation (T) was automatically 
calculated as such that 90% of control cells remained below this value. In parallel, 
the presence of bacteria within the area of each cell was also quantified. S. flexneri 
bacteria express DsRed at high levels and are therefore very effectively detected by 
automated image analysis. For automated detection, the "Robust Background 
Adaptive" algorithm described by Carpenter et al. was used (Carpenter et al., 2006). 
Briefly, the "Robust Background" method trims the brightest and dimmest 5% of pixel 
intensities off first, in a way that the remaining pixels represent a gaussian of intensity 
values that are mostly background pixels. It then calculates the mean and standard 
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 deviation of the remaining pixels and calculates the threshold as the mean + 2 times 
the standard deviation. As this is a dynamic method, the threshold value was 
calculated for each image. Performance of bacterial detection was checked by visual 
inspection of several images prior to automated processing. In control images (no 
infection), the algorithm generally classified less then 1% of cells as infected.  
Based on these measurements, cells containing bacteria and showing a NF-B 
activation ratio > T were defined as infected cells. Cells, which did not contain 
bacteria, but had a ratio > T were classified as bystanders. The nuclear mask was 
used to measure activation of MAP kinases or histone H3 for infected and bystander 
cell populations. To automatically quantify the fraction of ERK activated cells, a 
threshold based on p-ERK nuclear intensity was defined as described above. For 
Caco-2 cells, the intracellular accumulation of IL-8 was quantified by measuring the 
area of IL-8 granules in uninfected cells using threshold intensity and size exclusion 
values. In the experiment performed to test the effect of BFA, we used a lower 
threshold intensity value for IL-8 detection combined to a higher threshold value for 
size exclusion.  
 
Microinjection 
For microinjection, A549 cells were seeded subconfluently in 35 mm μ-dishes (Ibidi, 
Munich, Germany). Cells were microinjected with L-Ala-D--Glu-meso-diaminopimelic 
acid (TriDAP; 2 μg ml-1 in PBS from AnaSpec, San Jose, USA) using Eppendorf 
Femtotips II capillaries and an Eppendorf FemtoJet with an injection pressure (pi) of 
80 hPa. For identification of injected cells, the goat anti-rabbit-IgG-Alexa 488 
antibody (0.5 mg ml-1) was co-injected with TriDAP. Control cells were injected with 
the IgG-Alexa 488 antibody alone. After microinjection, growth medium containing 50 
μM monensin was added. After 3 hours, cells were fixed, stained for IL-8, and 
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 analyzed with a Revolution XD spinning disk confocal microscope (Andor technology, 
Belfast, Ireland). For dye transfer experiments, Caco-2 cells were microinjected with 
a solution containing LY and the anti-rabbit-IgG-Alexa 594 antibody. LY transfer to 
neighboring cells was analyzed 10-15 minutes after microinjection.  
 
Flow chamber experiments 
Caco-2 cells were seeded in a flow chamber (Ibidi, Munich, Germany) and used at 
confluency. For infection, bacteria were added to cells and the chamber centrifuged 
at 37°C for 10 minutes. A constant perfusion of pre-warmed assay medium was then 
immediately started at a flow rate of 1.5 ml min-1. After 1 hour, this solution was 
replaced by a solution containing 50 μM monensin and 100 g ml-1 gentamicin. After 
2 more hours, cells were fixed and stained for IL-8.  
 
Quantification of the propagation of IL-8 expression during S. flexneri infection 
of A431 and A431-Cx43 cells 
Quantification of the propagation of IL-8 across infection foci was performed by 
automated image analysis as follows. The "MeasureObjectNeighbors" analysis 
module of CellProfiler was used to classify cells into different subgroups based on 
their position relative to the infected cell: uninfected cells in direct contact with the 
infected cell belong to the subgroup "Position 1" (P1), uninfected cells in contact with 
P1 cells belong to P2, outer uninfected cells in contact with P2 cells belong to P3 et 
cetera. For each subgroup, the fraction of IL-8 positive cells was measured and 
compared between the two cell lines.  
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 Quantification of the propagation of IL-8 expression in mixed A431 and A431-
Cx43 cell populations 
In order to test whether Cx43 expression was required in bystander cells, the 
propagation from S. flexneri infected A431-Cx43 cells to either A431-Cx43 or A431 
cells, was analyzed. Cells were mixed prior seeding in the A431/A431-Cx43 ratios 
(70/30) and (10/90) and infected with S. flexneri at MOI 0.5 the next day. One hour 
after adding bacteria, cells were treated with monensin to trap IL-8 intracellularly. 
Following infection, cells were stained by immunofluorescence for IL-8 and Cx43, 
used here to identify A431 and A431-Cx43 cells (Cx43 negative: A431 cells, Cx43 
positive: A431-Cx43 cells). Cells surrounding S. flexneri infected A431-Cx43 cells 
were exclusively considered. For all these bystander cells, the position relative to the 
infected cell (positions 1 to 4 were only considered for analysis), as well as the 
identification of their neighbors, were defined by the "MeasureObjectNeighbors" 
analysis module of CellProfiler. In addition, the intensity of Cx43 and IL-8 was 
quantified for all cells. The propagation from infected A431-Cx43 to bystander A431-
Cx43 cells (A431/A431-Cx43 ratio 10/90) was quantified by measuring IL-8 
expression in A431-Cx43 cells that were in direct contact with infected cells (position 
1) or were connected to infected cells via other A431-Cx43 cells (positions 2,3,4 of 
the "A431-Cx43 path"). Alternatively, the propagation from infected A431-Cx43 to 
A431 cells (A431/A431-Cx43 ratio 70/30) was quantified by measuring IL-8 
expression in A431 cells having direct contact with infected A431-Cx43 cells (position 
1) or in adjacent A431 cells connected to infected cells exclusively via A431 cells 
(positions 2,3,4 of the "A431 path"). A431 cells in contact with uninfected A431-Cx43 
producing IL-8 cells were excluded from our analysis. A sketch illustrating the 
algorithm used for analysis is illustrated in Figure S7H.  
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Chapter III
Probing Shigella cell invasion,
intracellular growth and propagation
of inflammatory signals by
high-content image-based RNAi
screens
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1 Summary
The foodborne enteroinvasive bacterium Shigella flexneri infects the colonic epithe-
lium in humans causing an acute mucosal inflammation, also known as shigellosis.
In the submucosa, the pathogen actively invades intestinal epithelial cells (IECs)
by a so-called "trigger mechanism". S. flexneri makes use of a type III secretion
system (T3SS), a syringe-like nanomachine, to inject several effector proteins into
host cells. By targeting factors of the cytoskeletal machinery, these effectors induce
the formation of filapodial and lamellipodial extensions that engulf the invading
bacterium. Upon successful invasion, Shigella rapidly lyses the surrounding vac-
uole and replicates within the cytoplasm of infected cells. Infected IECs sense the
presence of intracellular bacteria and activate proinflammatory signaling cascades
in order to mount an innate immune response. Although several T3SS effectors
downregulate inflammation signaling in infected cells, massive production and se-
cretion of cytokines are observed during shigellosis. In fact, epithelial cells were
found to propagate proinflammatory signals to uninfected bystander cells, thereby
evading the immunosuppressive activity of effectors and strongly amplifying the
production of cytokines.
In this chapter, the implementation of a high-content RNAi screen to study aspects
of Shigella infection is reported. Using automated microscopy and image analy-
sis, cell invasion, intracellular growth and production of cytokines in bystander
cells during S. flexneri infection were quantified. To validate the assay, control
knockdowns of genes previously described in the context of Shigella infection were
performed. Furthermore, the reproducibility of the different readouts was quanti-
fied. Finally, results from screens performed on two kinome libraries from different
suppliers were compared.
2 Statement of contribution
All experiments mentioned in this chapter were performed by myself. Additionally,
I have optimized and validated the experimental protocols used for the screens
according to the standards defined by the InfectX research consortium. Prepara-
tion and spotting of siRNA kinome libraries was performed by Simone Muntwiler
and Simone Eicher (group of Ch. Dehio, Biozentrum, University of Basel). Image
analysis procedures were established by Mario Emmenlauer (group of Ch. Dehio,
Biozentrum, University of Basel) and myself. Eva Pujadas, Vincent Rouilly and
Michael Podvinec (Research IT, Biozentrum, University of Basel) have developed
the image analysis environment iBRAIN2. Data aggregation and feature Z scoring
was implemented by Pauli Rämö (group of Ch. Dehio, Biozentrum, University of
Basel). The data management software openBIS was developed by the group of
Bernd Rinn (CISD, ETH Zurich).
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3 Introduction
The enteroinvasive pathogen S. flexneri infects the colonic epithelium of humans
upon ingestion of contaminated water or food. The Gram-negative pathogen causes
an acute inflammation of the mucosa, called shigellosis, responsible for 1.1 million
deaths every year130. In the submucosa, S. flexneri infects intestinal epithelial
cells (IECs) by a so-called "trigger mechanism". Upon successful invasion, Shigella
starts to replicate and can spread throughout the tissue by actin-based motility135.
Intracellular bacteria are sensed by the pathogen recognition receptor Nod1 that
initiates an inflammatory response44.
When reaching the gut, S. flexneri crosses the intestinal epithelium by transcytosis
through M cells and evades the killing by macrophages117,159. Released into the sub-
mucosal space, S. flexneri interacts with receptors CD44 and α5β1 integrin on the
cell surface of intestinal epithelial cells (IECs)185,187. To invade IEC, the pathogen
makes use of a type III secretion system (T3SS), a syringe-like nanomachine, which
allows the translocation of effector proteins into the host cell cytoplasm. A sub-
set of these effectors induces membrane ruffles by targeting the host’s cytoskeletal
machinery. In the vicinity of entry foci, an increase in polymerized actin forming
filopodial and lamellipodial extensions is observed179. This process is controlled by
the small GTPases Rac1 and Cdc42192,193. The tyrosine kinases Src and Abl1/2 are
involved in the activation and membrane recruitment of the small GTPases196,201.
Src, in turn, is localized to entry sites by interaction with the bacterial translocator
protein IpaC200. The activation of Rac1 and of Cdc42 is further promoted by the
Shigella effector IpgB1209,212. Additionally, proteins of focal adhesions are associ-
ated with S. flexneri cell invasion. The small GTPase Rho is recruited to sites of
entry where it controls actin stress fibers and contributes to phosphorylation of
the focal adhesion kinase (FAK) by PKC217,218,226. The activation of FAK is en-
hanced by the bacterial translocator proteins IpaB/C, possibly through outside-in
signaling by the α5β1 integrin receptor189. FAK controls focal adhesion formation
through phosphorylation of paxillin and vinculin218. On the other hand, the effector
IpaA was reported to disrupt focal adhesions and stress fibers by interacting with
vinculin and Rho221,224,226. Moreover, the effector VirG promotes cell invasion by
destabilization of microtubules236,238. The concerted action of S. flexneri effectors
thus promotes the internalization of the bacteria in a process involving cytoskeletal
rearrangements, focal adhesions and microtubule destabilization.
Upon successful cell invasion, Shigella rapidly lyses the surrounding vacuole and is
released into the cytoplasm of IECs, which represents the main replicative niche for
the pathogen. Efficient replication (i.e. generation time less than 40 minutes) re-
quires a high degree of adaptation, which is highlighted by the fact that almost 25%
of the genes are significantly up- or downregulated in intracellular bacteria259. Nev-
ertheless, little is known about critical factors for successful survival and replication
in infected cells. The access to carbon sources and nutrients (e.g. iron, magnesium
and phosphate) has been suggested as important determinant for growth259,264.
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Furthermore, the pathogen needs to sustain oxidative stress265 and avoid killing
by autophagy163. Finally, S. flexneri injects effector proteins IpgD and Spa15 to
promote host cell survival235,266,270.
Infected IECs are able to sense intracellular S. flexneri through the pathogen recog-
nition receptor Nod1, which detects peptidoglycan moieties released from the bac-
terial surface44. Upon ligand binding, Nod1 triggers downstream signaling cascades
leading to the activation of NF-κB and the MAP kinases JNK and p3843,121. The
MAP kinase ERK is also activated in infected cells122. Collectively, these signals
promote the transcription of proinflammatory genes that will initiate an innate
immune response. Among these genes, the cytokine IL-8 was shown to be strongly
upregulated119. IL-8 plays a central role in the immune response to Shigella invasion
by recruiting polymorphonuclear cells (PMNs) to the site of infection123. Remark-
ably, S. flexneri translocates several effector proteins to downmodulate inflam-
mation. The effector OspG, for instance, interferes with NF-κB activation, while
OspF dephosphorylates the MAP kinases p38 and ERK125,126,278. An explanation
for these conflicting observations was recently provided, when infected cells were
shown to propagate inflammatory signals to their uninfected bystander cells304.
While infected cells were not able to express cytokines, this capacity was restored
in activated bystander cells. Moreover, it was shown that this cell-cell communi-
cation is mediated by gap junctions, although the precise molecular mechanism
remains currently unknown304.
In this chapter, the implementation of a high-content RNAi screen to study aspects
of Shigella virulence is introduced. Using automated microscopy and image anal-
ysis, cell invasion, intracellular growth and production of cytokines in bystander
cells during S. flexneri infection were quantified. To validate the assay, control
knockdowns of genes previously described in the context of Shigella invasion and
bystander activation were performed. Furthermore, reproducibility of the assay and
the different readouts were investigated. Finally, results from screens performed on
two kinome libraries from different suppliers were compared.
The high-content RNAi screen on Shigella cell invasion is part of the InfectX
project*, which compares results on pathogen entry from standardized RNAi screens
covering five bacterial (Bartonella, Brucella, Listeria, Salmonella and Shigella) and
four viral (adenovirus, rhinovirus, rotavirus and vaccinia) pathogens.
*The InfectX project is funded by the Swiss Initiative in Systems Biology. More information
about InfectX is available on the project homepage:
http://www.systemsx.ch/projects/systemsxch-projects/research-technology-and-development-
projects-rtd/infectx/
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4 Results
4.1 Implementation and optimization of an in vitro infection
assay for RNAi screens
To identify new proteins involved in S. flexneri cell invasion and intracellular
growth, as well as bystander IL-8 production, the in vitro infection assay previ-
ously described by Kasper et al.304 was adapted to be adequate for high-throughput
screening. The assay was upscaled from 96-well plates to 384-well plates. All liq-
uid handling steps, including siRNA transfection, cell seeding, infection, addition
of drugs, fixation and immunofluorescence staining, were automated using liquid
dispensers and pipetting robots.
To comply with the standards defined by the InfectX consortium, we used HeLa
CCL-2 cells instead of HeLa Kyoto α. Infections were performed using the non-
motile S. flexneri M90T ∆virG strain, which forms microcolonies when replicating
within cells and is therefore advantageous for image analysis304. To discriminate
between intra- and extracellular bacteria, S. flexneri ∆virG was transformed with a
plasmid coding for the fluorophore DsRed under control of the uhpT promoter. The
uhpT gene is part of an operon coding for a hexose phosphate transport system,
which is highly conserved among E. coli, S. typhimurium and S. flexneri305,306. The
expression of UhpT is strongly upregulated in response to the presence of glucose-6-
phosphate259,264 and therefore serves as an excellent sensor for intracellular Shigella.
Infections with S. flexneri carrying the plasmid reveal an increase in fluorescence
about two hours post infection and a strong signal is recorded after 3-3.5 hours of
infection (data not shown).
To promote adhesion to the cell surface, plates were centrifuged after adding the
bacteria. Extracellular bacteria were killed by adding gentamicin 30 minutes post
infection. At the same time, secretion was blocked by adding monensin307. This
allows to intracellularly trap cytokines, which would otherwise get secreted. After
a total infection time of 3.5 hours, cells were fixed and stained for DNA, F-actin and
the cytokine IL-8 using appropriate dyes and antibodies. By means of automated
microscopy, images from all wells were acquired and stored for subsequent image
analysis. A detailed description of the experimental procedures can be found in
section 5 of this chapter and an overview of the workflow is presented in Figure
III.1.
The different steps of the experimental workflow were optimized for quality, use
of reagents and reproducibility. Conditions for siRNA transfection were tested by
members of the InfectX consortium and subsequently standardized for all screens.
Reproducibility of the infection rate was significantly increased by using frozen
aliquots of bacterial culture for inoculation of day cultures, instead of inoculating
with colonies from agar plates. Infections on test plates revealed that an estimated
multiplicity of infection (MOI) of 15 results in a reproducible infection rate of 40%
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(data not shown). However, quantification of the infection rate on test plates re-
vealed the presence of plate effects. Displaying the infection rate as heat map with
respect to the position on the plate showed lower values for the left edge of the
plate, which gradually increased towards the right edge of the plate (Figure III.2).
One possible explanation for the presence of the gradient would be temperature
differences introduced during centrifugation. This was confirmed as the gradient
changed its orientation when plates were rotated by 180◦ prior to centrifugation.
While the differences in infection rate measured between the left and right edge
were initially up to 50%, the effect could be reduced to below 10% by shortening
the duration of centrifugation and by thoroughly equilibrating temperature in the
centrifuge before every run. Additionally, remaining temperature differences are
equilibrated more rapidly by incubating the assay plates on metal blocks that re-
main in the incubator. Figure III.2 presents the gradient in infection rate measured
by averaging all plates obtained from screening the Dharmacon kinome library (left)
and the Ambion kinome library (right).
4.2 Quantification of infection rate, intracellular growth and
bystander IL-8 production by automated image analysis
In order to identify the genes that alter the infection rate, intracellular growth or
bystander IL-8 production when depleted by RNAi, an automatic quantification
of the acquired images was established. For that purpose, the open source soft-
ware CellProfiler308 was used and extended by custom modules implemented in
MATLAB. The image analysis pipeline segments cell nuclei, the cell body, bacte-
rial microcolonies and IL-8 granules using object detection algorithms. For every
segmented object, features including intensities, area or shape can be extracted.
Bacterial microcolonies and IL-8 granules are additionally assigned to the cell that
contains them. Certain readouts (e.g. cell number) represent basic features, which
are determined during the image analysis procedure. However, most of the readouts
are only calculated after the image analysis, as they result from the combination of
several features. The infection rate is calculated by summing all cells containing at
least one bacterial object and by dividing by the total number of cells. The score for
intracellular replication of S. flexneri (referred to as intracellular growth) is quan-
tified by averaging the area occupied by bacterial microcolonies in infected cells.
Bystander IL-8 production is measured by calculating the fraction of uninfected
cells that contain IL-8 objects. To record the spread of proinflammatory signals,
the fraction was calculated depending on the distance to infected cells (direct con-
tact with infected cell, connected to infected cell by one uninfected cell,. . . ). In
this chapter, only cells directly neighboring infected cells are used to calculate the
fraction of IL-8 producing cells (referred to as bystander IL-8 production).
To validate knockdown efficiency and quantification of the main readouts, control
small interfering RNAs (siRNAs) were included into the screens. Non-targeting
III. High-content image-based RNAi screen -95-
Figure III.1 Assay setup for the high-content image-based RNAi screen. The siRNA
library from the supplier is diluted to the appropriate concentration and spotted into 384-well
plates. Transfection reagent is aliquoted into each well using an automated dispenser. HeLa CCL-
2 cells are seeded and incubated for 72 hours allowing the knockdown of the target gene. Cells
are then infected with a non-motile strain of S. flexneri M90T carrying a plasmid coding for
the fluorophore DsRed, which only gets expressed once the bacterium is intracellular. Plates are
briefly centrifuged and subsequently incubated at 37◦C. 30 minutes post infection, extracellular
bacteria are killed by adding gentamicin. Furthermore, secretion is blocked by adding monensin
allowing to trap IL-8 produced during infection. After a total infection time of 3.5 hours, cells are
fixed and stained for DNA, F-actin and IL-8. An automated microscope acquires images for all
wells at 4 different wavelengths. Afterwards, images are analyzed by specialized software and data
is stored for browsing and visualization. Detailed protocols of the screening assay are presented
in section 5 of this chapter.
Figure III.2 The infection rate is subject to plate effects. (A) Results from the Dharmacon
kinome library. The infection rate determined by automated image analysis was averaged over
all plates from 4 independent replicates (12 plates in total). The resulting average infection rate
is represented as a heat map with respect to the localization on the 384-well plate. (B) Results
from the Ambion kinome library. The infection rate determined by automated image analysis was
averaged over all plates from 2 independent replicates (12 plates in total). The resulting average
infection rate is represented as a heat map with respect to the localization on the 384-well plate.
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siRNAs and siRNAs targeting GFP were used as negative controls. Additionally,
some wells did not receive any siRNA (mock treated wells). The transfection effi-
ciency was validated by using siRNA against KIF11, which is known to result in
cell death when depleted from cells309. Figure III.3 (panels A and C) illustrates the
impact of a KIF11 knockdown on cell number. The negative control siRNAs only
mildly affect cell number (except for the Ambion EGFP siRNA). Mock treated
wells have consistently higher cell numbers. Noteworthy, several kinases included
in the kinome libraries (Figure III.3, panel A and C, siRNA) lead to a similar de-
crease in cell number as a KIF11 knockdown. The strong reduction in cell number
by KIF11 knockdown was stably reproduced in all assays, arguing for an efficient
and reproducible transfection efficiency.
To validate the assay with a functional readout, siRNAs against genes, which have
previously been associated with Shigella cell invasion, were included. As general
control for all InfectX screens, siRNA against ARPC3, a subunit of the Arp2/3
complex, and CDC42, a small GTPase important for the control of cytoskeletal
rearrangements, were chosen. In the Dharmacon kinome screen, we additionally
included siRNAs against the catalytic subunit of phosphatidylinositol 4-kinase
(PIK4CA) and ADP-ribosylation factor 1 (ARF1), for which we had previously
observed a reduction in Shigella cell invasion (S. Weichsel, unpublished results).
Figure III.3 (panels B and D) illustrates the effect of the different control siRNAs
on infection rate quantified by automated image analysis. For siRNA from both
suppliers, the ARPC3 knockdown results in a reduced infection rate. Similarly,
CDC42 knockdown significantly decreases invasion. However, only two siRNA se-
quences from Ambion show a reduction, while the third one has the opposite effect.
The reduction of invasion previously observed for an ARF1 knockdown could not
be reproduced in this assay. PIK4CA knockdown even resulted in a moderate in-
crease in infection rate. Eventually, these deviating observations result from the
modified experimental conditions (e.g. different cell line and transfection reagent).
Generally, the impact of positive controls on infection rate was not as strong as
expected. To further investigate this finding, knockdown efficiency of the positive
controls should be validated by western blotting. Noteworthy, the CDC42 knock-
down as well significantly reduces microcolony size (Figure III.3 panel F, CDC42),
which might indicate that the invasion process is delayed rather than inhibited.
In fact, several siRNAs from the kinome libraries show much more pronounced
changes in infection rate (Figure III.3, panel B and D, siRNA), indicating that the
assay is capable of detecting knockdowns affecting Shigella cell invasion.
Knockdowns for MAP3K7 (TAK1), CHUK (IKKα) and NOD1 were chosen as
positive controls for bystander IL-8 production, as these proteins are involved in the
signaling cascade downstream of Nod1-mediated pathogen recognition76. Depletion
of MAP3K7 consistently reduced bystander IL-8 production (Figure III.3, panel E).
Knockdown of CHUK did only result in a small decrease, while Nod1 knockdown
even moderately increased bystander IL-8 production (Figure III.3, panel E). To
pursue this observation, knockdown efficiency of the positive controls should be
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Figure III.3 Effect of the different control siRNAs on the main readouts. (A) Quantifi-
cation of cell number using siRNA from Ambion. The effect of negative control siRNAs (SISEL
NC1, SISEL NC2 and EGFP; grey) and the positive control KIF11 (red) on cell number are
represented. As reference, results from mock treated cells (MOCK; yellow) and from the Ambion
kinome library (siRNA; grey) are indicated. (B) Quantification of infection rate using siRNA from
Ambion. The effect of negative control siRNAs (SISEL NC1, SISEL NC2 and EGFP; grey) and
positive controls (ARPC3, CDC42; red) on infection rate are represented. As reference, results
from the Ambion kinome library (siRNA; grey) are indicated. (C) Quantification of cell number
using the siRNA from Dharmacon. The effect of negative control siRNAs (SCRAMBLED, GFP;
grey) and positive control KIF11 (red) on cell number is represented. As reference, results from
mock treated cells (MOCK; yellow) and from the Dharmacon kinome library (siRNA; grey) are
illustrated. (D) Quantification of infection rate using siRNA from Dharmacon. The effect of nega-
tive control siRNAs (SCRAMBLED, GFP; grey) and positive controls (ARPC3, CDC42, ARF1,
PIK4CA; red) on infection rate is represented. As reference, results from the Dharmacon kinome
library (siRNA; grey) are depicted. (E) Quantification of bystander activation using siRNA from
Dharmacon. The effect of negative control siRNAs (SCRAMBLED, GFP; grey) and positive con-
trols (MAP3K7, CHUK, NOD1; red) on bystander activation is represented. As reference, results
from the Dharmacon kinome library (siRNA; grey) are indicated. (F) Quantification of intracellu-
lar growth using siRNA from Dharmacon. The effect of negative control siRNAs (SCRAMBLED,
GFP; grey) and positive controls (ARPC3, CDC42; red) on intracellular growth is represented.
As reference, results from the Dharmacon kinome library (siRNA; grey) are indicated.
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validated by western blotting. Noteworthy, transfection of siRNA against RELA
(NF-κB p65 subunit), which is included in the kinome library from Dharmacon,
reduced bystander IL-8 production to the same extent as a MAP3K7 knockdown
(data not shown).
Since literature does not provide target genes that could serve as positive control for
intracellular growth, a direct validation of this measurement was not possible. On
the other hand, knockdowns that partially reduce infection rate are likely to affect
the microcolony size by delaying the entry process. Figure III.3 (panel F) reveals
that this is indeed the case for the ARPC3 and CDC42 knockdowns. The correlation
between infection rate and intracellular growth is a general observation, which is
confirmed when analyzing the entire kinome data set (Figure III.4, panel E). While
the effect of ARPC3 and CDC42 knockdown on intracellular growth might serve
as an indirect validation of the measurement, it also points out the challenging
discrimination between hits affecting cell invasion and intracellular growth.
A stable reproducibility of the main readouts between biological replicates is a
central prerequisite for assays intended for usage in high-throughput screens. The
kinome libraries were screened in duplicate (Ambion) and quadruplicate (Dharma-
con) and all experiments were performed independently from each other. Therefore,
the obtained datasets are ideal to verify the reproducibility of the main readouts.
Table III.1 presents the correlation coefficients obtained for the two libraries. The
correlation coefficients obtained for the Dharmacon library are generally lower than
for the Ambion library, which might partially reflect that these experiments were
performed over a longer time span. Among the major readouts, intracellular growth
has the lowest reproducibility for both libraries. It seems possible that the quan-
tification of bacterial replication by measuring microcolony size has the lowest
accuracy. Therefore, alternative features (e.g. integrated intensity of the micro-
colony) should be considered for quantification of intracellular growth. In general,
a correlation coefficient higher than 0.5 is adequate, but optimizations in the fea-
ture extraction and readout calculation (e.g. object classification) should allow to
further improve the reproducibility.
Table III.1 Correlation coefficients for the main readouts comparing replicates from
the kinome library.
Readout Dharmacon kinomea Ambion kinome
Cell number 0.67±0.07 0.79
Infection rate 0.50±0.03 0.78
Intracellular growth 0.50±0.03 0.54
Bystander IL-8 production 0.51±0.13 0.84
a Average of the 6 individual correlation coefficients.
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4.3 Correlations between readouts introduce a bias in the
generation of hit lists
A general procedure after feature extraction is the generation of hit lists by sort-
ing the genes according to a certain readout. While this approach is feasible for
basic features (e.g. cell number), it is problematic if the readout of interest cor-
relates with additional features. In the case of the kinome screen, the infection
rate negatively correlates with cell number (Figure III.4, panel A). Extracting top
hits by sorting according to the infection rate, would enrich genes that positively
or negatively affect cell number upon knockdown. Differences in cell number is a
common phenomenon of RNAi experiments and therefore needs to be considered
when generating hit lists. For the kinome data, the correlation between infection
rate and cell number can be approximated with a linear regression curve (Figure
III.4, panel A). Defining the corrected infection score as distance from the original
infection rate to the regression curve represents a simple way to account for the
bias introduced by variations in cell number.
Figure III.4 illustrates correlations for the main readouts of the Shigella infec-
tion assay. For instance, bystander activation strongly correlates with cell number
(Figure III.4, panel B). This outcome is expected, regarding the fact that the prop-
agation of inflammatory signals is cell-cell contact dependent304. Interestingly, no
obvious correlation between bystander activation and infection rate can be detected
(Figure III.4, panel C), indicating that the range of infection rate observed during
the experiment (i.e. 20-70%) does not significantly alter the capacity for bystander
activation.
The quantification of intracellular growth by microcolony size reveals correlations
with cell number, infection rate and cell size (Figure III.4, panels D-F). The cor-
relation with infection rate as well as cell size could be approximated by a linear
regression curve. On the other hand, the correlation between colony size and cell
number displays a non-linear behavior. A strong dependency is only observed at
low cell numbers. A second order polynomial regression curve is proposed as a pos-
sible approximation of the correlation (Figure III.4, panel D). The correlation of
colony size with several other features might partly explain the lower reproducibil-
ity observed for the readout of intracellular growth.
The correlations illustrated in Figure III.4 only represent a subset of possible de-
pendencies. Nevertheless, they indicate that hit list generation based on single
features can be misleading. Therefore, a thorough validation and correction of the
readouts used to generate hit lists is required.
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4.4 Comparison of results obtained by screening different
kinome libraries
The validation of potential hits represents the main goal of screening the kinome
with libraries from two different suppliers. It is therefore of interest to compare the
two datasets. However, the comparison is complicated, as the Dharmacon library
contains pooled siRNAs resulting in a single value per gene, while the Ambion
library generates three values for a single gene as consequence of three individual
siRNAs. As already mentioned for positive control CDC42, the three sequences
targeting the same gene do not necessarily generate the same effect. Therefore,
gene-wise comparison of the two libraries, using the average of the three individ-
ual sequences, results in a scarce correlation, even when comparing reproducible
features like cell number. Validation is therefore only reasonable when comparing
results for single genes and without averaging the values obtained from individual
sequences.
As stated in the previous section, the ranking or comparison of single features is
problematic because correlations with additional features can bias the outcome.
Hence, Figure III.5 includes features, which can bias the readout of interest, into
the visualization. The results obtained from screening the two kinome libraries for
a selection of genes are compared. Data resulting from screening the Dharmacon
library are indicated in blue and the outcome from the individual Ambion siRNAs
are depicted in red.
The comparison of cell counts (Figure III.5, panel A) illustrates the different out-
comes that can be obtained from the two libraries. For instance, the knockdown
of PLK1 leads to a massive reduction in cell number for all data points acquired.
Knockdown of WEE1 or AURKB results in a loss of cells when using the siRNA
pool from Dharmacon, but only two out of three sequences from Ambion con-
firm this observation. Finally, the effect observed with one library might not be
confirmed by the other, or possibly even opposite effects are measured.
Figure III.5, panel B compares the effect on the infection rate obtained for selected
genes. As infection rate negatively correlates with cell number (Figure III.4, panel
A), the marker size is used to visualize the corresponding cell count for every
data point. Therefore, large and small markers representing siRNAs that affect cell
number should be handled with caution. For example, the reduction in infection
rate observed for a TGFBR2 or PRKR knockdown might possibly be an indirect
result of the increased cell number. On the other hand, RPS6KA3, FRAP1 (mTOR)
and TGFBR1 represent promising candidates that should be further validated in
follow-up experiments.
Selected genes affecting bystander IL-8 production are presented in Figure III.5,
panel C. The marker size represents the cell count measured for the corresponding
data point, as bystander activation correlates with cell number. This indicates that
the increase in bystander IL-8 production observed for SLK knockdowns possibly
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represents an indirect result of increased cell number. TRIB3 and MASTL, on the
other hand, exemplify genes that are worth to be further investigated.
Figure III.4 Correlation between selected readouts. Data used for these plots is aggregated
from both kinome screens. (A) Correlation between infection rate and cell number. The infection
rate negatively correlates with the cell number. A linear fit is indicated in yellow. (B) Correlation
between bystander activation and cell number. Bystander activation positively correlates with
cell number. A linear fit is indicated in yellow. (C) Correlation between bystander activation
and infection rate. No correlation between the two features is observed. (D) Correlation between
intracellular growth and cell number. The majority of the population (population mean ± 3)
shows little correlation with cell number. At low cell numbers intracellular growth is increased.
A 2nd order polynomial fit is indicated in yellow. (E) Correlation between intracellular growth
and infection rate. Intracellular growth positively correlates with infection rate. A linear fit is
indicated in yellow. (F) Correlation between intracellular growth and cell size. Intracellular growth
positively correlated with cell size. A linear fit is indicated in yellow. For all linear fits the
corresponding R2 value is indicated.
Figure III.5 (following page) Comparison of selected genes from the Dharmacon and
Ambion library. (A-D) Blue markers represent the results obtained from screening the Dharma-
con kinome library in quadruplicate. Red markers represent the results obtained from screening
the Ambion library in duplicate. Each data point corresponds to the siRNA pool (Dharmacon) or
to an individual siRNA sequence (Ambion) of one replicate. (A) Effect of selected knockdowns on
cell number. (B) Effect of selected knockdowns on infection rate. The measured cell number for
every data point is visualized by the marker size. Large and small markers indicate increased cell
number and reduced cell number, respectively. (C) Effect of selected knockdowns on bystander
activation. The measured cell number for every data point is visualized by the marker size. Large
and small markers indicate increased cell number and reduced cell number, respectively. (D) Ef-
fect of selected knockdowns on intracellular growth. The measured infection rate of every data
point is visualized by the marker size. Large and small markers indicate increased infection rate
and reduced infection rate, respectively.
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Figure III.5, panel D summarizes the results obtained on intracellular growth for
selected genes. As mentioned in the previous section, microcolony size is corre-
lating with additional features among which the infection rate had the strongest
influence. Consequently, the size of the marker is representative of the infection
rate determined for the corresponding data point. Knockdowns for DCAMKL1,
OSR1 and MAP3K2 are confirmed by both libraries and are potential candidates
for additional experiments.
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5 Experimental Procedures
Cell Culture
HeLa CCL-2 ATCC cells were maintained at 37◦ and 5% CO2 in Dulbecco’s mod-
ified Eagle’s medium (DMEM; Sigma-Aldrich) supplemented with 10% heat-killed
FCS and 2mM L-Glutamine (Invitrogen). For all HTS protocols, cells were used
at passages seven to nine.
siRNA and transfection
RNA interference directed against cellular kinases was achieved using siRNA pools
of four sequences (ON-TARGETplus R© SMARTpool R© siRNA Library - Human Pro-
tein Kinase, Dharmacon) or three individual sequences per gene (Silencer R© Select
Human Kinase siRNA Library, Ambion). Kinome screens were performed at least
in duplicate for each library. All experiments were conducted in a 384-well plate
format. In addition to assay plates, control plates were included when screening the
library from Dharmacon. These plates contained control siRNAs for transfection
efficiency and cell toxicity, as well as, control siRNAs for Shigella invasion and IL-8
production. Assay plates included controls for transfection efficiency, cell toxicity
and Shigella invasion.
For each plate, 25µl of RNAiMAX (Invitrogen) in DMEM (0.1µl/24.9µl) mixture
was added to each well of the assay plates containing 1.6 picomoles siRNA diluted
in siRNA buffer (Thermo Scientific). Assay plates were then incubated at room
temperature for 1 hour. Following the incubation, 600 HeLa CCL-2 cells were
added per well in a volume of 50µl DMEM/16%FCS, resulting in a final FCS
concentration of 10%. Afterwards, plates were incubated at 37◦C and 5% CO2 for
72 hours prior to infection.
Bacterial strains
The non-motile S. flexneri strain M90T ∆virG was generously provided by P.
Sansonetti248. The strain was transfected with the plasmid pCK100, which ex-
presses DsRed under the control of the native promoter of the S. flexneri gene
uhpT. Briefly, the 251bp promoter region upstream of uhpT was amplified by
PCR (Primers: GAGAGAGAATGCAGTGCTCGATACCTGGCACT, GCTCTA-
GAGGGTTACTCCTGAAATGAATACCT) and ligated into pMW211 plasmid us-
ing BsmI and XbaI. The pMW211 plasmid was a generous gift from Dr. D. Bumann
(Biozentrum, University of Basel, Switzerland). Bacteria were grown in tryptic soy
broth (TSB; Fluka) containing 100 µg/ml ampicillin (Invitrogen). Aliquots of bac-
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terial culture in TSB/7%DMSO were stored at -80◦C and subcultured in 2ml TSB
on the day of use.
Infection assay
S. flexneri M90T ∆virG pCK100 were harvested in exponential growth phase
and coated with 0.005%poly-L-lysine (Sigma-Aldrich). Afterwards, bacteria were
washed with PBS and resuspended in assay medium (DMEM, 2mM L-Glutamine,
10mM HEPES). 20µl of bacterial suspension was added to each well with a final
multiplicity of infection (MOI) of 15. Plates were then centrifuged for 1 minute
at 37◦C and 13’000 rpm and incubated at 37◦C and 5%CO2 on aluminium plates.
After 30 minutes of infection, 75µl were aspirated from each well and monensin
and gentamicin were added to a final concentration of 66.7µM and 66.7 µg/ml,
respectively. After a total infection time of 3.5 hours, cells were fixed in 4% PFA
for 10 minutes. Liquid handling was performed using the Multidrop 384 (Thermo
Scientific) for dispension steps and the ELx50 Microplate Strip Washer (BioTek)
for aspiration steps.
Immunofluorescence
Cells were washed with PBS using the Power Washer 384 (Tecan). Subsequently,
cells were incubated with a mouse anti-human IL-8 antibody (1:300; BD Bio-
sciences) in staining solution (0.2% saponin in PBS) for 2 hours at room tem-
perature. After washing the cells with PBS, Hoechst (1:2000; Invitrogen), DY-495-
Phalloidin (1:250; Dyomics) and Alexa Fluor 647-coupled goat anti-mouse IgG
(1:400; Invitrogen) were added and incubated for 1 hour at room temperature.
After two washes with PBS, plates were sealed prior to imaging on automated
microscopes. The staining procedure was performed using the Biomek NXP Lab-
oratory Automation Workstation (Beckman Coulter).
Automated microscopy and image processing
Images were automatically acquired with an ImageXpress Micro (Molecular De-
vices). Per well, 4 wavelengths (360nm, 480nm, 594nm and 640nm) at 9 different
sites were imaged with a CFI Super Fluor 10x objective (Nikon). Image processing
and analysis was supported by the workflow processing manager iBRAIN2, which
was developed by Research IT (Biozentrum, University of Basel; Podvinec et al.,
manuscript in preparation). iBRAIN2 computes image quality control, shading
correction, image analysis and result summaries by parallel processing on a Linux
Beowulf-Cluster.
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Image analysis
Image analysis was performed with the open source software CellProfiler308 that
was extended by custom modules implemented in MATLAB (Mathworks) by M.
Emmenlauer (Biozentrum, University of Basel). Briefly, the analysis pipeline iden-
tifies cell nuclei, the cell body, bacterial microcolonies and IL-8 granules within
the corresponding images using object detection algorithms308. Additionally, the
region around the nucleus is defined as an additional object (perinucleus). Fea-
tures including intensity, texture, area and shape are extracted for every object.
Detected bacterial microcolonies and IL-8 granules are assigned to the cell that
contains them based on the cell segmentation. Subsequently, per well averages are
calculated for the infection rate, the average bacterial area per infected cell (in-
tracellular growth) and the fraction of uninfected cells producing IL-8 among cells
directly neighboring infected cells (bystander IL-8 production).
Data management, normalization and visualization
All data generated during image acquisition, image processing and image analysis
were stored in the data management system openBIS, which was developed by
the group of Dr. B. Rinn (CISD, ETH Zurich)310. All features obtained from im-
age analysis were normalized by subtracting the plate mean and dividing by the
standard deviation of the plate (Z score). For the calculation of the plate mean
and standard deviation only wells containing siRNA were considered. Z scoring
and result summaries were implemented by P. Rämö (Biozentrum, University of
Basel). Data was visualized using the program Spotfire (TIBCO software Inc.). If
not stated differently, all feature measurements represent Z scored values.
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6 Discussion and Outlook
In this chapter, the implementation of an S. flexneri in vitro infection assay suited
for image-based RNAi screens was described. The assay allows quantifying in-
fection rate, bacterial intracellular replication and bystander IL-8 production by
means of automated microscopy and image analysis. The experimental workflow
was validated by performing siRNA knockdowns against genes known to affect cell
number, Shigella cell invasion or bystander activation. Based on the results ob-
tained from these control knockdowns, it was concluded that the assay is able to
detect phenotypes for cell invasion, bystander activation and probably intracellular
growth.
The reproducibility of the assay and of the major readouts was quantified by com-
paring biological replicates obtained from screening two kinome libraries from dif-
ferent suppliers. In general, correlations among replicates were in the range of
0.5-0.8 depending on the library and the selected readout. The lowest correlation
was calculated for the quantification of intracellular growth, which is mainly based
on the microcolony size. Alternative features for quantifying intracellular growth
should therefore be considered. A more precise quantification is expected when
measuring integrated intensities of all microcolonies within a cell. The integrated
intensity should reflect the number of bacteria contained within each colony. Cur-
rently, additional scripts are implemented to calculate these values.
Sources of noise are the so-called plate effects, which were observed when quantify-
ing the infection rate. Temperature differences introduced during centrifugation of
the plates led to a gradual increase in infection rate from the left to the right edge
of each plate. The differences were reduced by adapting experimental procedures,
nonetheless the gradient is still present. Remarkably, the observed pattern is sim-
ilar on every plate. Fitting a polynomial curve to the smoothened pattern might
allow to computationally correct for the temperature-induced plate effect.
Scatter plots of different features reveal correlation between certain readouts (e.g.
infection rate and cell number). This correlation can strongly bias the results when
only considering a single readout. Often, these correlations follow a linear behavior.
Fitting the data with a linear regression curve might therefore allow to normalize
the readout. Scripts, which can correct for these effects, are currently under de-
velopment. Furthermore, Snijder et al.311 have reported that the local population
context of every cell can affect the measured readouts. Indeed, our preliminary
results indicate that Shigella preferentially infects cells at the edges of cell layers.
Therefore, population-context correction has to be included in the future image
analysis workflow.
Additionally, a program allowing cell classification based on supervised machine
learning (called CellClassifier) is currently being established312. The classifier en-
ables to train models, which can discriminate between different classes of cells (e.g.
infected and uninfected cells or IL-8 positive or negative cells). Furthermore, the
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program automatically calculates combinations of several models. This will, for
instance, allow to quantify the number of infected cells producing IL-8. The results
obtained from cell classification are expected to be more precise than the readouts
calculated from individual features.
After successfully screening the kinome libraries, the infection assay was performed
in duplicate on a genome-wide library (Dharmacon, pooled siRNA). Experiments
and image acquisition have been completed and the data from image analysis
should soon be available. Expectedly, that the genome-wide screen will bring forth
new candidate proteins involved in Shigella cell invasion, intracellular growth and
bystander IL-8 production. Promising genes will be validated in a secondary screen
using individual siRNAs from Ambion.
In conclusion, the implementation of an image-based high-throughput screen al-
lowing the quantification of S. flexneri cell invasion and intracellular growth, as
well as bystander IL-8 production has been presented. The assay was validated
by performing control knockdowns and by quantifying reproducibility using two
kinome libraries. Preliminary results have indicated a few promising candidates for
the different readouts. However, the data generated so far requires visual validation
and normalization of plate effects and feature correlations.
Chapter IV
Discussion and Outlook
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1 Discussion
The ability of a host organism to mount an immune response during infection
is critical for survival. Epithelial cells represent a first line of defense by forming
an impermeable cell layer that prevents microbial access to the underlying tissue.
Besides this function, epithelial cells serve as important sentinels for microbial in-
fections. By expressing pathogen recognition receptors (PRRs), epithelial cells can
recognize bacterial products and respond by secreting proinflammatory cytokines.
These cytokines induce an inflammatory response by attracting phagocytic cells to
the site of infection.
A massive inflammatory response is, for instance, observed during infection with
the enteroinvasive bacterium Shigella flexneri. The Gram-negative pathogen infects
the colonic epithelium in humans and replicates within intestinal epithelial cells.
The presence of intracellular Shigella is sensed by the PRR Nod144, which con-
tributes to the activation of proinflammatory signaling cascades. In our study, we
used an in vitro model for Shigella infection and visualized the activation of proin-
flammatory signals at the single-cell level. Infections at low MOI revealed that the
activation of the transcription factor NF-κB was not restricted to infected cells, but
could as well be observed in uninfected neighboring cells. Using phospho-specific
antibodies we could additionally show that the MAP kinases JNK, ERK and p38
get activated in uninfected cells adjacent to infected cells. Our results indicate that
infected cells, within minutes after infection, propagate proinflammatory signals to
uninfected bystander cells.
The concept of bystander cell activation has previously been described in other
contexts. For instance in wound healing, Ca2+ and ATP get released and activate
distant cells, thereby promoting cell migration towards the injured tissue313,314. In
radiotherapy of tumors, bystander effects represent a major problem, as irradiated
cells secrete cytokines and propagate signals through gap junctions that induce
DNA damage in non-irradiated cells315. Moreover, Patel and colleagues recently
reported the expression of interferon-β and TNFα in bystander cells upon recog-
nition of double-stranded DNA316. All these cases have in common that a local
aggression induces cell-cell communication, which amplifies the host response. Our
findings provide evidence that a similar mechanism is observed during bacterial
infection.
Remarkably, we found that the activation of the MAP kinase p38 is enhanced in
bystander cells. This is in line with a previous report that Shigella efficiently de-
phosphorylates p38 via the phosphothreonine-lyase activity of the effector protein
OspF125. In fact, p38 phosphorylation in infected cells was restored upon infection
with an ospF deletion strain in our study. This was confirmed by demonstrating
that histone H3, a downstream target of p38, is predominantly phosphorylated in
bystander cells during S. flexneri wild type infection. Again, histone H3 phospho-
rylation could be restored in infected cells when infecting with the ∆ospF strain.
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Noteworthy, no differences in the level of p38 and histone H3 phosphorylation
in bystander cells could be observed when comparing S. flexneri wild type and
∆ospF infections. This finding indicates that bystander activation might represent
a mechanism to evade the immunosuppressive activity of bacterial effectors.
Histone H3 controls accessibility to transcription factor binding sites of proinflam-
matory genes by modulating chromatin structure28. To assess the expression level
of proinflammatory genes, we focused on the cytokine IL-8, which is strongly upreg-
ulated during S. flexneri infection119. By means of immunofluorescence, we found
that the major source of IL-8 production are uninfected bystander cells. Infected
cells, on the other hand, were inefficiently producing IL-8, which was confirmed for
the expression of TNFα and GM-CSF, two other cytokines upregulated during S.
flexneri infection119. IL-8 expression in infected cells increased upon infection with
the S. flexneri ∆ospF strain, suggesting that OspF downregulates the expression
of cytokines. However, the gain in IL-8 production was very limited, indicating
that additional effectors such OspG, OspB or IpaH9.8 might contribute to the im-
munosuppressive activity of Shigella. Propagation of proinflammatory signals from
infected to uninfected cells thus allows the host to circumvent the immunosuppres-
sive activity of bacterial effectors and to massively amplify the total amount of
cytokines produced.
Intracellular Shigella are recognized by Nod1, which detects peptidoglycan frag-
ments 44. To address the role of peptidoglycan recognition in bystander activation,
we microinjected γ-D-glutamyl-meso-diaminopimelic acid (iE-DAP), a Nod1 lig-
and, into single cells. Surprisingly, we found the injection of iE-DAP to efficiently
induce IL-8 expression in bystander cells of microinjected cells. This demonstrates
that Nod1-mediated recognition of peptidoglycan moieties is sufficient to activate
the signaling cascade underlying bystander activation. We have further investi-
gated the role of Nod1 in bystander activation by performing infections in cells
depleted for Nod1 by RNAi. In preliminary experiments, only a slight reduction in
the number of bystander cells was observed, when Nod1 was depleted (unpublished
results). Although these experiments require validation, it seems likely that Nod1
is sufficient, yet not necessary, for inducing bystander activation. This outcome
indicates that additional PRRs, such as Nod2 or other Nod-like receptors, might
contribute to the activation of bystander cells.
In this work, the molecular mechanism that underlies bystander activation was ad-
dressed as well. Cell-cell communication is a concept abundantly found in nature
and can essentially be mediated by three different mechanisms: paracrine signal-
ing, direct diffusion of small molecules through gap junctions or membrane protein
interactions. Bystander IL-8 production was not affected when we interfered with
paracrine secretion by brefeldin A treatment or perfusion, pointing out that by-
stander activation was not mediated by secretion of signaling molecules. Instead,
bystander activation was strictly dependent on cell-cell contact. The hypothesis
of signaling through gap junctions was therefore tested by treating cells with gap
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junction inhibitors. Treatment with 18β-glycyrrhetinic acid and carbenoxolone,
two different gap junction inhibitors, resulted in a dose-dependent inhibition of
bystander IL-8 production. Additionally, cells poorly coupled by gap junctions
displayed a limited number of IL-8-producing bystander cells, which could be sig-
nificantly increased when overexpressing Connexin43 (Cx43) in these cells. Finally,
the expression of Cx43 was required in both infected and bystander cells to allow
an efficient propagation of inflammatory signals.
Gap junctions consist of two hemichannels located in the membrane of neighbor-
ing cells. Hemichannels are formed by a hexamer of connexin proteins. Interaction
between two hemichannels located in adjacent membranes results in a continuous
channel connecting the cytoplasm of two cells. Gap junctions therefore allow direct
intercellular diffusion of small molecules (i.e. <1-2 kDa), including ions, second
messengers, nucleotides, amino acids and metabolites317. Consequently, the medi-
ator of the cell-cell communication underlying bystander activation is expected to
be found among these molecules. Calcium, for instance, has already been associ-
ated with Shigella infections. Tran Van Nhieu and colleagues reported transient
peaks in intracellular calcium concentrations during cell invasion318. To visualize
changes in intracellular calcium concentrations, we performed live cell microscopy
of S. flexneri infection in A549 cells loaded with the calcium dye Fluo-4. In fact,
transient peaks in calcium concentrations that coincided with invasion events could
be observed. Moreover, the increase in calcium concentration propagated from the
infected cells to adjacent cells (unpublished results). However, treating cells with
the intracellular calcium chelator BAPTA-AM did not interfere with NF-κB activa-
tion in bystander cells, indicating that calcium is not mediating the propagation of
NF-κB activation. Nevertheless, calcium might potentially induce other pathways
in bystander cells. For instance the activation of ERK, which followed a transient
kinetic and preceded the activation of NF-κB, JNK and p38. Further studies are
required to understand the nature of these calcium waves – i.e. direct Ca2+ dif-
fusion, diffusion of IP3 or release of ATP – and their potential role in bystander
activation.
Besides calcium, other second messengers could diffuse through gap junctions. A
screen for small metabolites and nucleotides using high resolution mass spectrom-
etry 319 has revealed an increase in cAMP and cGMP concentrations early during
S. flexneri infection (T. Tschon, unpublished results). cAMP might be produced
in infected cells by adenylate cyclases and control NF-κB and MAP kinase signal-
ing in bystander cells through the activation of PKA320,321. Alternatively, cGMP,
produced by guanylate cyclases in infected cells, may contribute to signaling in by-
stander cells by activating PKG. Finally, peptidoglycan fragments (e.g. iE-DAP)
shed on the bacterial surface are small enough to passage through gap junctions.
One might speculate that these moieties could activate Nod1 signaling in bystander
cells. Further experiments are required to evaluate the different hypotheses.
Of equal interest to the nature of the diffusing mediator is the mechanism, by
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which the signal is propagated. Several models come in to question, which all have
in common that the mediator is initially produced or released in the infected cell
and diffuses to neighboring cells through gap junctions. In the simplest scenario,
the infected cell is the sole source for the mediator and the signal is propagated by
passive diffusion. This would result in a concentration gradient in the vicinity of
infected cells. Assuming an activation threshold (i.e. minimal mediator concentra-
tion) for signaling in bystander cells, the signal propagation would be self-limiting.
The condition of infected cells representing the sole source for the mediator is
met if the molecule would originate from bacterial peptidoglycan. Alternatively,
the signal propagation could be amplified by the production of additional media-
tor molecules in bystander cells. This positive feedback mechanism would allow a
more rapid signal propagation and increased spread. On the other hand, amplifica-
tion of the mediator results in a signal propagation that is no longer self-limiting.
This implies the existence of additional control mechanisms that negatively reg-
ulate bystander activation, as excessive inflammation is detrimental for the host.
Several parameters could assure a negative regulation, including rapid turnover of
the mediator or modification of gap junction permeability. Noteworthy, the second
messengers calcium, cAMP and cGMP, as well as the MAP kinase ERK are all able
to regulate gap junctional permeability through the phosphorylation of connexin
proteins317,322–326. Furthermore, it seems plausible that more than one signal might
be propagated from infected to bystander cells. One mediator might contribute to
the activation of proinflammatory signals, while a second signal limits the inflam-
mation to a confined area around the infected cell. Hitherto, no experimental data
is available to identify the mechanism that is underlying bystander activation.
Cell-cell communication through gap junctions represents a reoccurring principle
in many biological processes like cell growth, differentiation, migration and electric
coupling327. Consequently, gap junction deficiencies are associated with several dis-
eases including cataracts, hereditary deafness, neuropathies and cancer327. In addi-
tion, it has become increasingly clear that gap junctions are involved in processes of
the immune system. Neijssen and colleagues, for instance, have demonstrated that
small peptides can be transferred to neighboring cells through gap junctions. This is
of particular interest in the context of antigen presentation during viral infections,
as it allows infected cells to transfer viral peptides to specialized antigen-presenting
cells328,329. Furthermore, gap junctional communication between dendritic cells is
required for their activation330. The secretion of the chemokine CXCL12 by human
bone marrow stromal cells was recently shown to be controlled by calcium trans-
mission through gap junctions and by the activation of PKA331. Moreover, gap
junctions were proven to play a crucial role in drug-induced liver injury (DILI),
an inflammatory response to certain therapeutic compounds that can cause hep-
atic failure. Inhibition of gap junctional communication in mice limited DILI and
prevented hepatic failure332. The importance of gap junctions during inflammation
is further highlighted by the fact that many microbial pathogens target gap junc-
tions by modulating connexin expression or phosphorylation333,334. In fact, Shigella
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opens connexin hemichannels allowing release of ATP into the extracellular space.
This process enhances Shigella invasion and intercellular spread318. It is worth to
note that ATP release is not involved in bystander activation, as neither treatment
with apyrase or suramin, nor addition of extracellular ATP did affect the number
of bystander cells (unpublished results).
To validate whether bystander activation is a specific response to S. flexneri in-
fection or represents a more general mechanism, we performed infections with S.
typhimurium and L. monocytogenes, two enteroinvasive pathogens that are known
to induce IL-8 expression during infection of epithelial cells335. Indeed, IL-8 pro-
duction in bystander cells during infections with these bacteria could be observed,
although the frequency was lower when compared to S. flexneri infections. Dif-
ferences between the pathogens might explain this finding. Intracellular S. ty-
phimurium, for example, reside within a membrane-enclosed compartment, which
might interfere with efficient pathogen recognition. L. monocytogenes, on the other
hand, is a Gram-positive bacterium that might activate different pathogen recog-
nition receptors than Gram-negative bacteria. A recent study by Dolowschiak at
al., has pointed out that cell-cell communication observed during Listeria infection
of murine intestinal epithelial cells is independent of gap junctions, but is instead
mediated by the production of reactive oxygen intermediates (ROIs)336. In their
work, it was proposed that intracellular Listeria get detected by Nod-like receptors
(i.e. Nod2 and Nlrc4 ), which contribute to the production of ROIs by activating
the NADPH oxidase Nox4. The release of ROIs by infected cells induces the ex-
pression of Cxcl-2 (the mouse homolog of human IL-8) and Cxcl-5 in uninfected
bystander cells, through an unknown mechanism336. The differences observed for
S. flexneri and L. monocytogenes infections could indicate that different pathogens
induce alternative pathways to promote bystander activation. In addition, the two
studies were performed in distinct cell types (human A549 versus murine m-ICcl2
cells). Parallel infections with S. flexneri and L. monocytogenes, using the same
cell type, are required to properly determine the signaling pathways controlling
inflammation during invasion.
In summary, we have identified a mechanism of cell-cell communication that al-
lows infected cells to propagate proinflammatory signals to uninfected neighboring
cells. These bystander cells contribute to a substantial amplification of the immune
response during bacterial infections by producing cytokines like IL-8. In addition,
bystander activation assures an inflammatory response in the presence of immuno-
suppressive effector proteins in infected cells. Infections at low MOI might reflect
the early onset of shigellosis, when only a limited number of bacteria have reached
the basolateral surface of enterocytes. Indeed, experiments using the rabbit intesti-
nal loop model of shigellosis, revealed IL-8 production beyond sites of infection,
providing evidence for the physiological relevance of bystander IL-8 production in
vivo123.
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2 Outlook
Future work will focus on the characterization of the molecular mechanism underly-
ing bystander activation. In this context, the identification of the small molecule(s)
diffusing through gap junctions is of particular interest. Potential candidates, in-
cluding second messengers and peptidoglycan moieties, should be addressed. The
involvement of cAMP and cGMP, for example, could be validated by measur-
ing their concentrations during Shigella infection. As bystander NF-κB activation
can be observed as early as 15 minutes post infection, an increase in concentra-
tion would be expected within minutes after invasion. In addition, adenylate or
guanylate cyclases, as well as PKA and PKG could be targeted using RNAi or
pharmacological tools. To further investigate the role of calcium in bystander acti-
vation, phosphorylation of MAP kinases p38, JNK and ERK, as well as IL-8 expres-
sion should be measured in cells pretreated with the intracellular calcium chelator
BAPTA-AM. Increased calcium concentrations can also result from signaling by
the second messenger inositol-trisphosphate (IP3). IP3 is able to diffuse through
gap junctions and could induce calcium release from the ER in bystander cells
by binding to the IP3 receptor337. To validate an involvement of IP3, calcium re-
sponses, bystander NF-κB and MAP kinase activation should be monitored, while
treating cells with an inhibitor for phospholipase C338.
As an alternative to second messengers, peptidoglycan moieties could be diffusing
through gap junctions and activate Nod1 signaling in bystander cells. Fluorescently
labeled molecules of the Nod1 ligand iE-DAP could be microinjected into cells and
their diffusion monitored over time. If iE-DAP does indeed diffuse to neighboring
cells, the activation of NF-κB in these cells should be visualized. However, it is
questionable whether this experiment is representative for the physiological condi-
tion, as microinjection is likely to inject an excess of iE-DAP into cells. Therefore,
it might be more promising to test the requirement for the receptor Nod1 in by-
stander cells. If iE-DAP diffuses through gap junctions, Nod1 is expected to be
indispensable for the initiation of proinflammatory signaling in bystander cells.
Knockdown of Nod1 or overexpression of a dominant negative form of the receptor
(lacking the CARD domain) specifically in bystander cells and monitoring IL-8
expression should verify this hypothesis.
A more systematic approach to identify the small molecule(s) mediating bystander
activation makes use of high resolution mass spectrometry as described by Kiefer
et al.319. This technique allows to measure the concentration of metabolites in the
femtomole range. The emphasis will be placed on metabolites and nucleotides that
get produced within minutes after Shigella infection. Promising candidates could
be tested in the in vitro infection model using RNAi or pharmacological tools and
measuring bystander IL-8 production.
Besides the nature of the diffusing signal, further studies should focus on the pro-
teins and signaling pathways involved in the cell-cell communication. The image-
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based genome-wide RNAi screen described in Chapter III is expected to identify
new proteins involved in bystander activation. In addition, the phosphoproteome
of Shigella infected cells might identify signaling pathways required for bystander
activation. Comparing the phosphoproteome of cells infected at low MOI in the
presence or absence of gap junction inhibitors might reveal proteins that get specif-
ically phosphorylated in bystander cells. A similar dataset could be obtained by
isolating infected and uninfected cell populations using a fluorescence-activated
cell sorter prior to mass spectrometric analysis. Promising candidates should be
validated by siRNA knockdown either in infected or bystander cells. Preliminary
results from experiments with mixed wild type and knockdown cell populations
have revealed that depletion of TAK1 and the NF-κB subunit p65 in infected cells
does not interfere with bystander IL-8 production (T. Tschon, unpublished results).
This finding indicates that the signaling cascade mediating bystander activation
is triggered upstream of TAK1. Future experiments with mixed cell populations
will therefore focus on proteins upstream of TAK1, including Nod1/2, RIP2 and
cIAP1/2.
Monitoring the propagation of proinflammatory signals using live cell microscopy
would allow to quantify the kinetics and dynamics of bystander activation. Live S.
flexneri infections were already performed with a cell line expressing endogenous
levels of ERK-YFP339. Preliminary results revealed the propagation of ERK ac-
tivation to direct neighbors of infected cells. Stable overexpression of Connexin43
in these cells might increase the spread of ERK activation and allow the quan-
tification of bystander activation kinetics. Live cell experiments with cells stably
expressing the NF-κB subunit p65 tagged to GFP represent another option340. The
precise quantification of bystander activation kinetics may allow to determine the
underlying mechanism of signal propagation. As already mentioned in the previous
section, the signal could be propagated by passive diffusion of a mediator exclu-
sively produced in infected cells. Alternatively, the signal could be amplified by
the production of the mediator molecule in bystander cells, which would imply an
additional control mechanism that spatially limits the inflammation signaling. Fi-
nally, it seems plausible that more than one signaling molecule is propagated from
infected to bystander cells. For the diffusion of small molecules through gap junc-
tions within a monolayer of cells, several mathematical models have been deduced
and extended341–343. Making use of these mathematical models, one could predict
the propagation of signaling molecules for the proposed mechanisms and validate
the results by comparison with the experimental data obtained from live cell mi-
croscopy. This would be of particular interest upon perturbation of the system, for
example by treating cells with gap junction inhibitors.
Future work should also address the differences in bystander activation reported
for L. monocytogenes, S. typhimurium and S. flexneri infections304,336. Parallel in-
fections using both human and murine epithelial cells lines, might reveal whether
alternative routes for bystander activation exist in response to different pathogens.
In this context, the two proposed mechanisms, production of ROIs and signal-
IV. Discussion and Outlook -117-
ing through gap junctions, should be addressed by treating cells with respective
inhibitors or by siRNA knockdowns. The reduced frequency of bystander activa-
tion observed in S. typhimurium infections could be investigated by using a strain
expressing the Shigella translocator protein IpaC, which lyses the Salmonella-
containing vacuole after infection247. Moreover, it might be interesting to test
pathogens that invade epithelial cells without inducing a pronounced inflamma-
tory response (e.g. Salmonella typhi or Chlamydia spp.). Possibly, these bacteria
have evolved virulence factors to downregulate bystander activation344.
Besides the initiation and amplification of the inflammatory response, bystander
activation possibly provides protection to further bacterial invasion. Interferon-α,
for instance, was reported to provide a protective function against S. flexneri infec-
tion by inhibiting a Src-mediated pathway required for efficient Shigella invasion199.
This hypothesis could be validated by performing primary and secondary infections
with differently labeled bacteria. In the case of a protective function conferred by
bystander activation, a reduced secondary infection rate in the vicinity of primary
infected cells is expected. Another physiologically relevant function of bystander ac-
tivation could be the enhancement of transepithelial migration by PMNs. Transep-
ithelial migration is promoted by the apical secretion of the chemoattractant hep-
oxilin A3 by epithelial cells288,345. Upon infection, the production of hepoxilin A3
is upregulated by the activation of phospholipase A2 (PLA2), which is controlled
by the MAP kinases ERK and p38285,288,345. As ERK and p38 are phosphorylated
in bystander cells, the contribution of these cells to the secretion of hepoxilin A3
and transepithelial migration will be investigated. In the in vitro infection model,
the activation of PLA2 can be visualized by immunofluorescence using a phospho-
specific antibody and the involvement of ERK and p38 in the phosphorylation of
PLA2 could be validated by treating cells with respective inhibitors. The contri-
bution of bystander cells to transepithelial migration should be tested by infecting
polarized cell layers. Caco-2 and T84 cells are cultivated on filters to form a tight
epithelial layer that can be infected from the basolateral side288. Quantification of
transepithelial migration by neutrophils in the presence or absence of gap junction
inhibitors might reveal whether bystander cells contribute to this process. In addi-
tion, apically secreted hepoxilin A3 could be quantified using HPLC and MS/MS
as described by Mrsny et al.345.
The finding of Sansonetti and colleagues who showed that IL-8 expression is found
in epithelial cells beyond sites of infection123, represents a first line of evidence for
the in vivo relevance of bystander activation. Further work using animal models is
required to assess the contribution of bystander activation to immune responses.
In vivo infections with S. flexneri might be performed using the newborn mouse
model299, monitoring the production of Cxcl2 (the homolog of human IL-8) in tissue
sections. Furthermore, intranasal infections in mice, which lead to a massive inflam-
mation of the lung epithelium, could serve as a suitable model system300. Alterna-
tively, the production of IL-8 may be monitored in tissue sections of guinea pigs
infected intragastrically with S. flexneri302. One could also make use of the estab-
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lished in vivo infection models for L. monocytogenes and S. typhimurium in mice.
The relevance of bystander activation in the immune response against bacterial
infections should further be validated by administering gap junction inhibitors or
other drugs blocking bystander activation in vitro. The genome-wide RNAi screen is
expected to provide a better understanding of the molecular mechanism underlying
bystander activation. With this knowledge, the contribution of bystander activa-
tion to the innate immune response could be addressed more specifically by using
selected knockout mice. It is important to note that the verification of bystander
activation in vivo is technically demanding. Additional components of the innate
immune system, which can be excluded or controlled in vitro, will contribute to
the response observed during infections in animals. The production of cytokines in
uninfected cells could, for instance, result from paracrine signaling or by activation
of TLRs. It will be important to verify the contribution of additional pathways by
using appropriate knockout mice. TLR signaling, for instance, might be excluded
by using MyD88 -/- mice.
Chapter V
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1 Summary
Shigella flexneri injects several effector proteins into the cytoplasm of infected cells
to downregulate the inflammatory response. One of theses effectors, OspF, has been
described to harbor phosphothreonine lyase activity that irreversibly dephospho-
rylates the MAP kinases p38 and ERK. In our study we found that OspF also
regulated the activation of the transcription factor NF-κB and the MAP kinase
JNK. In contrast to p38 phosphorylation, which is strongly reduced during S.
flexneri infection, NF-κB and JNK activation was potentiated. This unexpected
effect of OspF was further shown to be dependent of the phosphothreonine activity
on p38. Knockdown experiments revealed that OspF disrupts a negative feedback
loop between p38 and the MAP3 kinase TAK1. Activation of p38 was found to
lead to the phosphorylation of TAB1, which in turn negatively regulated TAK1
activity. Interestingly, the potentiated activation of JNK did not enhance signaling
by c-Jun, a known target of JNK, as OspF interfered with c-Jun expression at the
transcriptional level. Thus, our data reveal that OspF controls the activation of
NF-κB, JNK and c-Jun. Additionally, we demonstrate the existence of a negative
feedback loop between p38 and TAK1 during S. flexneri infection. Finally, this
study validates the use of effector proteins as molecular tools to probe signaling
networks during bacterial infection.
2 Statement of contribution
I have performed initial experiments that had revealed differences in JNK phos-
phorylation when infecting cells with wild type or δospF S. flexneri (illustrated in
Figure 1). Additionally, I have performed the image analysis for NF-κB activation
during infection with wild type or ∆ospF S. flexneri (Figure 2B). The other ex-
periments were perfomed by Veronika Reiterer and Lars Grossniklaus. The paper
was written by Cécile Arrieumerlou and Veronika Reiterer.
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Shigella flexneri type III secreted effector OspF harbors a phosphothreonine lyase activity that irreversibly
dephosphorylates MAP kinases (MAPKs) p38 and ERK in infected epithelial cells and thereby, dampens innate
immunity. Whereas this activity has been well characterized, the impact of OspF on other host signaling
pathways that control inflammation was unknown. Here we report that OspF potentiates the activation of the
MAPK JNK and the transcription factor NF-κB during S. flexneri infection. This unexpected effect of OspF was
dependent on the phosphothreonine lyase activity of OspF on p38, and resulted from the disruption of a
negative feedback loop regulation between p38 and TGF-beta activated kinase 1 (TAK1), mediated via the
phosphorylation of TAK1-binding protein 1. Interestingly, potentiated JNK activation was not associated with
enhanced c-Jun signaling as OspF also inhibits c-Jun expression at the transcriptional level. Altogether, our
data reveal the impact of OspF on the activation of NF-κB, JNK and c-Jun, and demonstrate the existence of a
negative feedback loop regulation between p38 and TAK1 during S. flexneri infection. Furthermore, this study
validates the use of bacterial effectors as molecular tools to identify the crosstalks that connect important host
signaling pathways induced upon bacterial infection.
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1. Introduction
During bacterial infection, the ability of a host organism to mount
an innate immune response is critical to limit bacterial colonization.
Such a response is initiated by the recognition of bacterial components
including lipopolysaccharide (LPS), peptidoglycan and nucleic acids by
the Toll-like receptors (TLRs) and Nod-like receptors, which in turn
activate downstream proinflammatory cascades that orchestrate
innate immunity [1–3]. Despite a large spectrum of innate defense
mechanisms, many pathogens can effectively colonize their host.
Successful infection often results from evolutionary selected strategies
that circumvent or manipulate the host response to infection [4]. A
widespread stratagem developed by pathogenic bacteria consists of
injecting effector proteins into the cytoplasm or the nucleus of a target
cell to inhibit or usurp specific cellular processes or signaling pathways
[5]. This strategy is successfully exploited by the bacterium Shigella
flexneri to invade and colonize the intestinal epithelium of humans,
causing an acute mucosal inflammation called shigellosis or bacillary
dysentery [6]. Once in contact with the basolateral surface of epithelial
cells, these bacteria inject, by means of a type III secretion (T3S)
apparatus, a set of effector proteins that promote their internalization.
In addition, S. flexneri interfereswithmultiple host signaling pathways
to dampen the inflammatory response of infected epithelial cells [7].
This response is initiated by initial sensing of bacterial invasion via a
pool of membrane-localized Nod1 proteins, recruited at the site of
bacterial entry and remaining on cell membrane fragments after
rupture of the internalization vacuole [8,9]. This early recognition is
potentiated by Nod1-mediated sensing of peptidoglycan-derived
peptides released by bacteria multiplying in the cytoplasm of infected
epithelial cells [10]. Peptidoglycan recognition is generally followed by
the homo-dimerization of Nod1, the recruitment and polyubiquitina-
tion of the kinase RICK/RIPK2 and the sequential activation of TGF-β-
activated kinase-1 (TAK1), amember of themitogen-activated protein
(MAP) kinases kinase kinase (MAP3K) family [11]. TAK1 forms with
the proteins TAK1-binding protein 1 (TAB1), TAB2 and/or TAB3 a
complex that controls the activation of downstream key signaling
pathways that lead to activation of the transcription factors nuclear
factor-kappa B (NF-κB) and activator protein-1 (AP-1) and induce
proinflammatory gene expression [12,13]. Once activated, TAK1
phosphorylates inhibitor of NF-κB (IκB) kinase-β (IKKβ) at key serine
residues in the activation loop, resulting in its activation and leading to
the phosphorylation and degradation of IκB and the nuclear
translocation of NF-κB [14] . It has been recently reported that both
IKKα and IKKγ/NEMO also contribute to NF-κB activation during
S. flexneri infection [15]. In addition, TAK1 phosphorylates members of
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the MAP kinase kinase (MAP2K) family, which in turn phosphorylate
and activate the MAP kinases Jun N-terminal kinase (JNK) and p38
[12].
Interestingly, S. flexneri has developed a set of T3S effectors that
interferewith inflammation signaling and downregulate the expression
of the inflammatory chemokine interleukin-8 (IL-8) IL-8, which recruits
polymorphonuclear cells to the site of infection [7]. Among these
effectors, OspF harbors a phosphothreonine lyase activity, which leads
to the irreversible dephosphorylation of p38 and ERK in the nucleus of
infected cells [16,17]. Theeliminationof aphosphate byOspF suppresses
MAPKactivity by changing theconformationof theactivation loop. It has
been reported that a defect in MAPK activation is associated with
inhibition of histoneH3phosphorylation andgene-specific repressionof
a subset of NF-κB regulated genes, including IL-8 [16]. A recent study
from our laboratory, monitoring IL-8 expression at the single-cell level,
confirms the role of OspF on IL-8 expression in infected cells and shows
that, uninfected bystander epithelial cells constitute the main source
of IL-8 secretion during S. flexneri infection [18].
Whereas the phosphothreonine lyase activity of OspF on MAPKs
has been well characterized [16,17], the impact of OspF on other host
signaling pathways remains unknown. Here we report that, in addi-
tion to the dephosphorylation of p38 and ERK, OspF potentiates the
activation of the JNK and NF-κB pathways triggered by S. flexneri
infection. This unexpected effect of OspF was dependent on p38 and
resulted from the disruption of a negative feedback loop regulation
between p38 and TAK1 mediated via the phosphorylation of TAB1.
Interestingly, potentiated JNK activation was not associated with
enhanced c-Jun signaling as OspF also inhibits c-Jun expression at the
transcriptional level. Altogether, our data reveal the broad impact of
OspF on the activation of NF-κB, JNK and c-Jun and the crosstalks that
connect these signaling pathways during bacterial infection.
2. Materials and methods
2.1. Cell lines and reagents
Mouse embryonic fibroblasts (MEFs) from wild-type and p38α
knockout mice were kindly provided by Prof. A.R. Nebreda (CNIO,
Madrid, Spain). MEFs and HeLa Kyoto cells [19] were cultured in
DMEM, supplemented with 10% FCS, antibiotics and L-glutamine.
Antibodies against TAK1, MAPK p38, the phosphorylated form of
MAPK p38, JNK, TAK1 and c-Jun were obtained from Cell Signaling
Technology. Total c-Jun antibody was obtained from BD Transduction
Laboratories. Antibodies against IκBα, NF-κB p65 and Lamin B were
purchased from Santa Cruz. Antibodies against TAB1 and phosphor-
ylated TAB1 were obtained from the laboratory of Prof. Philip Cohen
(Dundee University, Dundee, Scotland, UK). Antibody against actin
was purchased from Milipore. TNFα was from R&D systems.
2.2. Bacterial strains
The icsA (virG) deletion mutant (ΔvirG) generated in the M90T
S. flexneri 2a strain was generously provided by Prof. P. Sansonetti
(Institut Pasteur, Paris, France). The ΔvirG ΔospF mutant was
generated as previously described [15]. All S. flexneri strains were
transformed with the pMW211 plasmid to express the DsRed protein
under control of a constitutive promoter. The pMW211 plasmid was a
generous gift from Prof. D. Bumann (Biozentrum, University of Basel,
Switzerland).
2.3. Plasmids and transfection
OspF was amplified using the following oligos: ospF-1 sense
(5′-actgggatccatgcccataaaaaagccctgtc) and ospF-2 antisense (5′-actg-
gaattcctactctatcatcaaacgataaaa) from S. flexneri MT90 using Vent-
DNA-polymerase (New England Biolabs). The resulting PCR fragment
was cloned into the BamHI/EcoRI sites of the pCMV-Tag3B vector
(Stratagene) called pIS11 (pCMV-Tag3B::ospF). For cDNA transfection,
HeLa cells were seeded in a 6-well plate at a density of 400,000 cells/
well. The next day, cells were transfected with 2 ug of plasmid using
FugeneHDTM (Roche) according to the manufacturer's instructions.
2.4. siRNA transfection
Transfection of siRNAs was carried out using Lipofectamine 2000
(Invitrogen). HeLa cells, seeded in a 6-well plate (100,000 cells/well),
were reversely transfected with 10 nM siRNA according to the manu-
facturer's instructions. Cells were used 72 h after transfection.
2.5. Cell lysis and immunoblotting
Cells were washed twice in ice cold PBS, lysed in PhosphoSafeTM
extraction reagent (Novagen), incubated on ice for 20 min and sub-
sequently centrifuged at 4 °C for 20 min at 16,000 g. BCA Protein Assay
kit (Pierce) was used to determine protein concentration. 10–15 ug of
protein was subjected to SDS-polyacrylamide gels and electroblotted
onto nitrocellulose membranes. Immunoblotting was performed using
primary antibodies diluted in phosphate buffered saline 0.1% tween
containing 5% bovine serum albumin or 5% nonfat dry milk. HRP-
conjugated secondary antibodieswerepurchased fromGEHealthcare or
Cell signaling technologyorThermoScientific. Theblotsweredeveloped
with an enhanced chemiluminescence method (ECL, Pierce).
2.6. Infection assay
S. flexneri strains were grown in tryptic soy broth (TSB) to
exponential log phase at 37 °C and coated with poly-L-lysine before
infection. 30 min before infection, complete growth medium was
replaced by DMEM supplemented with 10 mM Hepes and 2 mM
L-glutamine (assay medium). Bacteria were added to cells in 96-well
or 6-well plates at the indicatedmultiplicity of infection (MOI). Infection
was initiated by centrifuging the plates for 5 min and placing them at
37 °C for the indicated timeperiods. Extracellular bacteriawere killedby
adding gentamycin (50 μg/ml) 30 min after infection.
2.7. Immunofluorescence
Cells were fixed in 4% paraformaldehyde in PBS. For p-JNK staining,
cells were permeabilized in 0.3% Triton X-100 in PBS and subse-
quently blocked using 5% goat serum in PBS. Cells were incubated
with p-JNK antibody in 10% goat serum in PBS overnight. For NF-κB
and phospho-p38 staining, cells were permeabilized and blocked in
0.3% Triton X-100 5% goat serum in PBS for one hour. Subsequently,
cells were incubated with the appropriate primary antibody in 0.3%
Triton X-100 5% goat serum in PBS overnight followed, by incubation
with Alexa 647- or Alexa 488-conjugated secondary antibodies. In
addition, cells were stained with Hoechst to visualize nuclei.
2.8. Automated microscopy and image analysis
Images were automatically acquired with an ImageXpress Micro
(Molecular devices, Sunnyvale, USA). At each site, images at 360 nm,
480 nm, 594 nmand 640 nmwere acquired to visualizeHoechst, DsRed
expressing S.flexneri andAlexa647- orAlexa 488-conjugated secondary
antibodies. Image analysis was performed with CellProfiler [20]. The
activation of NF-κBwas determined by calculating the nuclear/cytosolic
intensity ratio of the NF-κB p65 staining as previously described [18].
2.9. Subcellular fractionation
Preparation of nuclear proteins was adapted from Mattioli et al.
[21]. Briefly, cells were lysed in buffer A (10 mM HEPES/KOH, pH 7.9,
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10 mM KCl, 0.1 mM EDTA, 1 mM DTT, and 0.5 mM PMSF). After
incubation at 4 °C for 20 min, TritonX-100 (final concentration: 0.25%)
was added to the lysates. The sampleswere then centrifuged for 30 s at
16,000 g and the pellets dissolved in 40 μl of buffer C (20 mM HEPES/
KOH, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM DTT, 0.5 mM PMSF).
Samples were incubated on ice for 15 min and frequently vortexed.
Subsequently, samples were centrifuged for 20 min at 16,000 g.
Supernatants were transferred into fresh tubes. Protein concentration
was determined by BCA Protein Assay kit. Equal amounts of protein
were subjected to SDS page.
2.10. Quantitative real-time PCR
The level of c-JunmRNAwasmeasured by quantitative real-time PCR
(qRT-PCR) as follows. Total RNA was isolated from cells infected with
ΔvirG and ΔvirG ΔospF S. flexneri for 1 h using the RNeasy Mini Kit
(Qiagen). Total RNA was reverse transcribed using oligo(dT)15 primer
(Promega) with Superscript III reverse transcriptase (Invitrogen). qRT-
PCR was performed on StepOne Real time PCR system (Applied
Biosystems)using theSYBRgreenPCRMasterMix (AppliedBiosystems).
GAPDH was used as an internal control to normalize mRNA expression.
Eachsamplewas analyzed in triplicate. Theprimer sequencesused are as
follows. c-Jun-forward: 5′-AGGAGGAGCCTCAGACAGTG; c-Jun-reverse:
5′-AGCTTCCTTTTTCGGCACTT;GAPDH-forward: 5′-GAAGGTGAAGGTCG-
GAGTC; GAPDH-reverse: 5′-GAAGATGGTGATGGGAT TTC.
2.11. Statistical analysis
Data presented in themanuscript are representative of at least three
independent experiments. Data are expressed as mean±standard
deviation of triplicate samples or as indicated in the figure legends.
p values were calculated with a two-tailed two-sample equal variance
t-test.
3. Results
3.1. OspF dephosphorylates p38 and potentiates the activation of JNK
The activation of the JNK signaling pathway is critical to mount an
inflammation response against S. flexneri infection [22]. Therefore, in
order to characterize the impact of OspF on inflammation signaling,we
examined whether OspF affected the activation of JNK during infection.
The effect of OspF on the activation of p38 was analyzed in parallel for
comparison. To avoid secondary invasion resulting from intercellular
bacterial motility that would complicate the analysis of time course
experiments, the non-motile virG deletion mutant (ΔvirG) [23] was
used as the reference background strain in the entire study. The
activation of p38 and JNK was analyzed by western immunoblotting at
different time-points after infection of HeLa epithelial cells with
S. flexneri ΔvirG or with a virG ospF double deletion mutant (ΔvirG
ΔospF). Phospho-specific antibodies that detect p38 phosphorylated at
residues threonine 180 and tyrosine 182 (p-p38) and p46 and p54 JNKs
phosphorylated at residues threonine 183 and tyrosine 185 (p-JNKs) of
the activation loop were used. As previously described [16,17], no
detectable phosphorylation of p38 was found in cells infected with
ΔvirG S. flexneri (Fig. 1A, upper panel) whereas massive p-p38 was
found during infection with ΔvirG ΔospF (Fig. 1A, lower panel),
confirming the role of OspF in the dephosphorylation of p38 during
S. flexneri infection. Surprisingly, in contrast to p38, the phosphorylation
of both p46 and p54 JNKs was more prolonged in cells infected with
ΔvirG bacteria compared to ΔvirG ΔospF infected cells (Fig. 1B and C),
showing for the first time, that OspF positively regulated JNK signaling
during infection. This result was unexpected given that the phospho-
threonine lyase activity of OspF was reported to also dephosphorylate
JNK in a cell transfection assay [17]. The effects of OspF on p38 and JNK
activation were confirmed by immunofluorescence microscopy experi-
ments using the phospho-specific antibodies described above.Whereas
almost no p-p38 staining was found in cells infected with dsRed-
expressing S. flexneri ΔvirG (Fig. 1D, middle panel), high nuclear p-JNK
intensitywas still detected90 minafter infection (Fig. 1E,middle panel).
In contrast, p38 phosphorylation was found in cells infected with ΔvirG
ΔospF (Fig. 1D, right panel), but these cells exhibited a weak p-JNK
staining (Fig. 1E, right panel), indicating that OspF induced a sustained
activation of JNK during infection. Taken together, these data confirm
the inhibitory effect of OspF on p38 and show that OspF enhances JNK
activation during S. flexneri infection of epithelial cells.
3.2. OspF enhances the activation of NF-κB induced by S. flexneri
infection and TNF-α stimulation
In addition to JNK and p38, the activation of the transcription factor
NF-κB is critical during S. flexneri infection to induce the expression of
various proinflammatory genes and to promote host cell survival [24].
The NF-κB pathway is turned on downstream of peptidoglycan
recognition via Nod1 and the subsequent activation of TAK1 and the
IKK complex. To investigate the effect of OspF onNF-κBduring infection,
we examined the impact of this effector on the translocation of the
NF-κB subunit p65, resulting from the phosphorylation and degradation
of IκB proteins initiated by the IKK complex [15]. The localization of p65
was first addressed by immunofluorescence microscopy with a p65
antibody. In uninfected cells, p65 was found in the cytoplasm (Fig. 2A,
left panel), indicating that NF-κB was inactive. As expected, cells
infected with S. flexneri ΔvirG for 90 min exhibited a strong nuclear
translocation of p65 (Fig. 2A, middle panel). Interestingly, the nuclear
localization of p65 in cells infected with ΔvirG ΔospF bacteria wasmore
modest (Fig. 2A, rightpanel). Quantificationofp65nuclear translocation
at different time-points, by calculation of the nuclear/cytoplasmic p65
intensity ratio with automated image processing, indicated that,
whereas initial p65 translocation was similar in ΔvirG and ΔvirG
ΔospF infected cells, a more transient nuclear localization was observed
afterΔvirGΔospF infection (Fig. 2B). A similar result was obtainedwhen
monitoring the nuclear localization of p65 by western blot analysis in
nuclear extracts of infected cells (Fig. 2C), showing that, in contrast to its
inhibitory activity on p38, OspF enhances NF-κB activation following
S. flexneri infection. During bacterial challenge, epithelial cells are
exposed tomicrobial products including peptidoglycan and LPS but also
to proinflammatory cytokines, such as tumor necrosis factor alpha
(TNF-α), that also induce NF-κB activation. To better characterize the
modeof actionofOspFonNF-κBactivation,we testedwhetherOspFalso
potentiated the activationofNF-κB triggeredbyTNF-α. For this purpose,
HeLa cells were transiently transfected with an empty vector or a
plasmid encoding OspF, and stimulated with TNF-α. Το verify the
activity of ectopic OspF expression on cell signaling, we first examined
its effect on the phosphorylation of p38 induced by TNF-α stimulation
(Fig. 2D, upper panel). Whereas p-p38 was detected in TNF-α-
stimulated cells transfected with the empty vector, almost no
phosphorylation was detected in cells expressing OspF, confirming
that this effector inhibited TNF-α-induced p38 activation. We then
tested the activity of OspF on TNF-α-induced NF-κB activation by
monitoring the degradation of IκBα after stimulation. We found that
OspF effectively potentiated the degradation of IκBα after TNF-α
stimulation (Fig. 2D, lower panel), indicating that the expressionofOspF
was sufficient to enhance NF-κB signaling in cells. Taken together, these
data show that OspF potentiates the activation of JNK and NF-κB, and
that this effector has thus a broad impact on inflammation signaling
during bacterial infection.
3.3. OspF potentiates the activation of JNK by a p38-dependent
mechanism
OspF harbors a phosphothreonine lyase activity that removes the
phosphate group of threonine residues present in the activation loop
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of MAPKs [17]. As p38 is an important target of OspF, we tested
whether the potentiation of JNK activation by OspF was dependent on
p38. To test this hypothesis, we investigated by western blot analysis
the phosphorylation of JNKs during infection of mouse embryonic
fibroblasts wild-type (wt MEFs) or deficient for p38α (p38−/−MEFs)
previously described by Ambrosino et al. [25]. In line with the data
obtained in HeLa cells, the phosphorylation of p46 and p54 JNKs was
more sustained after ΔvirG than ΔvirG ΔospF infection in wt MEFs
(Fig. 3, left panels), indicating that the positive regulation of JNK by
OspF was not restricted to HeLa cells but corresponded to a general
regulation mechanism. In contrast, the profile of JNK activation was
similar after ΔvirG and ΔvirG ΔospF infection in p38−/− MEFs,
showing that OspF had no effect on JNK in absence of p38 (Fig. 3,
right panels) and therefore, that OspF regulated the activation of JNK
via a p38-dependent mechanism. Whereas wt MEFs infected with
ΔvirG ΔospF bacteria showed a transient JNK activation (Fig. 3, bottom
left panel), sustained activation was found in wt MEFs infected with
ΔvirG (Fig. 3, top left panel) and in p38−/−MEFs infected with ΔvirG
(Fig. 3, top right panel) or ΔvirG ΔospF bacteria (Fig. 3, bottom right
panel). As these conditions corresponded to high and low/no p38
Fig. 1. OspF dephosphorylates p38 and potentiates JNK activation. (A) OspF dephosphorylates p38 in infected cells. Whole cell lysates from HeLa cells, infected at MOI=40 with
S. flexneri ΔvirG or ΔvirG ΔospF for indicated time periods, were analyzed by western immunoblotting using a phospho-specific antibody that detects p38 phosphorylated at
threonine 180 and tyrosine 182 residues (p-p38). Total p38 was used as loading control. (B) OspF prolongs the activation of JNK during infection. Lysates from HeLa cells infected at
MOI=40with S. flexneri ΔvirG orΔvirGΔospF for indicated time periods were analyzed bywestern immunoblotting using a phospho-specific antibody that detects p46 and p54 JNKs
phosphorylated at residues threonine 183 and tyrosine 185 (p-p46 and p-p54 JNKs). Actin was used as loading control. (C) Densitometric quantification of phosphorylated p46
(lower panel) and p54 (upper panel) JNKs at different time-points of ΔvirG or ΔvirG ΔospF infection based on western blot analysis shown in (B); graph representative of 3
independent experiments. (D) Analysis of p38 phosphorylation by immunofluorescence microscopy. HeLa cells were mock treated (control) or infected with S. flexneri ΔvirG or
ΔvirG ΔospF at MOI=30 for 60 min. After fixation, cells were stained for p-p38 and DNA (Hoechst). In overlay images, p-p38 is in green, S. flexneri in red. (E) Analysis of JNK
phosphorylation by immunofluorescence microscopy. HeLa cells were mock treated (control) or infected with ΔvirG or ΔvirG ΔospF S. flexneri at MOI=30 for 90 min. After fixation,
cells were stained for p-JNK and DNA (Hoechst). In the overlay images, p-JNK is in green, S. flexneri in red; scale bars, 20 μm.
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activation respectively, these data suggested that activated p38
inhibited JNK and therefore, that OspF potentiated JNK signaling
through its inhibitory effect on p38. Taken together, these data
demonstrate that OspF upregulates the activation of JNK via a p38-
dependent mechanism, suggesting that OspF affects JNK signaling
indirectly via its phosphothreonine lyase activity on p38. In addition,
these results also provide evidence for a new crosstalk between the
p38 and JNK pathways during S. flexneri infection.
3.4. OspF potentiates the activation of JNK and NF-κB by disrupting a
p38/TAK1 negative feedback loop regulation
In order to determine howOspF potentiated the activation of NF-κB
and JNK while dephosphorylating p38, we examined the upstream
mechanisms controlling these pathways during infection. It has been
proposed that the activation of NF-κB, p38, and JNK occurs down-
stream of TAK1 activation following peptidoglycan recognition via
Fig. 2. OspF potentiates the activation of NF-κB after S. flexneri infection or TNF-α stimulation. (A) Localization of NF-κB p65 in response to S. flexneri infection. HeLa cells were mock
treated (control) or infected at MOI=40 with ΔvirG or ΔvirG ΔospF S. flexneri for 90 min. After fixation, cells were stained with a p65 antibody. In overlay images, p65 is in red,
S. flexneri in green; scale bar, 20 μm. (B) Quantification of the nuclear translocation of p65 by automated image analysis at different time-points of infection. The nuclear/cytoplasmic
p65 intensity ratio was calculated as described in Materials and methods. The data shown are mean values +/− SD of 4 wells per condition; graph representative of 3 independent
experiments; *p=8.73E−03, **p=9.60E−03, ***p=6.31E−05. (C) NF-κB p65 nuclear localization analyzed by western immunoblotting after cell fractionation. Nuclear extracts
from HeLa cells infected at MOI=40 with ΔvirG or ΔvirG ΔospF S. flexneri for indicated time periods were analyzed by western immunoblotting using a p65 antibody. The nuclear
protein Lamin B was used as loading control. (D) Effects of OspF on the activation of p38 and NF-κB upon TNF-α stimulation. Lysates from HeLa cells, transiently transfected with an
empty vector or OspF containing plasmid (pOspF) and stimulatedwith TNF-α for indicated time periods, were analyzed bywestern immunoblotting. The activation of p38 and NF-κB
was analyzed by detecting p-p38 (upper panel) and IκBα (lower panel), respectively. Actin was used as loading control.
Fig. 3. OspF potentiates the activation of JNK via a p38-dependent mechanism. Whole cell lysates from wt MEFs (left panels) and p38−/−MEFs (right panels) infected at MOI=40
with S. flexneri ΔvirG (upper panels) or ΔvirG ΔospF (lower panels) for indicated time periods were analyzed by western immunoblotting using a phospho-specific antibody that
detects p46 and p54 JNKs phosphorylated at residues threonine 183 and tyrosine 185 (p-p54 and p-p46 JNKs). Actin was used as loading control.
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Nod1 [26]. As peptidoglycan recognition is the main pathway leading
to inflammation signaling during S. flexneri infection [10], it was
expected that TAK1 controls the downstream activation of p38, JNK
and NF-κB during infection. This assumption was directly tested by
monitoring the activation of p38, JNK and NF-κB in HeLa cells depleted
of TAK1 by RNA interference (RNAi). The activation of p38 and JNKwas
examined by western blot analysis using the phospho-specific
antibodies described above. The activation of NF-κB was analyzed by
measuring the degradation of IκBα. To prevent the dephosphorylation
of p38 by OspF, the effect of TAK1 knockdown on the activation of p38
was examined in cells infected with ΔvirG ΔospF bacteria. For the
analysis of JNK andNF-κB activation, cellswere infectedwith S. flexneri
ΔvirG. Knocking down TAK1 reduced the activation of p38 (Fig. 4A)
and JNK (Fig. 4B), as well as the degradation of IκBα (Fig. 4B) induced
by infection, confirming that p38, JNK and NF-κB were activated
downstream of TAK1 during S. flexneri infection.
As NF-κB and JNK are activated downstream of TAK1 and are both
positively regulated by OspF, we tested whether OspF directly
potentiated TAK1 activation during S. flexneri infection. HeLa cells
were infected with ΔvirG or ΔvirG ΔospF bacteria and the activation of
TAK1 was analyzed by western immunoblotting using a phospho-
specific antibody that detects TAK1phosphorylated in its activation loop
at threonine 187 [27]. As expected, TAK1 phosphorylation was induced
during ΔvirG infection (Fig. 4C). Interestingly, a more modest
phosphorylation was found in cells infected with ΔvirG ΔospF
(Fig. 4C), showing that OspF potentiated TAK1 activation during
infection. Because cells infected with S. flexneri ΔvirG ΔospF exhibited
a high degree of p38 activation (Fig. 1A), we tested whether the low
level of TAK1 activation observed in these cells was caused by p38. We
addressed this question by monitoring the phosphorylation of TAK1 in
HeLa cells depleted of p38 byRNAi afterΔvirGΔospF S. flexneri infection.
Knockingdownp38 increased TAK1phosphorylation (Fig. 4D), showing
that p38 negatively regulates TAK1 during S. flexneri infection. As OspF
blocks p38 activation, these results suggested that OspF potentiated
TAK1 indirectly via its phosphothreonine lyase activity on p38.
Based on the observation that TAK1 functions upstream of p38
activation during infection and the data showing that, TAK1 activation
was negatively regulated by a p38-dependent mechanism, we
Fig. 4. OspF potentiates the activation of JNK and NF-κB by blocking the p38/TAK1 negative feedback loop. (A) Effect of TAK1 knockdown on S. flexneri infection-induced p38
activation. HeLa cells, transfected with control or TAK1 siRNAs, were infected at MOI=40with ΔvirG ΔospF S. flexneri for indicated time periods. Whole cell lysates were analyzed by
western immunoblotting for p-p38. Actin was used as loading control. (B) Effect of TAK1 knockdown on S. flexneri infection-induced JNK activation and IκBα degradation. HeLa cells,
transfected with control or TAK1 siRNAs, were infected at MOI=40 with ΔvirG S. flexneri for indicated time periods. Whole cell lysates were analyzed by western immunoblotting
using indicated antibodies. Actin was used as loading control. (C) Effect of OspF on TAK1 activation during S. flexneri infection.Whole cell lysates fromHeLa cells, infected atMOI=40
with S. flexneri ΔvirG or ΔvirG ΔospF for indicated time periods, were analyzed by western immunoblotting using a phospho-specific antibody that detects TAK1 phosphorylated at
threonine 187 (p-TAK1). Cells treated with assay medium (AM) were used as control. Total TAK1 and actin were used as loading control. (D) Effect of p38 knockdown on the
activation of TAK1 induced byΔvirGΔospF infection. Whole cell lysates from HeLa cells, infected at MOI=40with S. flexneri ΔvirGΔospF for indicated time periods, were analyzed by
western immunoblotting using a p-TAK1 antibody. (E) Effect of OspF on TAB1 activation during S. flexneri infection. Whole cell lysates from HeLa cells, infected at MOI=40 with S.
flexneri ΔvirG or ΔvirG ΔospF for indicated time periods, were analyzed by western immunoblotting using a phospho-specific antibody that detects TAB1 phosphorylated at serine
423 (p-TAB1). Cells treated with assay medium (AM)were used as control. Actin was used as loading control. (F) Effect of p38 knockdown on the activation of TAB1 induced byΔvirG
ΔospF infection. Whole cell lysates from HeLa cells, infected at MOI=40 with S. flexneri ΔvirG ΔospF for indicated time periods, were analyzed by western immunoblotting with a p-
TAB1 antibody. Actin was used as loading control.
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hypothesized that p38 negatively regulated TAK1 activation via a
negative feedback loop. A similar negative feedback regulation between
p38 and TAK1 was previously reported [28]. The authors showed that
p38 suppresses the activity of TAK1 by phosphorylating TAB1 at serine
423. To test whether this feedback mechanism was effective during
S. flexneri infection and could explain the activity of OspF on TAK1
activation, we compared the phosphorylation of TAB1 in HeLa cells
infected with ΔvirG or ΔvirG ΔospF S. flexneri by western immunoblot-
ting using a phospho-specific antibody that detects TAB1 phosphory-
lated at serine 423 (p-TAB1). Residual p-TAB1 was found in untreated
cells whereas almost no signal was detected after infection with ΔvirG
bacteria (Fig. 4E). In contrast, higher phosphorylation was induced by
ΔvirG ΔospF infection (Fig. 4E), showing that OspF blocks the
phosphorylation of TAB1 during infection and suggesting that OspF
potentiates TAK1 activation by preventing the phosphorylation of TAB1
by p38. This hypothesis was directly tested by examining whether the
phosphorylation of TAB1 found in ΔvirG ΔospF infected cells was
reduced after p38 knockdown. A reduction of p-TAB1was found in p38-
depleted cells compared to control cells (Fig. 4F). This result indicated
that the high level of p-TAB1 found in ΔvirG ΔospF infected cells was
dependent on p38 and therefore, that OspF prevented the phosphor-
ylation of TAB1 via its phosphothreonine lyase activity on p38
activation. Taken together, these data show that OspF potentiates the
activation of TAK1 and the downstream activation of NF-κB and JNK, by
disrupting the negative feedback loop between p38 and TAK1, which is
mediated via the phosphorylation of TAB1.
3.5. OspF blocks c-Jun expression at the transcriptional level
As OspF strongly potentiated JNK activation during S. flexneri
infection, we investigated the impact of this effector on the phosphor-
ylation of c-Jun, a pivotal JNK substrate involved in various JNK-
dependent biological processes including inflammatory responses,
apoptosis, survival and cell cycle. c-Jun is a member of the AP-1 family
of transcription factors and is phosphorylated on serine 63 and serine
73 within its N-terminal region by JNKs. The phosphorylation of c-Jun
was analyzed by western immunoblotting using a phospho-specific
antibody that detects c-Jun phosphorylated at serine 63. Surprisingly,
the amount of phosphorylated c-Jun was lower in cells infected with
ΔvirG S. flexneri compared to cells infected with ΔvirG ΔospF bacteria
(Fig. 5A). A reduced level of total c-Jun was also found after ΔvirG
infection compared to ΔvirG ΔospF (Fig. 5A), showing that OspF
negatively regulates c-Jun signaling during S. flexneri infection. c-Jun
expression is regulated at the transcriptional and posttranscriptional
level. For the latter, the phosphorylation of c-Jun by JNK at serine 63
stabilizes c-Jun proteins by inhibiting ubiquitin-dependent degradation
[29]. The effect of OspF on c-Jun expressionmay therefore be explained
by an inhibition of c-Jun transcription or a defect in the stability of c-Jun
proteins. In order to test whether OspF had an effect on the
transcription of c-Jun, the level of c-Jun mRNA was analyzed by
quantitative real-time PCR in control uninfected,ΔvirG andΔvirGΔospF
infected cells. An increase of c-Jun mRNA was found after one hour of
infection (Fig. 5B), confirming that c-Jun is an early gene induced upon
S. flexneri infection in epithelial cells. Interestingly, the level of mRNAs
was more strongly induced after ΔvirG ΔospF than ΔvirG infection,
indicating that OspF prevented the transcription of c-Jun. Taken
together, these results show that, although OspF potentiates the
activation of JNK, it negatively regulates c-Jun signaling by strongly
inhibiting the transcription of c-Jun. As c-Jun is an important
transcription factor for the regulation of proinflammatory genes such
as IL-8 [30], these data reveal a new mechanism by which OspF blocks
inflammation signaling in S. flexneri infected cells.
Fig. 5. OspF blocks the transcription of c-Jun during S. flexneri infection. (A) Effect of OspF on the phosphorylation and expression of c-Jun during S. flexneri infection. Whole cell
lysates from HeLa cells, left untreated or infected at MOI=40 with S. flexneri ΔvirG or ΔvirG ΔospF for indicated time periods, were analyzed by western immunoblotting using a
phospho-specific antibody that detects c-Jun phosphorylated at serine 63 (p-c-Jun) or a c-Jun antibody detecting total c-Jun. Actin was used as loading control. (B) Effect of OspF on
the level of c-Jun mRNA during S. flexneri infection. Quantification of c-Jun mRNA was measured by quantitative real-time PCR after 1 h of infection with ΔvirG or ΔvirG ΔospF
S. flexneri. Uninfected cells were used as control. Values represent relative quantities (RQ)±RQmax and RQmin of triplicate samples and indicate c-JunmRNA expression relative to
assay medium stimulated cells after normalization to GAPDH mRNA levels; graph representative of 3 independent experiments. (C) Model describing the impact of OspF on
inflammation signaling during S. flexneri infection.
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4. Discussion
Immune responses to bacterial infection are controlled by the
complexmolecular interactions that occur between the host signaling
network and various bacterial products present at the surface of
bacteria or released during infection. Structural components including
LPS, peptidoglycan and lipoproteins as well as numerous bacterial
proteins interact with specific receptors or signaling pathways and
trigger or shape specific facets of host defense. In the case of S. flexneri
infection, multiple T3S effectors interfere with the inflammatory
response of infected epithelial cells, which is mainly triggered after
recognition of peptidoglycan released by intracellular bacteria.
Among these effectors, OspF is one the best characterized [17]. This
effector protein harbors a phosphothreonine lyase activity that
mediates irreversible dephosphorylation of MAP kinases and con-
tributes to the repression of NF-κB-regulated genes by blocking the
phosphorylation of histone H3 and thereby affecting chromatin access
to transcription factors [16]. Here we broadly analyzed the impact of
OspF on inflammation signaling, and in particular, examined whether
OspF also affected the JNK and NF-κB pathways, which are also critical
to mount an inflammation response during bacterial infection.
Interestingly, we found that in addition to the inhibition of p38 and
ERK activation, OspF potentiates the activation of JNK during
infection. Indeed, both p46 and p54 JNKs were more strongly
activated after infection with an OspF deletion mutant. Interestingly,
our data showed that the initial peak of activation was not affected by
OspF but instead that OspF was required to obtain a prolonged JNK
activation. This result was unexpected as a phosphothreonine lyase
activity of OspF towards JNK has been reported in vitro or in a cell
transfection assay [17]. In addition to potentiating the activation of
JNK, our data showed that OspF also enhanced the activation of NF-κB
during S. flexneri infection or after stimulation with the proinflam-
matory cytokine TNF-α. These results were also surprising because
several S. flexneri T3S effectors tend to block the activation of NF-κB
during infection. For example, the protein OspG inhibits the activity of
ubiquitinated E2s (Ub conjugating enzymes) that are essential for the
ubiquitination of phospho-IκBα by E3 ubiquitin ligase SCFβ-TrCP,
thereby preventing NF-κB activation [31]. The effector IpaH9.8
inhibits the NF-κB pathway by targeting the essential scaffolding
protein of the IKK complex NEMO/IKKγ for proteasome-dependent
degradation after polyubiquitination [32]. Finally, it has been recently
reported that the effector OspZ, present as a full length protein in
S. flexneri 6 but not in S. flexneri 2a, also inhibits the activation of NF-κB
during infection by a mechanism that remains unclear [33]. It is
interesting to note that despite these effectors (at least OspG and
IpaH9.8 in S. flexneri 2a), we found that the nuclear translocation of
p65 during S. flexneri infectionwas still robust. This observation favors
a model where the activation of NF-κB results from a fine balance
between the inhibitory activities of OspG and IpaH9.8 and the positive
regulation caused by OspF. As blocking NF-κB signaling seems to
correspond to one of the strategies selected throughout evolution by
S. flexneri to dampen inflammation in response to infection, we
hypothesized that the positive effect of OspF reflected an indirect
consequence of its phosphothreonine lyase activity on MAPKs.
We validated this assumption by demonstrating that the effect of
OspF on JNK signaling was dependent on p38. Indeed, we found that
OspF failed to affect the level of JNK activation in cells deficient for p38.
Furthermore, we showed that high p38 activity during infection was
associated with transient JNK activation whereas no/low activity,
found in wt MEFs infected with ΔvirG bacteria or in p38−/−MEFs, was
associated with sustained JNK activation. These results indicated that
p38 negatively regulates JNK, and that OspF affects JNK signaling
indirectly via its phosphothreonine lyase activity on p38. In addition to
unraveling a new activity of OspF on host signaling, these data also
reveal a newcrosstalk betweenp38 and JNKpathways during bacterial
infection in epithelial cells. Crosstalks between signaling pathways are
a common theme in cellular signaling. JNK and p38, which share
common upstream regulators, are activated simultaneously in
response to many stimuli, including cytokines, UV light or osmotic
stress. Although they can synergize for the activation of AP-1 [34], they
often have opposite effects. For example, JNK and p38 exert opposing
effects on the development ofmyocyte hypertrophy [35] and inmouse
models of liver cancer [36]. In addition to crosstalks taking place at the
level of downstream targets, it has been reported that p38 can also
negatively regulate JNK activity. The first evidence for this crosstalk
was the observation that chemical inhibition of p38, with the
commonly used p38 inhibitor SB203580, strongly increased the
activation of JNK induced by interleukin-1 and sorbitol in epithelial
cells, and by LPS inmacrophages [28]. As SB203580 also inhibits RIPK2
[37], an upstream kinase essential for S. flexneri-induced inflammation
signaling, this drug could not be used in our study. Instead, the
crosstalk between p38 and JNKwas unraveled by combining the use of
OspF, which functions as an irreversible p38 inhibitor, and p38−/−
MEFs or RNAi, which are needed to confirm that the effect of OspF
results from its activity towards p38.
Because JNK and NF-κB were both potentiated by OspF, we tested
whether this effect was mediated by an effect of OspF on the upstream
common kinase TAK1. Following peptidoglycan recognition, the
receptor Nod1 undergoes oligomerization and this mechanism leads
to the subsequent recruitment of the kinase RIPK2 and the activation of
TAK1. TAK1 functions as a MAP3K upstream of p38 and JNK, and
phosphorylates IKKβ leading to NF-κB activation. We confirmed that
TAK1 functions upstream of JNK, NF-κB and p38 activation during
S. flexneri infection by showing that the activation of these pathways
was impaired in TAK1-depleted cells. Furthermore, we found that OspF
enhanced the activation of TAK1 during infection, suggesting that the
potentiation of JNK and NF-κB pathways by OspF is mediated by its
effect on TAK1. Finally,we showed that the reduction of TAK1 activation
found in cells infected with ΔvirG ΔospF bacteria is dependent on the
expression of p38, as high TAK1 phosphorylation was restored when
p38 expression was reduced by RNAi. As TAK1 functions upstream of
p38, JNK and NF-κB activation, and because the activation of TAK1
depends onp38during infection, ourdata suggested that p38negatively
regulated TAK1 via a negative feedback loop. This hypothesis was
further demonstrated by showing that p38 phosphorylates TAB1, a
mechanism that inhibits the activation of TAK1 [28]. Therefore, we
propose that OspF, via its phosphothreonine lyase activity which
dephosphorylates p38, disrupts the negative feedback loop occurring
between p38 and TAK1, resulting in enhanced TAK1 activation and
sustained JNK and NF-κB activation. A model based on these data is
illustrated in Fig. 5C.
JNK and NF-κB are two pathways important for the regulation of
various cellular responses during infection, including inflammation,
apoptosis and cell survival [24,38]. An increase in NF-κB activation by
OspF could be associatedwith enhanced inflammation or a better host
cell survival to infection. However, as OspF also impairs the accessi-
bility of chromatin to transcription factors [16], the positive regulation
of OspF on NF-κB activation may stay functionally silent. Sustained
activation of JNK is usually associated with an increase of apoptosis
[39], suggesting that OspFmay indirectly affect the survival of infected
cells. To test whether OspF affected the signaling pathways down-
stream of JNK, we examined its effect on c-Jun, which is involved in
the regulation of many functions controlled by JNK. Interestingly, we
found that although OspF potentiated the activation of JNK, it reduces
the amount of phosphorylated c-Jun. This effect wasmost likely due to
the fact that OspF affects the transcription of c-Jun and therefore, that
less proteins are produced when OspF is secreted. Taken together,
these data suggest that, in addition to the well characterized effect of
OspF on IL-8 expression [16], OspF also impairs IL-8 expression by
reducing the expression of c-Jun, an immediate-early gene whose
product c-Jun functions as an essential transcription factor for IL-8
expression [30] (Fig. 5C). More work is needed to elucidate how OspF
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blocks c-Jun transcription. We hypothesize that this may also be a
consequence of reduced histone H3 phosphorylation, which is
required for efficient c-Jun transcription [40,41] (Fig. 5C).
Because the host signaling pathways are highly interconnected,
targeting a host protein has multiple consequences within the
signaling network. As a general strategy, targeting the center of a
negative feedback regulation in the host signaling network leads to
the indirect regulation of multiple linked signaling pathways. When
these indirect effects are beneficial or functionally silent, they may
favor or not interfere with the evolutionary-driven selection process
of the optimum host target. Conversely, when they turned out to be
detrimental to the pathogen, they may contribute to counter-select a
specific pathogenic strategy.
5. Conclusion
In conclusion, our data show that OspF has a complex impact on
host signaling during infection. We found that, whereas OspF
dephosphorylates p38, this effector potentiates the activation of JNK
and NF-κB. This unexpected effect results from the disruption of a
negative feedback loop between p38 and TAK1, which is mediated via
the phosphorylation of TAB1 during infection. In addition, OspF
inhibits c-Jun expression at the transcriptional level. Taken together,
our data reveal new insights into the impact of OspF on host signaling
during infection by S. flexneri and validate the use of bacterial effectors
as molecular tools to identify the crosstalks that connect signaling
pathways during bacterial infection.
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Abbreviations
Abl v-abl Abelson murine leukemia viral oncogene homolog
AD acid transactivation domain
Afa afimbrial adhesin
AIM absent in melanoma
Akt v-akt murine thymoma viral oncogene homolog
AMP antimicrobial peptide
AP-1 activator protein 1
APC antigen-presenting cell
ASC apoptosis-associated speck-like protein containing a CARD
Atg autophagy related homolog
BIR baculoviral inhibitory repeat
cAMP cyclic adenosine monophosphate
CARD caspase recruitment domain
CCL chemokine (C-C motif) ligand
Cdc cell division cycle
cGMP cyclic guanosine monophosphate
CHUK conserved helix-loop-helix ubiquitous kinase
cIAP inhibitor of apoptosis protein homolog C
CIITA MHC class II transactivator
CLR C-type lectin receptor
Crk v-crk sarcoma virus CT10 oncogene homolog
Cx43 Connexin43
CXCL chemokine (C-X-C motif) ligand
-132- V. Abbreviations
DAMP danger-associated molecular pattern
DC dendritic cell
DILI drug-induced liver injury
dsDNA double-stranded DNA
EGF epidermal growth factor
EGFP enhanced green fluorescent protein
EGFR EGF receptor
ER endoplasmatic reticulum
ERK extracellular signal-regulated kinase
Esp E. coli secreted protein
F-actin filamentous actin
FAK focal adhesion kinase
FIIND function-to-find domain
FKHR forkhead in rhabdomyosarcoma
GAP GTPase-activating protein
GEF guanine-nucleotide exchange factor
GFP green fluorescent protein
GSK3 glycogen synthase kinase 3
GTPase guanosine triphosphatase
HIN200 hematopoietic expression, IFN-inducible, nuclear localization and length of
200 amino acids
HPLC high-performance liquid chromatography
IAP inhibitor of apoptosis protein
Ics intracellular spread
IEC intestinal epithelial cell
iE-DAP γ-D-glutamyl-meso-diaminopimelic acid
IκBα Inhibitor of NF-κB α
IKK inhibitor of κ light polypeptide gene enhancer in B-cells kinase
IL interleukin
IL-8 interleukin-8
V. Abbreviations -133-
INF interferon
Inl internalin
IP3 inositol-trisphosphate
Ipa invasion plasmid antigens
Ipg invasion plasmid gene
IRAK IL-1 receptor-associated kinase
IRF interferon regulatory factor
ISGF interferon-stimulated gene factor
JNK JUN N-terminal kinase
LPS lipopolysaccharide
LRR leucine-rich repeat
M cells microfold cells
Mad2L2 mitotic arrest deficient 2-like protein 2
MAP2 kinase mitogen-activated protein kinase kinase
MAP3 kinase mitogen-activated protein kinase kinase kinase
MAP kinase mitogen-activated protein kinase
MAVS mitochondrial antiviral signaling protein
MD-2 myeloid differentiation protein-2
MDP muramyl dipeptide
MEFs mouse embryonic fibroblasts
MEKK MAP/ERK kinase kinase
Met met proto-oncogene
MLC myosin light chain
MOI multiplicity of infection
MS/MS tandem mass spectrometry
MSK mitogen- and stress-activated kinase
MurNAc N-acetyl muramic acid
Mxi membrane expression of Ipa
MyD88 myeloid differentiation primary response gene (88)
-134- V. Abbreviations
NACHT domain present in NAIP, CIITA, HET-E and TP-1
NAD NACHT-associated domain
NAIP neuronal apoptosis inhibitor protein
NBD nucleotide-binding domain
NEMO NF-κB essential modulator
NETs neutrophil extracellular traps
NF-κB nuclear factor of κ light polypeptide gene enhancer in B-cells
NK natural killer
NLR Nod-like receptor
NLRA acidic domain containing NLR
NLRB BIR domain containing NLR
NLRC CARD domain containing NLR
NLRP pyrin domain containing NLR
NLRX no strong N-terminal homology NLR
Nod nucleotide-oligomerization domain
N-WASP neural Wiskott-Aldrich syndrome protein
Osp outer Shigella proteins
PAMP pathogen-associated molecular pattern
PGRP peptidoglycan recognition protein
PI3K phosphoinositide-3-kinase
PIP phosphatidylinositol-5-phosphate
PIP2 phosphatidylinositol-4,5-bisphosphate
PKA protein kinase A
PKC protein kinase C
PKG protein kinase G
PLA2 phospholipase A2
PMN polymorphonuclear neutrophil
PRR pathogen recognition receptor
PtdIns phosphatidylinositol
V. Abbreviations -135-
PYD pyrin domain
Rac ras-related C3 botulinum toxin substrate
Rho ras homolog
RIP2 receptor-interacting protein 2
RLR RIG-I-like receptor
RNAi RNA interference
ROI reactive oxygen intermediate
ROS reactive oxygen species
RpoS RNA polymerase sigma factor S, sigma 38
SCID severe combined immunodeficient
SCV Salmonella-containing vacuole
Sip Salmonella invasion protein
siRNA small interfering RNA
Spa surface presentation of antigen
Src v-src sarcoma viral oncogene homolog
ssRNA single-stranded RNA
T3SS type III secretion system
T4SS type IV secretion system
TAB TAK1-binding protein
TAK1 Transforming growth factor-activated protein kinase 1
TBK1 TANK-binding kinase 1
TIR Toll-IL-1 receptor
TIRAP TIR domain containing adaptor protein
TLR Toll-like receptor
TNF tumor necrosis factor
TRAF TNF receptor-associated factor
TRAM TIR domain-containing adapter molecule
TRIF TIR domain containing adaptor inducing interferon-β
U2AF U2 small nuclear RNA auxiliary factor
-136- V. Abbreviations
UbcH5 ubiquitin-conjugating enzyme E2 D1
UPEC uropathogenic E. coli
Vir virulence
WASP Wiskott-Aldrich syndrome protein
YFP yellow fluorescent protein
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